Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,neutrophil degranulation (GO:0043312),0.692319635808533,3.2248308326058113,0.0,0.0,0.0,67/140,12.39%,ITGB2;ARPC5;CD47;CTSC;FTH1;RHOA;HMGB1;ACTR10;B2M;CNN2;TMEM30A;COTL1;RAP1B;CTSB;CYBA;ERP44;CAP1;NPC2;PSMA2;CSNK2B;GGH;SRP14;RAB5C;RAC1;IQGAP1;DYNLL1;COMMD3;DBNL;CTSA;PSMC3;PSMD13;PYCARD;DEGS1;ARL8A;GMFG;PRDX6;SURF4;SDCBP;MAN2B1;CSTB;GSTP1;PNP;RAB4B;ITGAL;LAMTOR3;HEXB;LAMTOR1;TRAPPC1;UNC13D;RAB18;RAB14;LAMTOR2;PSMB1;TBC1D10C;PAFAH1B2;PSEN1;ASAH1;LAMP2;GOLGA7;DNAJC3;LTA4H;GSDMD;ACTR1B;NDUFC2;COPB1;CAPN1;STXBP2
gsea,neutrophil activation involved in immune response (GO:0002283),0.6911818131682721,3.2129622826139728,0.0,0.0,0.0,67/141,12.39%,ITGB2;ARPC5;CD47;CTSC;FTH1;RHOA;HMGB1;ACTR10;B2M;CNN2;TMEM30A;COTL1;RAP1B;CTSB;CYBA;ERP44;CAP1;NPC2;PSMA2;CSNK2B;GGH;SRP14;RAB5C;RAC1;IQGAP1;DYNLL1;COMMD3;DBNL;CTSA;PSMC3;PSMD13;PYCARD;DEGS1;ARL8A;GMFG;PRDX6;SURF4;SDCBP;MAN2B1;CSTB;GSTP1;PNP;RAB4B;ITGAL;LAMTOR3;HEXB;LAMTOR1;TRAPPC1;UNC13D;RAB18;RAB14;LAMTOR2;PSMB1;TBC1D10C;PAFAH1B2;PSEN1;ASAH1;LAMP2;GOLGA7;DNAJC3;LTA4H;GSDMD;ACTR1B;NDUFC2;COPB1;CAPN1;STXBP2
gsea,cellular protein metabolic process (GO:0044267),-0.7961681932683426,-3.201700579091924,0.0,0.0,0.0,57/146,3.81%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;ABCA3;RPS6;SHISA5;MRPL9;MRPL52;UBA52;SIAH2;MRPL24
gsea,neutrophil mediated immunity (GO:0002446),0.6889019520048326,3.1923939511411494,0.0,0.0,0.0,76/143,16.43%,ITGB2;ARPC5;CD47;CTSC;FTH1;RHOA;HMGB1;ACTR10;B2M;CNN2;TMEM30A;COTL1;RAP1B;CTSB;CYBA;ERP44;CAP1;NPC2;PSMA2;CSNK2B;GGH;SRP14;RAB5C;RAC1;IQGAP1;DYNLL1;COMMD3;DBNL;CTSA;PSMC3;PSMD13;PYCARD;DEGS1;ARL8A;GMFG;PRDX6;SURF4;SDCBP;MAN2B1;CSTB;GSTP1;PNP;RAB4B;ITGAL;LAMTOR3;HEXB;LAMTOR1;TRAPPC1;UNC13D;RAB18;RAB14;LAMTOR2;PSMB1;TBC1D10C;PAFAH1B2;PSEN1;ASAH1;LAMP2;GOLGA7;DNAJC3;LTA4H;GSDMD;ACTR1B;NDUFC2;COPB1;CAPN1;STXBP2;FUCA2;SNAP29;VAPA;KMT2E;RAB31;APEH;DYNC1LI1;NCSTN;MAPK1
gsea,gene expression (GO:0010467),-0.820442753224816,-3.138860783301866,0.0,0.0,0.0,50/127,1.79%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6
gsea,cellular macromolecule biosynthetic process (GO:0034645),-0.8685789176852908,-3.0819664740427384,0.0,0.0,0.0,51/109,1.82%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6;EEF2
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.9382348187458563,-3.0420914745275955,0.0,0.0,0.0,54/89,2.08%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;TUT4;DDX5;NBDY;RPS6;EIF3E
gsea,cytokine-mediated signaling pathway (GO:0019221),0.6371729801550937,2.919753904797138,0.0,0.0,0.0,57/142,12.81%,IL2RB;ITGB2;CDC42;IFNGR1;SLA2;RBX1;PSMB8;UGCG;PSMB3;YWHAZ;B2M;CNN2;RAP1B;CRLF2;PSMA2;EGR1;CSNK2B;IL12RB1;TALDO1;CAPZA1;PSMB10;PSMA1;IL12RB2;MAPK3;STAT3;GRB2;AIP;PSMB9;PSMC3;PSMA7;ILK;PSMD13;PYCARD;UBE2V1;PSMB4;LIMS1;TRADD;PELI1;ARF1;SP100;BOLA2;INPP5D;PSMD9;RPS6KA4;JAK3;IFI35;IL2RG;TXNDC17;UBC;PSMB1;PITPNA;PSMF1;TGFB1;IL20RA;LCK;NOD1;IL3RA
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.7484896501745776,2.9045026568682277,0.0,0.0,0.0,26/50,11.72%,ID2;PSMB8;PSMB3;PSMA2;ANAPC11;PSMB10;PSMA1;DYNLL1;PSMB9;PSMC3;DCTN3;PSMA7;MAPRE1;PSMD13;PSMB4;SSNA1;PAFAH1B1;PSMD9;MAD2L1BP;UBC;PSMB1;UBE2D1;SIRT2;ANAPC2;PPP2R1A;PSMF1
gsea,positive regulation of intracellular protein transport (GO:0090316),0.7270286683251064,2.9003638972257355,0.0,0.0,0.0,33/62,16.22%,ITGB2;YWHAH;RAC2;YWHAZ;TMEM30A;SH3GLB1;UBL5;YWHAB;HCLS1;YWHAQ;UBE2L3;RAB29;OAZ1;CASP8;ITGB1BP1;EMD;LEPROT;SAR1B;PDCD10;TPR;GSK3A;PSEN1;TOMM7;B3GAT3;UBE2J2;SAR1A;SORL1;TGFB1;UBE2D3;PPP3CC;MIEF2;ARIH2;MFF
gsea,membrane organization (GO:0061024),0.6540771997647681,2.896604270239517,0.0,0.0,0.0,59/95,23.68%,ARPC2;CD3G;ACTR3;ARPC5;ARPC4;ARRB2;SH3GLB1;PDCD6IP;GLTP;TOR1AIP1;GRB2;CLTA;AP2S1;AGFG1;CHMP2A;EMD;ARPC3;SAR1B;MTCH1;CHMP6;BIN1;TOR1AIP2;SNX3;SCARB2;FNBP1;VPS4A;RABIF;UBC;VTI1B;AP2M1;CHMP5;SAR1A;CHMP3;AP2A1;VAMP3;EPN1;ARPC1A;SNAP29;CHMP2B;VAPA;SH3KBP1;PLEKHA3;RABEP1;SLC9A3R1;DNM2;VPS4B;MITD1;NAPG;CHMP1B;DNM1L;FCHO1;PPT1;ATP2C1;VAMP2;VAPB;SPAST;STX18;SNAP23;NECAP1
gsea,translation (GO:0006412),-0.8970708238200321,-2.8521527040324024,0.0,0.0,0.0,57/87,3.81%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6;EEF2;MRPL9;MRPL52;MRPS34;UBA52;TRMT112;MRPL24
gsea,peptide biosynthetic process (GO:0043043),-0.9242814498624288,-2.8377897394785396,0.0,0.0,0.0,50/79,1.79%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.7508723007372204,2.8240575513644712,0.0,0.0,0.0,23/41,15.01%,RBX1;PSMB8;PSMB3;PSMA2;EGR1;PSMB10;PSMA1;MAPK3;PSMB9;PSMC3;PSMA7;PSMD13;UBE2V1;PSMB4;PELI1;PSMD9;RPS6KA4;UBC;PSMB1;PSMF1;NOD1;PSMD8;PSMD4
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.7744081391305832,2.798935079323053,0.0,0.0,0.0,20/40,11.86%,CDC42;PSMB8;PSMB3;RHOA;PSMA2;ARRB2;PSMB10;PSMA1;RAC1;PSMB9;PSMC3;PSMA7;AP2S1;PSMD13;PSMB4;PSMD9;PSMB1;AP2M1;PSMF1;AP2A1
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.8019025584070598,2.7953529251229017,0.0,0.0,0.0,12/30,5.48%,ARPC2;CDC42;CD3G;ACTR3;ARPC5;ARPC1B;ARPC4;RAC1;MAPK3;GRB2;WAS;ARPC3
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.8019025584070598,2.7953529251229017,0.0,0.0,0.0,12/30,5.48%,ARPC2;CDC42;CD3G;ACTR3;ARPC5;ARPC1B;ARPC4;RAC1;MAPK3;GRB2;WAS;ARPC3
gsea,regulation of establishment of planar polarity (GO:0090175),0.7684805129538218,2.784581607356565,0.0,0.0,0.0,20/42,11.86%,CDC42;PSMB8;PSMB3;RHOA;PSMA2;ARRB2;PSMB10;PSMA1;RAC1;PSMB9;PSMC3;PSMA7;AP2S1;PSMD13;PSMB4;PSMD9;PSMB1;AP2M1;PSMF1;AP2A1
gsea,ncRNA processing (GO:0034470),-0.9394788693813463,-2.7725522726861254,0.0,0.0,0.0,39/59,1.79%,RPL27A;RPL34;RPL9;RPL19;RPL18;RPS27;RPS14;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPLP2;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS7;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPL28;RPL38;RPL13A;TUT4;RPS6
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.7263863809449438,2.7685943589971616,0.0,0.0,0.0,24/54,11.86%,GNG2;CALM1;CDC42;GNB1;PSMB8;PSMB3;RHOA;PSMA2;ARRB2;PSMB10;PSMA1;RAC1;PPP3CA;PSMB9;PSMC3;PSMA7;AP2S1;PSMD13;PSMB4;PSMD9;PSMB1;AP2M1;PSMF1;AP2A1
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.6253965843542081,2.758468430191206,0.0,0.0,0.0,41/93,17.13%,CAPZB;CTSC;ACTR10;CAPZA1;DYNLL1;DCTN3;RAB29;IER3IP1;RAB1A;TMED5;CNIH1;TMED9;TMED10;SAR1B;COPE;TRAPPC6B;RAB1B;TRAPPC2;TMED7;TRAPPC1;BCAP31;VTI1B;TRAPPC2L;SEC13;ERGIC2;YKT6;BET1;DCTN4;SAR1A;TRIP11;COPB1;SEC22B;GOSR1;RAB2A;VAPA;YIF1B;YIF1A;DYNC1LI1;TRAPPC5;TMEM115;DCTN6
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7405292188890481,2.732114444236234,0.0,0.0,0.0,21/41,11.72%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;DYNLL1;PSMB9;PSMC3;DCTN3;PSMA7;MAPRE1;PSMD13;PSMB4;RAB11A;SSNA1;PAFAH1B1;PSMD9;PSMB1;PPP2R1A;PSMF1
gsea,regulation of primary metabolic process (GO:0080090),0.7338841930931431,2.7299243173278067,0.0,0.0,0.0,22/45,13.74%,ID2;PSMB8;PSMB3;EDF1;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;CERS2;PSMA7;PSMD13;OAZ1;PSMB4;SIN3B;PSMD9;PSMB1;ZFP69;SREBF1;PSMF1;PSMD8;GPS2
gsea,ephrin receptor signaling pathway (GO:0048013),0.7485528326358774,2.7214750002478927,0.0,0.0,0.0,18/34,16.04%,ARPC2;CDC42;ACTR3;ARPC5;ARPC1B;ARPC4;RHOA;RAC1;AP2S1;SDCBP;ARPC3;AP2M1;PSEN1;AP2A1;ARPC1A;CHN1;APH1B;NCSTN
gsea,cellular component assembly (GO:0022607),0.648408479912114,2.7169574835500248,0.0,0.0,0.0,33/86,19.07%,IL2RB;CDC42;CD3G;ELOB;RAC2;YWHAZ;RHOA;VASP;CAPZA1;RAC1;GPAA1;STX7;ILK;TAPBP;SKAP2;WAS;LIMS1;RAD21;VMP1;PDCD10;PPP2R1A;TGFB1;VAMP3;CORO1B;PARVG;BAG6;BSN;SLC9A3R1;NAPG;YTHDF2;CD3E;QSOX1;DNM1L
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.7996504401759593,2.7162847619684745,0.0,0.0,0.0,21/30,13.62%,PSMB8;PSMB3;B2M;NCF4;CYBA;PSMA2;TAP1;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;TAPBP;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;VAMP3;SEC22B;PSMD8
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.6471740129722785,2.7063470455095513,0.0,0.0,0.0,27/57,13.62%,THY1;CD3G;SLA2;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;LIME1;PSMB9;PSMC3;DENND1B;PSMA7;PSMD13;SPG21;LAT;WAS;PSMB4;INPP5D;PSMD9;PSMB1;ITK;PSMF1;ZAP70;LCK;PTPN22;PSMD8
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.8110505897751453,2.7035418476149915,0.0,0.0,0.0,21/29,13.62%,PSMB8;PSMB3;B2M;NCF4;CYBA;PSMA2;TAP1;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;TAPBP;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;VAMP3;SEC22B;PSMD8
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5891465867168835,2.6984763339801976,0.0,0.0,0.0,51/124,18.93%,SH2D2A;ARPC2;CDC42;ACTR3;ARPC5;ARPC1B;ARPC4;RHOA;NCF4;CYBA;RAC1;MAPK3;STAT3;GRB2;POLR2K;ATP6V1G1;AP2S1;SDCBP;ARPC3;PXN;POLR2G;RGS14;POLR2J;RAB14;GSK3A;AP2M1;PSEN1;STAP1;ATP6V1A;SIRT2;NTRK1;ATP6V0B;ZAP70;AP2A1;LCK;ATP6V1E1;INSRR;POLR2I;ARPC1A;LTK;ATP6V0D1;CHN1;APH1B;NCSTN;TYRO3;MAPK1;VAV1;PAK2;CD3E;PTPN2;ITGAV
gsea,ribosome biogenesis (GO:0042254),-0.9468677181282682,-2.6983074802001905,0.0,0.0,0.0,38/54,1.79%,RPL27A;RPL34;RPL9;RPL19;RPL18;RPS27;RPS14;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPLP2;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS7;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPL28;RPL38;RPL13A;RPS6
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.8054145101947947,2.6836436048702472,0.0,0.0,0.0,15/24,13.19%,YWHAH;RAC2;YWHAZ;SH3GLB1;UBL5;YWHAB;YWHAQ;UBE2L3;CASP8;LEPROT;GSK3A;TOMM7;UBE2J2;UBE2D3;PPP3CC
gsea,protein transport (GO:0015031),0.5544203542577787,2.6729964966014355,0.0,0.0,0.0,71/157,20.86%,CD3G;YWHAH;ARL5A;UNC119;EHD1;LAPTM5;RAB5C;ARF5;CTSA;RAB8B;STX7;ATP6V1G1;RAB29;RAB1A;CHMP2A;TMED5;TMED9;TMED10;VMP1;VPS29;SAR1B;ARF1;RAB8A;ARF6;GGA1;RAB1B;TMED7;RAB18;RAB14;STX12;TBC1D10C;RAB19;SEC13;SCAMP2;TBC1D9B;SNX6;LAMP2;GOLGA7;ATP6V1A;SAR1A;CHMP3;SLC10A7;ATP6V0B;AP2A1;TBC1D16;SYS1;TBC1D2B;ARHGAP1;ATP6V1E1;STXBP2;SVBP;SYNRG;ARFRP1;CHMP2B;VPS26A;ATP6V0D1;SCAMP3;SLU7;RAB31;RAB6A;RAB3A;DNM2;SNX15;NAPG;PDCD6;CHMP1B;NEURL1B;PPT1;ATP6V1H;MCOLN1;ATP6AP1
gsea,cellular response to interleukin-1 (GO:0071347),0.6874367241348877,2.6673544166522736,0.0,0.0,0.0,25/49,15.01%,RBX1;PSMB8;CD47;PSMB3;PSMA2;EGR1;PSMB10;PSMA1;MAPK3;PSMB9;PSMC3;PSMA7;PSMD13;PYCARD;UBE2V1;PSMB4;PELI1;PSMD9;RPS6KA4;UBC;PSMB1;PSMF1;NOD1;PSMD8;PSMD4
gsea,Fc receptor signaling pathway (GO:0038093),0.6986713581333999,2.658444554936265,0.0,0.0,0.0,21/42,11.72%,CALM1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;RAC1;MAPK3;PPP3CA;GRB2;PSMB9;PSMC3;PSMA7;PSMD13;LAT;PSMB4;MAPK9;PSMD9;PSMB1;ITK;PSMF1
gsea,organelle organization (GO:0006996),0.5640943623331527,2.651564090118248,0.0,0.0,0.0,52/134,20.68%,THY1;PLAAT3;CDC42;CAPZB;CNN2;PDCD6IP;REEP5;BSCL2;STX7;RAB29;RAB1A;SURF4;CHMP2A;TMED5;TMED9;TMED10;VMP1;SAR1B;SSBP1;CHMP6;BIN1;TOR1AIP2;TMED7;RAB18;RAB14;VPS4A;SIPA1;PKD2;ARHGAP4;CHMP5;SAR1A;CHMP3;TRIP11;GBA;CHMP2B;RAB2A;VAPA;MIEF2;SH3KBP1;RAB31;SLC9A3R1;PEX16;VPS4B;YTHDF2;CHMP1B;DNM1L;PEX19;ARAP3;FITM2;CHCHD2;VPS51;MCOLN1
gsea,regulation of mRNA stability (GO:0043488),0.7079020934083315,2.6487192660991496,0.0,0.0,0.0,19/40,15.01%,PSMB8;PSMB3;YWHAZ;PSMA2;PSMB10;PSMA1;YWHAB;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;CARHSP1;PSMD9;UBC;PSMB1;PSMF1;PSMD8;PSMD4
gsea,rRNA processing (GO:0006364),-0.939455055206569,-2.640354801789352,0.0,0.0,0.0,39/52,2.48%,RPL27A;RPL34;RPL9;RPL19;RPL18;RPS27;RPS14;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPLP2;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS7;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPL28;RPL38;RPL13A;RPS6;NSA2
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.9665362122345635,-2.6364941658047347,0.0,0.0,0.0,51/63,2.08%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6;EIF3E
gsea,rRNA metabolic process (GO:0016072),-0.9527370419678763,-2.6334095757653184,0.0,0.0,0.0,38/51,1.79%,RPL27A;RPL34;RPL9;RPL19;RPL18;RPS27;RPS14;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPLP2;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS7;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPL28;RPL38;RPL13A;RPS6
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.541332483361228,2.63230148997696,0.0,0.0,0.0,71/159,22.61%,RBX1;PSMB8;TBX21;PSMB3;NDFIP2;PSMA2;ANAPC11;ARRB2;NTAN1;PSMB10;PSMA1;UBE2I;PSMB9;PSMC3;PSMA7;PSMD13;UBE2L3;VPS28;PPP1R11;PSMB4;PTTG1;PELI1;UBE2A;VPS37B;RNF166;RMND5B;WWP2;TSG101;PSMD9;VPS4A;RNF187;PSMB1;PCNP;GSK3A;UBE2D1;MVB12A;SIRT2;RNF125;ANAPC2;PSMF1;RNF4;ZNRF3;UBL7;UBE2D3;SHARPIN;PSMD8;ZFAND2B;NEDD8;AMFR;GID8;RNF6;OS9;FBXO22;MAEA;BAG6;PSMD4;ARIH2;VPS4B;UBE2W;KCTD6;FEM1C;KCTD5;RNF20;RNF115;RNF13;PSMD5;FBXW11;ARMC8;UBQLN2;RNF185;RNF7
gsea,cell junction assembly (GO:0034329),0.8321403408335002,2.624037326833089,0.0,0.0,0.0,10/26,5.38%,CDC42;RHOA;VASP;TLN1;CAPZA1;DBNL;ILK;RAB29;LIMS1;VMP1
gsea,protein targeting to ER (GO:0045047),-0.9472517031953938,-2.60880153856632,0.0,0.0,0.0,50/63,1.79%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.7352082264790026,2.59403946849395,0.0,0.0,0.0,12/31,5.48%,ARPC2;CDC42;CD3G;ACTR3;ARPC5;ARPC1B;ARPC4;RAC1;MAPK3;GRB2;WAS;ARPC3
gsea,proteasomal protein catabolic process (GO:0010498),0.5837377981687762,2.5916759876647486,0.0,0.0,0.0,34/92,15.01%,RBX1;PSMB8;TBX21;PSMB3;PSMA2;ARRB2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PELI1;UBE2A;RMND5B;WWP2;PSMD9;RNF187;PSMB1;PCNP;GSK3A;SIRT2;DERL1;PSMF1;RNF4;UBE2D3;SHARPIN;PSMD8;ZFAND2B;GID8;MAEA;BAG6;PSMD4
gsea,positive regulation of interleukin-1 production (GO:0032732),0.8303806029992992,2.5843731828244385,0.0,0.0,0.0,8/18,5.89%,S100A13;HMGB1;EGR1;STAT3;PYCARD;CASP8;TMED10;PANX1
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.7173983832170553,2.5818130090119684,0.0,0.0,0.0,20/35,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;ILK;PSMD13;PYCARD;PSMB4;LIMS1;TRADD;PSMD9;TXNDC17;PSMB1;PSMF1;PSMD8;PSMD4
gsea,MAPK cascade (GO:0000165),0.5958025072376917,2.5799750178888474,0.0,0.0,0.0,36/96,13.62%,IL2RB;CALM1;RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;MAPK3;GRB2;YWHAB;PSMB9;PSMC3;PSMA7;PSMD13;LAT;PPP1CC;PSMB4;MEF2A;ABHD17A;LAMTOR3;RASAL3;PSMD9;JAK3;LAMTOR2;IL2RG;UBC;PSMB1;GOLGA7;LYPLA1;PTPRA;PSMF1;TGFB1;IL3RA;MAP2K2;PSMD8
gsea,cellular response to amino acid starvation (GO:0034198),0.6848699627829696,2.5755261502337663,0.0,0.0,0.0,19/33,17.73%,LAMTOR4;SH3GLB1;MAPK3;RHEB;ATP6V1G1;LAMTOR3;LAMTOR1;LAMTOR5;LAMTOR2;SEC13;ATP6V1A;ATP6V0B;ATP6V1E1;NPRL2;RRAGC;ATP6V0D1;KPTN;MAPK1;RRAGA
gsea,response to amino acid starvation (GO:1990928),0.6848699627829696,2.5755261502337663,0.0,0.0,0.0,19/33,17.73%,LAMTOR4;SH3GLB1;MAPK3;RHEB;ATP6V1G1;LAMTOR3;LAMTOR1;LAMTOR5;LAMTOR2;SEC13;ATP6V1A;ATP6V0B;ATP6V1E1;NPRL2;RRAGC;ATP6V0D1;KPTN;MAPK1;RRAGA
gsea,sphingolipid metabolic process (GO:0006665),0.6554242117223069,2.568316545331999,0.0,0.0,0.0,22/47,15.47%,ESYT1;UGCG;GLTP;CTSA;CERS2;ELOVL1;DEGS1;SPTLC2;CERS4;HEXB;SPTSSA;ORMDL2;ASAH1;PPP2CA;SERINC1;CERS5;PPP2R1A;SUMF1;GBA;B4GALNT1;VAPA;PLA2G15
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),0.6684574584193056,2.5668721435243445,0.0,0.0,0.0,27/52,11.43%,NDUFB7;UQCC2;NDUFA11;NDUFB8;NDUFA13;NDUFS5;NDUFC1;NDUFB6;PET100;NDUFA2;NDUFB2;COX20;NDUFV3;NDUFS6;NDUFB9;NDUFS4;COA3;NDUFB3;NDUFA1;NDUFB4;NDUFAF3;NDUFB10;NDUFA3;NDUFA8;UQCRFS1;NDUFC2;NDUFS7
gsea,regulation of mRNA catabolic process (GO:0061013),0.6960565428532282,2.5641524718815445,0.0,0.0,0.0,19/39,15.01%,PSMB8;PSMB3;YWHAZ;PSMA2;PSMB10;PSMA1;YWHAB;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;CARHSP1;PSMD9;UBC;PSMB1;PSMF1;PSMD8;PSMD4
gsea,positive regulation of hydrolase activity (GO:0051345),0.6852956293520963,2.5612888048749123,0.0,0.0,0.0,12/36,10.97%,THY1;CALM1;HMGB2;CALM3;RHOA;DOCK10;SEMA4D;MAPRE2;NDUFA13;LIMS1;RALBP1;NTRK1
gsea,T cell receptor signaling pathway (GO:0050852),0.622246290738759,2.558805085327609,0.0,0.0,0.0,25/53,15.01%,THY1;CD3G;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;DENND1B;PSMA7;PSMD13;LAT;WAS;PSMB4;INPP5D;PSMD9;PSMB1;ITK;PSMF1;ZAP70;LCK;PTPN22;PSMD8;PSMD4
gsea,NIK/NF-kappaB signaling (GO:0038061),0.7893374088818891,2.5563638065325027,0.0,0.0,0.0,16/26,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;COPS8;PSMF1;PSMD8;PSMD4
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.7117866910665469,2.552353460315999,0.0,0.0,0.0,22/34,18.34%,CAPZB;ACTR10;CAPZA1;DYNLL1;CLTA;DCTN3;AP2S1;SAR1B;AP1S2;ARF1;SEC13;LAG3;AP2M1;DCTN4;ACTR1B;AP2A1;AP1S1;OSBPL1A;DYNC1LI1;DCTN6;DNM2;AP1S3
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.7117866910665469,2.552353460315999,0.0,0.0,0.0,22/34,18.34%,CAPZB;ACTR10;CAPZA1;DYNLL1;CLTA;DCTN3;AP2S1;SAR1B;AP1S2;ARF1;SEC13;LAG3;AP2M1;DCTN4;ACTR1B;AP2A1;AP1S1;OSBPL1A;DYNC1LI1;DCTN6;DNM2;AP1S3
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.7117866910665469,2.552353460315999,0.0,0.0,0.0,22/34,18.34%,CAPZB;ACTR10;CAPZA1;DYNLL1;CLTA;DCTN3;AP2S1;SAR1B;AP1S2;ARF1;SEC13;LAG3;AP2M1;DCTN4;ACTR1B;AP2A1;AP1S1;OSBPL1A;DYNC1LI1;DCTN6;DNM2;AP1S3
gsea,regulation of mitotic cell cycle (GO:0007346),0.6342830478151331,2.540052057564836,0.0,0.0,0.0,27/56,15.01%,PSMB8;PSMB3;PSMA2;ANAPC11;PSMB10;PSMA1;IQGAP1;PSMB9;PSMC3;BTG3;PSMA7;PSMD13;SDCBP;PSMB4;PKN2;PSMD9;PSMB1;UBE2D1;ANAPC2;SRA1;PSMF1;TGFB1;CDK9;PSMD8;MAEA;RPS6KB1;PSMD4
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.6680304073058959,2.5382300378629905,0.0,0.0,0.0,15/37,14.33%,THY1;CALM1;CALM3;RHOA;LIME1;CDC37;SNF8;PYCARD;PDCD10;TSG101;PPP2CA;CCNH;LRP5;MAP2K2;SYAP1
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.9549321584242024,-2.5360172217961914,0.0,0.0,0.0,50/59,1.79%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.6651840933251473,2.5281995072766996,0.0,0.0,0.0,17/34,19.22%,CTSC;RAB1A;CNIH1;TMED10;SAR1B;PPP6C;TRAPPC6B;RAB1B;TRAPPC2;TRAPPC1;TRAPPC2L;SEC13;BET1;SEC22B;TRAPPC5;PDCD6;TRAPPC3
gsea,vesicle coating (GO:0006901),0.6651840933251473,2.5281995072766996,0.0,0.0,0.0,17/34,19.22%,CTSC;RAB1A;CNIH1;TMED10;SAR1B;PPP6C;TRAPPC6B;RAB1B;TRAPPC2;TRAPPC1;TRAPPC2L;SEC13;BET1;SEC22B;TRAPPC5;PDCD6;TRAPPC3
gsea,COPII vesicle coating (GO:0048208),0.6651840933251473,2.5281995072766996,0.0,0.0,0.0,17/34,19.22%,CTSC;RAB1A;CNIH1;TMED10;SAR1B;PPP6C;TRAPPC6B;RAB1B;TRAPPC2;TRAPPC1;TRAPPC2L;SEC13;BET1;SEC22B;TRAPPC5;PDCD6;TRAPPC3
gsea,ribonucleoprotein complex assembly (GO:0022618),-0.7070542875135639,-2.5275285152597577,0.0,0.0,0.0,13/41,5.87%,RPS27;RPS14;RPS28;RPS5;RPL6;RPL11;RPS19;RPL24;RPL38;SRPK2;YTHDC1;NOP53;RBM5
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.7718283482655548,2.521546005518055,0.0,0.0,0.0,17/27,15.01%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PKD2;PSMF1;PSMD8;PSMD4
gsea,cytoplasmic translation (GO:0002181),-0.9613132123026514,-2.516314993978139,0.0,0.0,0.0,49/57,1.79%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6
gsea,COPII-coated vesicle budding (GO:0090114),0.6583429885926277,2.5157917685520736,0.0,0.0,0.0,19/37,19.22%,CTSC;RAB1A;CNIH1;TMED10;SAR1B;PPP6C;TRAPPC6B;RAB1B;TRAPPC2;TRAPPC1;TRAPPC2L;SEC13;BET1;SAR1A;SEC22B;VAPA;TRAPPC5;PDCD6;TRAPPC3
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.6999243046067266,2.4993259177305207,0.0,0.0,0.0,20/32,15.01%,RBX1;PSMB8;ELOB;PSMB3;RBPJ;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;UBC;PSMB1;SIRT2;PSMF1;PSMD8;PSMD4
gsea,protein-DNA complex assembly (GO:0065004),0.7479359314393152,2.4891937524688466,0.0,0.0,0.0,20/31,15.01%,RBX1;PSMB8;PSMB3;HMGB2;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;UBC;PSMB1;CCNH;GTF2H5;PSMF1;PSMD8;PSMD4
gsea,ribonucleoprotein complex biogenesis (GO:0022613),-0.9190008482346369,-2.4884648320346257,0.0,0.0,0.0,10/18,1.79%,RPS28;RPS24;RPL35A;RPL26;RPS16;RPS7;RPL11;RPS19;RPL38;RPS6
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7593406132413761,2.4880274518368046,0.0,0.0,0.0,20/28,15.01%,PSMB8;PSMB3;PSMA2;ANAPC11;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PTTG1;PSMD9;UBC;PSMB1;UBE2D1;ANAPC2;PSMF1;PSMD8;PSMD4
gsea,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.7355003590345268,2.486785083999994,0.0,0.0,0.0,21/31,11.43%,NDUFB7;NDUFA11;NDUFB8;NDUFA13;NDUFS5;NDUFC1;NDUFB6;NDUFA2;NDUFB2;NDUFV3;NDUFS6;NDUFB9;NDUFS4;NDUFB3;NDUFA1;NDUFB4;NDUFB10;NDUFA3;NDUFA8;NDUFC2;NDUFS7
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5176183437540505,2.4860163650624045,0.0,0.0,0.0,71/134,28.29%,RBX1;PSMB8;TBX21;PSMB3;PSMA2;ANAPC11;ARRB2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PTTG1;UBXN8;PELI1;UBE2A;SEC61B;RMND5B;WWP2;PSMD9;UBC;RNF187;PSMB1;PCNP;GSK3A;UBE2D1;UBE2J2;JKAMP;SIRT2;DERL1;ANAPC2;PSMF1;RNF4;UBE2D3;SHARPIN;PSMD8;ZFAND2B;AMFR;GID8;OS9;RNF121;MAEA;BAG6;PSMD4;FBXO2;UBE2W;FBXO6;FEM1C;KCTD5;CUL2;PSMD5;WFS1;FBXW11;ARMC8;UBQLN2;RNF185;UFD1;DNAJB9;FBXO9;KCTD10;PSMD10;UBXN2A;SMURF1;UBE2K;UBXN1;TRIM2;TRIM13;PPP2R5C;UBE2J1
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.9581153692357012,-2.4811447926457566,0.0,0.0,0.0,50/58,1.79%,RPL27A;RPL34;RPS12;RPS20;RPL9;RPL19;RPS21;RPL18;RPS27;RPS14;RPS10;RPL23;RPL37A;RPS28;RPL22;RPL29;RPS9;RPS4X;RPL21;RPL36;RPL30;RPS24;RPL36A;RPL35A;RPS5;RPLP2;RPS23;RPS29;RPL37;RPL17;RPL26;RPL35;RPL18A;RPL6;RPS16;RPS15A;RPS7;RPS3;RPL12;RPL11;RPS19;RPL39;RPL32;RPL24;RPS13;RPL28;RPS11;RPL38;RPL13A;RPS6
gsea,regulation of stress fiber assembly (GO:0051492),0.8229599292717978,2.480358866960287,0.0,0.0,0.0,7/20,6.13%,CDC42;CD47;RHOA;RAC1;WAS;ITGB1BP1;PXN
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.6805424405207404,2.4798714317227866,0.0,0.0,0.0,34/53,12.25%,COX5A;NDUFB7;COX5B;COX6A1;UQCRB;COX7B;NDUFA11;COX8A;COX6B1;NDUFB8;NDUFA13;UQCR11;NDUFS5;COX6C;NDUFC1;NDUFB6;NDUFA2;NDUFB2;NDUFV3;UQCRQ;NDUFS6;NDUFB9;NDUFS4;NDUFB3;NDUFA1;NDUFB4;SDHC;NDUFB10;NDUFA3;NDUFA8;UQCRFS1;NDUFC2;NDUFS7;COX4I1
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.6454165846939584,2.476297213122661,0.0,0.0,0.0,26/43,18.18%,CALM1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;RAC1;MAPK3;PPP3CA;GRB2;PSMB9;PSMC3;PSMA7;PSMD13;LAT;PSMB4;MAPK9;PSMD9;PSMB1;ITK;PSMF1;PSMD8;PSMD4;MAPK1;VAV1;PAK2
gsea,regulation of autophagy (GO:0010506),0.5437065923949334,2.4733107300665607,0.0,0.0,0.0,45/92,23.46%,HMGB1;LAMTOR4;SH3GLB1;CTSA;RHEB;STAT3;ATP6V1G1;VPS29;RAB8A;LAMTOR3;LAMTOR1;LAMTOR5;CAPNS1;LAMTOR2;GSK3A;SNX6;ATP6V1A;SIRT2;SREBF1;ATP6V0B;CAPN1;ATP6V1E1;PTPN22;DRAM2;GBA;NPRL2;RRAGC;RMC1;MTMR9;VPS26A;ATP6V0D1;TICAM1;TRIM27;RRAGA;DNM1L;PRKAG1;DAPK3;PIP4K2C;STK11;RUBCN;ATP6V1H;CDK5;UBQLN2;ATP6V1C1;EXOC7
gsea,substantia nigra development (GO:0021762),0.8132627141048129,2.46750096026473,0.0,0.0,0.0,8/18,3.56%,CALM1;CDC42;YWHAH;CALM3;RHOA;DYNLL1;COX6B1;YWHAQ
gsea,Golgi organization (GO:0007030),0.638783123603614,2.4671415036733606,0.0,0.0,0.0,16/44,14.47%,CDC42;YWHAZ;RAB29;RAB1A;SURF4;TMED5;TMED9;TMED10;VMP1;PDCD10;TMED7;VTI1B;BET1;TRIP11;SEC22B;RAB2A
gsea,protein-containing complex subunit organization (GO:0043933),0.6657367034470001,2.4656348296397126,0.0,0.0,0.0,15/35,19.07%,IL2RB;CD3G;ELOB;CAPZA1;GPAA1;TAPBP;SKAP2;WAS;TPR;PPP2R1A;VAMP3;SLC9A3R1;NAPG;CD3E;DNM1L
gsea,integrin-mediated signaling pathway (GO:0007229),0.8242863929417125,2.4652593247843972,0.0,0.0,0.0,9/21,5.87%,THY1;ITGB2;CDC42;ZYX;CD47;ILK;LAT;ITGB1BP1;FERMT3
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.7808830313058609,2.4633842236501273,0.0,0.0,0.0,17/25,15.01%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;VPS4A;PSMB1;PSMF1;PSMD8;PSMD4
gsea,cell junction organization (GO:0034330),0.8003657914642958,2.4616267452420737,0.0,0.0,0.0,11/23,11.89%,CDC42;RHOA;VASP;CAPZA1;RAB8B;ILK;LIMS1;VMP1;TJP3;PSEN1;TGFB1
gsea,aerobic electron transport chain (GO:0019646),0.6835900080413414,2.4610024779105744,0.0,0.0,0.0,34/52,12.25%,COX5A;NDUFB7;COX5B;COX6A1;UQCRB;COX7B;NDUFA11;COX8A;COX6B1;NDUFB8;NDUFA13;UQCR11;NDUFS5;COX6C;NDUFC1;NDUFB6;NDUFA2;NDUFB2;NDUFV3;UQCRQ;NDUFS6;NDUFB9;NDUFS4;NDUFB3;NDUFA1;NDUFB4;SDHC;NDUFB10;NDUFA3;NDUFA8;UQCRFS1;NDUFC2;NDUFS7;COX4I1
gsea,positive regulation of cell growth (GO:0030307),0.722136715196932,2.456627759222724,0.0,0.0,0.0,10/26,13.29%,CDC42;RPS6KA1;SEMA4D;MTPN;DBNL;SDCBP;ITSN2;TWF2;DBN1;TAF9B
gsea,intracellular protein transport (GO:0006886),0.518895978867729,2.453001799899936,0.0,0.0,0.0,53/124,18.77%,YWHAH;ARL5A;EHD1;LAPTM5;RAB5C;ARF5;CTSA;STAT3;STX7;CDC37;SNF8;RAB29;RAB1A;SURF4;VPS28;TMED5;TMED9;TMED10;VPS29;SAR1B;ARF1;VPS36;ARF6;GGA1;RAB1B;TPR;TMED7;RAB18;RAB14;STX12;TBC1D10C;RAB19;SEC13;TBC1D9B;SNX6;LAMP2;SAR1A;SORL1;AP2A1;TGFB1;TBC1D16;TBC1D2B;STXBP2;SYNRG;ARFRP1;VPS26A;SLU7;RAB31;RAB6A;SNX15;NAPG;AP1S3;PDCD6
gsea,regulation of cytokinesis (GO:0032465),0.738878360084383,2.4503521225705605,0.0,0.0,0.0,8/21,8.71%,CALM1;CDC42;CALM3;RHOA;SH3GLB1;RAB11A;PKN2;VPS4A
gsea,post-translational protein modification (GO:0043687),0.536279048693902,2.450131495836778,0.0,0.0,0.0,53/107,24.43%,RBX1;PSMB8;ELOB;PSMB3;NUCB1;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;RAB1A;PSMB4;ATG5;DDA1;RAB8A;RAB11A;RAB1B;PSMD9;COMMD1;APLP2;PSMB1;COPS8;DNAJC3;PSMF1;SUMF1;FUCA2;ASB6;PSMD8;NEDD8;FBXO22;RAB2A;PSMD4;FBXO2;FBXW2;RAB3A;KCTD6;FBXO6;FEM1C;QSOX1;CUL2;PSMD5;WFS1;FBXW11;ASB8;RNF7;ADAM10;PNPLA2;FBXO9;RAB11B;COPS6;PSMD10
gsea,multivesicular body assembly (GO:0036258),0.7235977761694344,2.4438211940569725,0.0,0.0,0.0,17/25,18.99%,PDCD6IP;SNF8;VPS28;CHMP2A;RAB11A;VPS37B;VPS36;CHMP6;TSG101;VPS4A;CHMP5;MVB12A;CHMP3;VTA1;CHMP2B;VPS4B;CHMP1B
gsea,multivesicular body organization (GO:0036257),0.7235977761694344,2.4438211940569725,0.0,0.0,0.0,17/25,18.99%,PDCD6IP;SNF8;VPS28;CHMP2A;RAB11A;VPS37B;VPS36;CHMP6;TSG101;VPS4A;CHMP5;MVB12A;CHMP3;VTA1;CHMP2B;VPS4B;CHMP1B
gsea,protein-containing complex assembly (GO:0065003),0.5300143441105676,2.4271882203152457,0.0,0.0,0.0,40/98,19.22%,IL2RB;CD3G;RBX1;ELOB;CTSC;CSNK2B;CAPZA1;DBNL;GPAA1;TAPBP;SKAP2;RAB1A;CASP8;WAS;ITGB1BP1;CNIH1;TMED10;TRADD;SAR1B;FERMT3;PPP6C;TRAPPC6B;RAB1B;TRAPPC2;TRAPPC1;TRAPPC2L;SEC13;AP2M1;BET1;GSDMD;PPP2R1A;VAMP3;SEC22B;TRAPPC5;SLC9A3R1;NAPG;CD3E;PDCD6;DNM1L;TRAPPC3
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),0.6904302397667705,2.4242170556696157,0.0,0.0,0.0,22/37,11.43%,NDUFB7;NDUFA11;NDUFB8;NDUFA13;NDUFS5;NDUFC1;NDUFB6;NDUFA2;NDUFB2;NDUFV3;NDUFS6;NDUFB9;NDUFS4;NDUFB3;NDUFA1;NDUFB4;NDUFAF3;NDUFB10;NDUFA3;NDUFA8;NDUFC2;NDUFS7
gsea,NADH dehydrogenase complex assembly (GO:0010257),0.6904302397667705,2.4242170556696157,0.0,0.0,0.0,22/37,11.43%,NDUFB7;NDUFA11;NDUFB8;NDUFA13;NDUFS5;NDUFC1;NDUFB6;NDUFA2;NDUFB2;NDUFV3;NDUFS6;NDUFB9;NDUFS4;NDUFB3;NDUFA1;NDUFB4;NDUFAF3;NDUFB10;NDUFA3;NDUFA8;NDUFC2;NDUFS7
gsea,platelet degranulation (GO:0002576),0.7059147605221072,2.422981383346749,0.0,0.0,0.0,10/28,12.39%,CALM1;TLN1;SRGN;WDR1;FERMT3;APLP2;VTI1B;LAMP2;TGFB1;STXBP2
gsea,cellular response to starvation (GO:0009267),0.5714309076729797,2.420716496826382,0.0,0.0,0.0,28/59,20.46%,LAMTOR4;STK24;SH3GLB1;STK26;MAPK3;RHEB;ATP6V1G1;ATG5;LAMTOR3;LAMTOR1;LAMTOR5;LAMTOR2;SEC13;LAMP2;ATP6V1A;SREBF1;ATP6V0B;ATP6V1E1;BECN1;NPRL2;RRAGC;ATP6V0D1;WDR45B;KPTN;MAPK1;RRAGA;PRKAG1;ATP6V1H
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.8022268906360319,2.4145800041584913,0.0,0.0,0.0,16/21,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;OAZ1;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4
gsea,regulation of cellular amine metabolic process (GO:0033238),0.8022268906360319,2.4145800041584913,0.0,0.0,0.0,16/21,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;OAZ1;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4
gsea,cellular protein modification process (GO:0006464),0.46093058153753846,2.4144692102986203,0.0,0.0,0.0,145/349,26.43%,CD3G;PPP1CA;RBX1;PSMB8;ELOB;UGCG;PSMB3;YWHAZ;NUCB1;STK24;PSMA2;RUNX3;UBL5;PSMB10;PSMA1;UBE2I;STK26;MAPK3;PTPN18;PPP3CA;UBL4A;GPAA1;PSMB9;PSMC3;PSMA7;ILK;PSMD13;UBE2L3;HCST;GMFG;RAB1A;PPP1CC;MAN2B1;PSMB4;PPM1H;ATG5;DDA1;MAPK9;RAB8A;RAB11A;TGFBR2;ALG5;TBK1;WWP2;PPP6C;RAB1B;PKN2;PGGT1B;PSMD9;ATG3;RPS6KA4;JAK3;PRKCH;COMMD1;APLP2;USP25;PSMB1;GSK3A;MORC3;PPP2CA;COPS8;DNAJC3;MARK2;SIRT2;NTRK1;PTPRA;PPP2R1A;PSMF1;ZAP70;TGFB1;SUMF1;LCK;CDK9;UBE2D3;FUCA2;PTPN22;PPP3CC;ASB6;PSMD8;ILKAP;SETD3;NEDD8;LTK;LIPE;FBXO22;RAB2A;WDR45B;PSMD4;MTMR2;FBXO2;B4GALT7;NGLY1;LCMT1;MAPK1;PIGT;MAP3K6;FBXW2;RAB3A;TAOK3;PRKACB;PAK2;KCTD6;FBXO6;FEM1C;QSOX1;PRKAG1;PMM2;DAPK3;FAM220A;SIRT7;STK11;CUL2;PSMD5;ATG4B;WFS1;CDK5;FBXW11;ASB8;PARP4;PIGS;AKT2;CSNK1G2;CTBP1;RNF7;ADAM10;PNPLA2;MTMR6;CDC42BPG;FBXO9;RCE1;RAB11B;PTPRR;COPS6;PSMD10;FNIP2;NEK3;PARP16;CDC42BPA;PXK;ALG1;PRKAB1;ST6GALNAC2;PRKACA;MAP4K5;ENGASE
gsea,positive regulation of protein localization to membrane (GO:1905477),0.6884642911091022,2.407443433736137,0.0,0.0,0.0,9/34,8.25%,ITGB2;YWHAH;YWHAZ;YWHAB;YWHAQ;CASP8;ITGB1BP1;ARF6;PRKCH
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.7097387096262298,2.4045094624301075,0.0,0.0,0.0,7/24,6.13%,SH2D2A;CDC42;RHOA;NCF4;CYBA;RAC1;PXN
gsea,DNA-dependent DNA replication (GO:0006261),0.6894070175541286,2.4041896255351696,0.0,0.0,0.0,18/31,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;POLE4;PSMD13;PSMB4;SSBP1;PSMD9;UBC;PSMB1;PSMF1;PSMD8;PSMD4
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.6727884517650965,2.4027065103019023,0.0,0.0,0.0,17/36,15.39%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4;FBXO2
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.723829710695625,2.39409694139345,0.0,0.0,0.0,9/23,14.25%,ARPC2;CDC42;ACTR3;RAC2;RAC1;MIEN1;TWF2;P2RY12;AKIRIN1
gsea,endomembrane system organization (GO:0010256),0.5681939658563043,2.3914663627895005,0.0,0.0,0.0,19/61,16.58%,CDC42;SRGN;REEP5;RAB29;RAB1A;SURF4;TMED5;TMED9;TMED10;VMP1;LAMTOR1;TOR1AIP2;TMED7;VPS4A;TRIP11;CHMP2B;RAB2A;VAPA;SLC9A3R1
gsea,pre-replicative complex assembly (GO:0036388),0.7824450236155551,2.387402263552149,0.0,0.0,0.0,16/21,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;UBC;PSMB1;PSMF1;PSMD8;PSMD4
gsea,cellular response to lipid (GO:0071396),0.6342380923594158,2.3872487561607607,0.0,0.0,0.0,14/42,14.37%,HMGB2;RHOA;HMGB1;NDUFA13;PYCARD;UBE2L3;GSTP1;STAP1;CHMP5;TWF2;NR3C1;ADCY3;LTK;TICAM1
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5737114449004563,2.386012556832217,0.0,0.0,0.0,20/61,15.02%,LITAF;S100A13;NDFIP2;RHOA;TMEM9B;UBE2V1;CASP8;GOLT1B;TRADD;PELI1;TBK1;LAMTOR5;CFLAR;SLC35B2;FKBP1A;NOD1;SHARPIN;TICAM1;VAPA;TRIM27
gsea,regulation of cell cycle phase transition (GO:1901987),0.7250417182903456,2.3839279638262454,0.0,0.0,0.0,18/27,15.01%,PSMB8;PSMB3;PSMA2;ANAPC11;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;UBE2D1;ANAPC2;PSMF1;PSMD8;PSMD4
gsea,cellular response to interleukin-12 (GO:0071349),0.768766237561403,2.375051910631952,0.0,0.0,0.0,12/18,9.44%,CDC42;CD47;CNN2;RAP1B;IL12RB1;TALDO1;CAPZA1;IL12RB2;AIP;ARF1;BOLA2;PITPNA
gsea,Ras protein signal transduction (GO:0007265),0.6204925073242691,2.3748657180725745,0.0,0.0,0.0,14/43,12.23%,GNB1;ARHGDIB;RAC2;RHOA;RAP1B;RASSF1;RAC1;DBNL;GRB2;LAT;WAS;G3BP2;ARHGAP4;ARHGAP1
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5574951206697856,2.3730570711894434,0.0,0.0,0.0,26/78,15.02%,LITAF;S100A13;NDFIP2;RHOA;LIME1;PYCARD;TMEM9B;UBE2V1;CASP8;GOLT1B;GSTP1;TRADD;PELI1;TBK1;LAMTOR5;CARD19;PPM1N;CFLAR;SLC35B2;FKBP1A;ZFAND6;NOD1;SHARPIN;TICAM1;VAPA;TRIM27
gsea,positive regulation of lamellipodium organization (GO:1902745),0.8331265593982569,2.3711890155847315,0.0,0.0,0.0,5/15,2.31%,ARPC2;CDC42;ACTR3;RAC2;RAC1
gsea,cellular response to oxygen-containing compound (GO:1901701),0.551311660003721,2.3700714100813522,0.0,0.0,0.0,32/80,19.80%,GNG2;GNB1;HMGB2;RHOA;HMGB1;LAMTOR4;RAP1B;EGR1;MAPK3;NDUFA13;PYCARD;GSTP1;MAPK9;PXN;LAMTOR3;LAMTOR1;PRDX5;LAMTOR5;LAMTOR2;STAP1;PKD2;CHMP5;TWF2;P2RY12;RRAGC;LTK;TICAM1;MAPK1;HCN2;RRAGA;NSMF;MYD88
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.749225661973629,2.3664682906961776,0.0,0.0,0.0,9/18,12.48%,LAPTM5;BEX3;PYCARD;CASP8;TRADD;MTCH1;CFLAR;LCK;NOD1
gsea,cellular response to tumor necrosis factor (GO:0071356),0.6239893677166387,2.364528705469441,0.0,0.0,0.0,23/44,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;ILK;PSMD13;PYCARD;PSMB4;LIMS1;TRADD;PSMD9;TXNDC17;PSMB1;ASAH1;ZFAND6;PSMF1;GBA;PSMD8;PSMD4
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.797642107796793,2.363283806973826,0.0,0.0,0.0,16/20,15.01%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.8218997104169159,2.3632465875267044,0.0,0.0,0.0,7/15,10.76%,CALM1;CALM3;CSNK2B;PPP1R11;PPP1R15B;PTPA;FKBP1A
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.7746570710149362,2.361900490030608,0.0,0.0,0.0,16/22,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;OAZ1;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4
gsea,glycolipid metabolic process (GO:0006664),0.7495091442561852,2.3583844731571504,0.0,0.0,0.0,9/19,13.45%,ESYT1;UGCG;GLTP;CTSA;HEXB;ASAH1;SUMF1;GBA;B4GALNT1
gsea,ribosomal small subunit biogenesis (GO:0042274),-0.9028750919521458,-2.3542129051716394,0.0,2.1825658299151314e-05,0.001,9/15,1.79%,RPS27;RPS14;RPS28;RPS24;RPS5;RPS16;RPS7;RPS19;RPS6
gsea,regulation of protein targeting to mitochondrion (GO:1903214),0.7615633901207927,2.3508204919510787,0.0,0.0,0.0,11/17,15.84%,RAC2;SH3GLB1;UBL5;UBE2L3;LEPROT;GSK3A;TOMM7;UBE2J2;SREBF1;UBE2D3;ARIH2
gsea,cellular protein localization (GO:0034613),0.4947863188970996,2.3483540639883276,0.0,0.0,0.0,53/123,18.77%,YWHAH;ARL5A;EHD1;LAPTM5;RAB5C;ARF5;CTSA;STX7;RAB29;RAB1A;TMED5;TMED9;TMED10;VPS29;SAR1B;ABHD17A;ARF1;ARF6;LAMTOR3;LAMTOR1;GGA1;RAB1B;TM9SF3;TMED7;RAB18;RAB14;LAMTOR2;STX12;TBC1D10C;RAB19;SEC13;TBC1D9B;SNX6;SAR1A;AP2A1;TBC1D16;TBC1D2B;STXBP2;SYNRG;CORO1B;ARFRP1;RRAGC;VPS26A;WDR45B;SLU7;RAB31;TM9SF1;RAB6A;SNX15;RRAGA;NAPG;USP4;PDCD6
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6666077424205429,2.3476650448155403,0.0,0.0,0.0,18/31,15.01%,RBX1;PSMB8;ELOB;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;UBC;PSMB1;PSMF1;PSMD8;PSMD4
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.6478942980219903,2.3416328780200417,0.0,0.0,0.0,12/32,12.19%,CDC42;CAPZB;RAC1;WAS;ATG5;ARF6;ATG3;TBC1D10C;TBC1D9B;TWF2;TBC1D16;TBC1D2B
gsea,positive regulation of protein targeting to mitochondrion (GO:1903955),0.7763037405965355,2.328728525245128,0.0,0.0,0.0,10/16,15.84%,RAC2;SH3GLB1;UBL5;UBE2L3;LEPROT;GSK3A;TOMM7;UBE2J2;UBE2D3;ARIH2
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.7674816129369764,2.3273497479771814,0.0,0.0,0.0,5/19,5.06%,CDC42;RAC1;ILK;ITGB1BP1;LIMS1
gsea,actin filament organization (GO:0007015),0.6502616185678767,2.3246245332148314,0.0,0.0,0.0,11/34,13.43%,CDC42;RAC2;ARPC4;RHOA;RAC1;WAS;TMOD3;MAD2L2;DBN1;CORO1B;RND1
gsea,regulation of immune response (GO:0050776),0.6526765222510962,2.3207075390717393,0.0,0.0,0.0,17/37,13.03%,ITGB2;CD3G;SLA2;KLRD1;B2M;PDCD1;DENND1B;HCST;CASP8;KLRC1;N4BP1;ITGAL;LAG3;GPR108;FKBP1A;SPPL2A;PTPN22
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.7264464115209363,2.3201277952868757,0.0,0.0,0.0,10/19,13.74%,LAPTM5;PYCARD;CASP8;GSTP1;TRADD;CFLAR;OTULIN;SPPL2A;SHARPIN;GPS2
gsea,positive regulation of transport (GO:0051050),0.7800850870236309,2.3182303572909957,0.0,0.0,0.0,6/22,9.62%,IL2RB;CD47;CYBA;PYCARD;IL2RG;GSK3A
gsea,cellular response to hypoxia (GO:0071456),0.631073033654386,2.3033687500645637,0.0,0.0,0.0,19/36,15.01%,RBX1;PSMB8;ELOB;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;UBC;PSMB1;SIRT2;PSMF1;PSMD8;PSMD4
gsea,negative regulation of cell migration (GO:0030336),0.7195495501198125,2.301667136137009,0.0,0.0,0.0,6/30,4.82%,THY1;ARHGDIB;STK24;RAC1;STK26;ITGB1BP1
gsea,regulation of actin filament polymerization (GO:0030833),0.710830157806402,2.299788050510337,0.0,1.3017617120242743e-05,0.001,11/23,12.03%,VASP;COTL1;MTPN;DBNL;HCLS1;PYCARD;BIN1;ARF6;ARHGAP18;TWF2;DBN1
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.7464696100555667,2.2989826644135802,0.0,1.2907298331088144e-05,0.001,10/16,19.49%,CDC42;GRB2;ZGPAT;CHMP6;TSG101;SNX6;EPN1;SH3KBP1;PTPN2;RNF115
gsea,mitotic cytokinetic process (GO:1902410),0.7478762481845551,2.2931625136293734,0.0,1.279883363923026e-05,0.001,11/16,18.99%,RHOA;PDCD6IP;CHMP2A;CHMP6;VPS4A;CHMP5;CHMP3;CHMP2B;VPS4B;MITD1;CHMP1B
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5982511745625951,2.2923523630786335,0.0,1.2692176692236675e-05,0.001,20/53,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;ILK;PSMD13;PSMB4;PSMD9;PPM1N;PSMB1;ZEB2;PSMF1;TGFB1;PSMD8;GID8;PSMD4
gsea,protein localization to membrane (GO:0072657),0.5606056703326819,2.290238312615723,0.0,1.2587282669986784e-05,0.001,13/70,7.63%,THY1;ITGB2;ARL5A;EHD1;SH3GLB1;RAB8B;RAB29;ITGB1BP1;ABHD17A;RAB8A;ITGAL;RAB11A;TM9SF3
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.7487188197771718,2.2890065260918107,0.0,1.2484108221872139e-05,0.001,4/19,5.06%,CDC42;RAC1;ILK;LIMS1
gsea,macroautophagy (GO:0016236),0.5196881693728159,2.2789223891486223,0.0,2.476522281412034e-05,0.002,33/67,25.70%,CSNK2B;DYNLL1;TOMM6;SNF8;VPS28;CHMP2A;ATG5;VPS37B;VPS36;CHMP6;TSG101;ATG3;VPS4A;TOMM22;VTI1B;TOMM7;LAMP2;MVB12A;CHMP3;VTA1;BECN1;SNAP29;CHMP2B;ILRUN;VPS4B;PRKAG1;ATG4B;ARL8B;SRC;RUBCNL;CHMP4B;GABARAPL2;PRKAB1
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.7484573635663092,2.276687831261119,0.0,2.456550327529679e-05,0.002,11/17,9.44%,CDC42;CNN2;RAP1B;IL12RB1;TALDO1;CAPZA1;IL12RB2;AIP;ARF1;BOLA2;PITPNA
gsea,regulated exocytosis (GO:0045055),0.6023677851198815,2.2742432722269377,0.0,2.436897924909441e-05,0.002,19/45,24.11%,CALM1;TLN1;SRGN;WDR1;TMED10;FERMT3;APLP2;VTI1B;LAMP2;TGFB1;STXBP2;RAB31;CTSW;RAB3A;QSOX1;CDK5;VAMP2;TEX264;RAB11B
gsea,negative regulation of protein phosphorylation (GO:0001933),0.6119956340710969,2.273066187371144,0.0,2.4175574651879377e-05,0.002,18/47,23.20%,THY1;CALM1;CALM3;SEMA4D;FKBP8;ITGB1BP1;GSTP1;PPP1R15B;DNAJC3;SIRT2;TGFB1;TRIM27;SAMSN1;PAK2;PIP5KL1;PDE4D;GNAQ;NCK1
gsea,positive regulation of cell differentiation (GO:0045597),0.537616653964567,2.266933500260221,0.0,2.3985215796352767e-05,0.002,20/68,14.50%,ID2;CDC42;RPS6KA1;RHOA;SDCBP;BNIP2;SUCO;MEF2A;MAPK9;RUNX2;TGFBR2;CCDC71L;PRKCH;NUDT21;LRP5;TGFB1;CTNNBIP1;AKIRIN1;SYAP1;BLOC1S6
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.5325867687517845,2.2660782421636037,0.0,2.379783129794376e-05,0.002,40/81,25.41%,UBL5;HNRNPL;LSM5;ISY1;POLR2K;ZCRB1;LSM6;RALY;SNRPC;SNRNP27;LSM4;POLR2G;CWC15;NUDT21;POLR2J;SF3B6;TRA2B;SF3B1;DNAJC8;SF3B5;PUF60;CDC5L;GEMIN7;ZRSR2;POLR2I;SLU7;AQR;SF1;ZMAT2;SNIP1;SRSF11;WBP4;ELAVL1;GPKOW;BCAS2;SMNDC1;XAB2;SYF2;FRG1;POLR2D
gsea,response to endoplasmic reticulum stress (GO:0034976),0.6369468620091016,2.2640038644502973,0.0,2.36133519855566e-05,0.002,19/32,25.78%,ERP44;UFM1;PPP1R15B;TMX1;SELENOK;TMCO1;BCAP31;DDRGK1;DERL1;UFC1;ATF6B;OS9;BAG6;WFS1;RNF185;NCK1;DNAJB9;RNF139;ATP2A1
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.7251579817860042,2.2573485023642657,0.0,2.3431710816436933e-05,0.002,11/19,17.46%,CDC42;VASP;WDR1;HCLS1;PYCARD;BIN1;ARF6;STAP1;PFDN2;KATNBL1;FCHSD1
gsea,regulation of protein catabolic process (GO:0042176),0.6073421110254403,2.254692698816261,0.0,2.3252842794937416e-05,0.002,16/36,18.57%,CTSA;NDUFA13;SNF8;OAZ1;VPS28;AGAP2;CHMP6;WWP2;SNX3;MAD2L2;GSK3A;SIRT2;SORL1;SEC22B;SNX12;NKD1
gsea,positive regulation of interleukin-1 beta production (GO:0032731),0.7679403015134125,2.24940785726289,0.0,2.307668489497577e-05,0.002,6/15,11.04%,EGR1;STAT3;PYCARD;CASP8;PANX1;GSDMD
gsea,regulation of actin filament-based process (GO:0032970),0.6768374502291685,2.248188028273957,0.0,2.290317598599099e-05,0.002,9/23,13.43%,ABRACL;RAC2;RHOA;CNN2;RAC1;IQGAP1;ARHGAP18;TWF2;RND1
gsea,substrate adhesion-dependent cell spreading (GO:0034446),0.7744449574758965,2.2448184418084365,0.0,2.2732256762214936e-05,0.002,10/15,18.93%,RHOA;RAC1;ILK;FERMT3;PXN;VAMP3;PARVG;LAMB3;TYRO3;ITGAV
gsea,protein targeting to mitochondrion (GO:0006626),0.691169746682823,2.2438281465448546,0.0,2.256386967508742e-05,0.002,12/20,16.22%,AIP;NDUFA13;DNAJC19;PAM16;TSPO;BCAP31;TIMM10B;TOMM22;TOMM7;TOMM40L;DNLZ;MFF
gsea,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.7865285168877486,2.2412551804441194,0.0,2.2397958868652955e-05,0.002,4/15,5.06%,CDC42;RAC1;ILK;LIMS1
gsea,regulation of stem cell differentiation (GO:2000736),0.6621813140597402,2.240815953007928,0.0,2.2234470117786874e-05,0.002,18/32,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;CBFB;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;NUDT21;PSMB1;PSMF1;LDB1;PSMD8;PSMD4
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.5691638740195919,2.2361998904113087,0.0,2.207335076910726e-05,0.002,20/59,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;ILK;PSMD13;PSMB4;PSMD9;PPM1N;PSMB1;ZEB2;PSMF1;TGFB1;PSMD8;GID8;PSMD4
gsea,mRNA processing (GO:0006397),0.5055281170138685,2.2357296419051833,0.0,2.1914549684437423e-05,0.002,51/99,26.79%,UBL5;HNRNPL;LSM5;ISY1;POLR2K;ZCRB1;LSM6;RALY;SNRPC;SNRNP27;LSM4;POLR2G;AURKAIP1;CWC15;NUDT21;POLR2J;SF3B6;TRA2B;SF3B1;RNGTT;DNAJC8;SF3B5;PUF60;CDC5L;PRPF18;CCNH;GTF2H5;GEMIN7;ZRSR2;POLR2I;SLU7;RAMAC;AQR;SF1;ZMAT2;KIN;SNIP1;SRSF11;CHTOP;WBP4;ELAVL1;GPKOW;BCAS2;SMNDC1;XAB2;SYF2;FRG1;POLR2D;PRMT9;PRKACA;CDC40
gsea,response to calcium ion (GO:0051592),0.7188122361330939,2.235487265159225,0.0,2.1758017186691442e-05,0.002,6/21,5.05%,CALM1;ANXA11;CALM3;IQGAP1;PPP3CA;MEF2A
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.7230379295991755,2.2324773269192972,0.0,2.1603705008062424e-05,0.002,11/20,18.93%,RHOA;RAC1;ILK;FERMT3;PXN;VAMP3;PARVG;LAMB3;TYRO3;YTHDF2;ITGAV
gsea,cell-matrix adhesion (GO:0007160),0.6663483978278724,2.227945826239173,0.0,3.217734936060001e-05,0.003,10/35,9.97%,THY1;ITGB2;ZYX;RAC1;ILK;ITGB1BP1;FERMT3;ITGAL;TIMM10B;ITGA2
gsea,positive regulation of growth (GO:0045927),0.7350719654647646,2.2242115488054264,0.0,3.195233293150491e-05,0.003,4/16,4.39%,CDC42;RPS6KA1;MTPN;SDCBP
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.582788922243671,2.223691052767286,0.0,3.173044173059168e-05,0.003,15/36,17.05%,ARF5;RER1;TAPBP;RAB1A;SURF4;TMED9;TMED10;COPE;RAB1B;TMED7;ERGIC2;COPB1;SEC22B;TMEM115;RAB6A
gsea,small GTPase mediated signal transduction (GO:0007264),0.6041793158847913,2.222793929716025,0.0,3.151161109796691e-05,0.003,16/36,14.11%,GNB1;RASSF1;NUCB1;RAC1;RHEB;GRB2;LAT;G3BP2;RAB18;RALBP1;ARHGAP18;ARHGAP1;ARHGAP30;RGS19;RRAGC;ARHGAP33
gsea,regulation of cell migration (GO:0030334),0.550265116012605,2.221321833198888,0.0,3.129577814524111e-05,0.003,21/91,12.16%,THY1;RHOA;DOCK10;STK24;SEMA4D;RAC1;STK26;PPP3CA;STAT3;MAPRE1;SDCBP;MIEN1;TRADD;PDCD10;MGAT3;FERMT3;DDRGK1;ARHGAP4;SORL1;TGFB1;LDB1
gsea,protein polyubiquitination (GO:0000209),0.46548911871055665,2.2207766853470305,0.0,3.1082881695273484e-05,0.003,49/140,21.15%,RBX1;PSMB8;PSMB3;PSMA2;ANAPC11;PSMB10;PSMA1;CBFB;PSMB9;PSMC3;PSMA7;PSMD13;UBE2L3;UBE2V1;PSMB4;DDA1;PELI1;UBE2A;TPP2;RNF166;MKRN1;WWP2;PSMD9;UBC;RNF187;PSMB1;UBE2D1;UBE2J2;RNF125;ANAPC2;PSMF1;RNF4;UBE2D3;SHARPIN;PSMD8;AMFR;RNF6;FBXO22;PSMD4;TRIM27;FBXO2;ARIH2;FBXW2;UBE2W;FBXO6;RNF20;RNF115;PSMD5;FBXW11
gsea,ceramide metabolic process (GO:0006672),0.6873609375861407,2.21661017774956,0.0,3.0872862224359475e-05,0.003,12/20,15.47%,CERS2;DEGS1;SPTLC2;CERS4;SPTSSA;ORMDL2;ASAH1;PPP2CA;CERS5;PPP2R1A;GBA;PLA2G15
gsea,cytoskeleton organization (GO:0007010),0.6182713018747941,2.216314881853769,0.0,3.066566180674632e-05,0.003,14/39,19.97%,THY1;CAPZB;RAC2;RHOA;CNN2;RAC1;BIN1;SIPA1;ARHGAP4;RND1;SH3KBP1;RND2;ARAP3;FITM2
gsea,regulation of cell differentiation (GO:0045595),0.5846814442907587,2.2119939797282067,0.0,3.0461224061368013e-05,0.003,15/49,13.98%,ID2;YWHAH;RPS6KA1;UQCC2;RUNX3;CBFB;PURB;RUNX2;BIN1;PPP2CA;PPP2R1A;TGFB1;CDK9;GPS2;LTK
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.642290896216833,2.211373537363568,0.0,3.02594941006967e-05,0.003,9/26,14.37%,HMGB2;RHOA;HMGB1;PYCARD;GSTP1;STAP1;CHMP5;SIRT2;TICAM1
gsea,glycosphingolipid metabolic process (GO:0006687),0.7446816542008002,2.208918287997799,0.0,3.006041848161317e-05,0.003,9/18,13.45%,ESYT1;UGCG;GLTP;CTSA;HEXB;ASAH1;SUMF1;GBA;B4GALNT1
gsea,regulation of cell cycle process (GO:0010564),0.6445844741246731,2.207100986103227,0.0,2.9863945158203932e-05,0.003,5/26,6.19%,CALM1;CDC42;CALM3;SH3GLB1;RAB11A
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.5463495148063575,2.204576546104795,0.0,4.945003906066236e-05,0.005,30/64,24.61%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;EMD;PSMD9;MAD2L2;PSMB1;GSK3A;PSMF1;ZNRF3;PSMD8;AMFR;PSMD4;SLC9A3R1;NKD1;STK11;PSMD5;ANKRD6;TLE6;IGFBP6;PSMD10;LIMD1
gsea,supramolecular fiber organization (GO:0097435),0.5477181520343168,2.2025144830339216,0.0,5.8957207860712276e-05,0.006,26/79,18.12%,CDC42;ITM2B;RAC2;RHOA;B2M;RAC1;PPIB;DNAJB6;CRIPT;TMOD3;GGA1;MAD2L2;UBC;FKBP1A;KATNA1;SORL1;DBN1;KATNAL1;CORO1B;RND1;LAMB3;APH1B;B4GALT7;NCSTN;VPS4B;RND2
gsea,post-Golgi vesicle-mediated transport (GO:0006892),0.5501525534227595,2.201443122861627,0.0,5.857927704109233e-05,0.006,27/45,23.60%,FTH1;CLTA;CHMP2A;AP1S2;ARF1;COMMD1;RAB14;RABIF;SCAMP2;GOLGA7;BLOC1S4;SORL1;AP2A1;SYS1;EXOC5;AP1S1;BLOC1S6;SCAMP3;BLOC1S3;RABEP1;DNM2;AP1S3;EXOC6;VAMP2;GOPC;CCDC93;SNAP23
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.677992598373943,2.2005728428554243,0.0,5.820616062681786e-05,0.006,17/28,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;CBFB;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;LDB1;PSMD8;PSMD4
gsea,protein insertion into ER membrane (GO:0045048),0.6950093445840133,2.198510065340237,0.0,5.783776720512914e-05,0.006,13/20,16.25%,UBL4A;SEC61G;TRAM1;EMC7;EMD;SEC61B;EMC10;EMC3;WDR83OS;UBE2J2;VAPA;BAG6;EMC2
gsea,positive regulation of protein transport (GO:0051222),0.6853010834389763,2.197757854926565,0.0,5.747400766295852e-05,0.006,10/23,11.89%,RAB29;IER3IP1;OAZ1;VPS28;TMED10;PDCD10;ARF6;TPR;B3GAT3;TGFB1
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.7578692058424596,2.197237162467036,0.0,5.7114795115065025e-05,0.006,6/15,11.89%,ITGB2;CYBA;GRB2;GSTP1;TGFBR2;TGFB1
gsea,protein deubiquitination (GO:0016579),0.4770355377462667,2.1945520123616267,0.0,5.676004483484723e-05,0.006,39/92,24.43%,PSMB8;PSMB3;RHOA;TAF10;PSMA2;ARRB2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;OTUB1;OTULINL;PSMD9;SNX3;USP25;UBC;PSMB1;UBE2D1;OTULIN;PSMF1;BECN1;TAF9B;PSMD8;ACTR5;NEDD8;PSMD4;TFPT;USP4;BABAM2;PSMD5;USP38;OTUB2;USP48;UFD1;RCE1;PSMD10
gsea,regulation of lipid metabolic process (GO:0019216),0.6447022720314451,2.192530846825877,0.0,5.6409674187718546e-05,0.006,8/26,13.74%,ID2;EDF1;NPC2;CERS2;SIN3B;ZFP69;SREBF1;GPS2
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.7357252724884138,2.1900683499369356,0.0,5.6063602566934996e-05,0.006,9/16,19.49%,CDC42;GRB2;TSG101;MVB12A;SHKBP1;EPN1;SH3KBP1;PTPN2;RNF115
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.5062248322710456,2.1830716865343605,0.0,6.500870988706589e-05,0.007,40/88,25.41%,UBL5;HNRNPL;LSM5;ISY1;POLR2K;ZCRB1;LSM6;RALY;SNRPC;SNRNP27;LSM4;POLR2G;CWC15;NUDT21;POLR2J;SF3B6;TRA2B;SF3B1;DNAJC8;SF3B5;PUF60;CDC5L;GEMIN7;ZRSR2;POLR2I;SLU7;AQR;SF1;ZMAT2;SNIP1;SRSF11;WBP4;ELAVL1;GPKOW;BCAS2;SMNDC1;XAB2;SYF2;FRG1;POLR2D
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.6559851512380077,2.1822413262088807,0.0,7.384539166392247e-05,0.008,9/28,14.33%,CALM1;CALM3;RHOA;PDCD10;PPP2CA;PKD2;TGFB1;MAP2K2;SYAP1
gsea,negative regulation of protein binding (GO:0032091),0.669117798434108,2.180528399295532,0.0,7.340053990691088e-05,0.008,9/19,18.89%,PPP1CA;B2M;ARRB2;TMBIM6;ITGB1BP1;SORL1;CTNNBIP1;MITD1;LRPAP1
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),0.6165136002990154,2.1784253582429716,0.0,7.296101571585153e-05,0.008,10/32,11.89%,ZYX;RHOA;ARRB2;LIMS1;PXN;TGFBR2;UBC;FKBP1A;NR3C1;TGFB1
gsea,regulation of neuron differentiation (GO:0045664),0.7427888346250456,2.17675620393601,0.0,9.065840494454766e-05,0.01,4/19,6.55%,ID2;YWHAH;RHOA;BIN1
gsea,protein modification process (GO:0036211),0.6033023640102477,2.172264862209642,0.0,9.012196467860359e-05,0.01,15/31,17.21%,UBL5;UBE2I;UBL4A;UBE2L3;MAN2B1;WWP2;ATG3;USP25;UBE2D3;NEDD8;FBXO22;FBXO2;B4GALT7;LCMT1;FBXW2
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.7000857406822865,2.1629483295592604,0.0,0.00011646938611699535,0.013,6/18,9.65%,IFNGR1;HMGB1;CYBA;STAT3;PYCARD;PSEN1
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.6812114085749907,2.159146790395101,0.0,0.00011578827859584332,0.013,17/27,15.01%,PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;CBFB;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;LDB1;PSMD8;PSMD4
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.6478308586667914,2.158920158110228,0.0,0.00011511509092958841,0.013,8/26,11.89%,ZYX;RHOA;ARRB2;PXN;TGFBR2;UBC;FKBP1A;TGFB1
gsea,endosome transport via multivesicular body sorting pathway (GO:0032509),0.6878659343061435,2.156614266477092,0.0,0.0001144496857797064,0.013,12/19,18.99%,LEPROTL1;CHMP2A;LEPROT;CHMP6;TMEM50A;CHMP5;MVB12A;CHMP3;VTA1;CHMP2B;VPS4B;CHMP1B
gsea,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.7806777332475879,2.1561314624280716,0.0,0.00012254515426987132,0.014,4/15,1.93%,CDC42;RHOA;WDR1;PDCD6IP
gsea,regulation of cellular component size (GO:0032535),0.7047478958101001,2.1549857025992694,0.0,0.00012184489624547205,0.014,6/17,9.64%,PPP1CA;LAMTOR4;MTPN;RAC1;LAMTOR5;AP2M1
gsea,regulation of translation (GO:0006417),-0.5632499943799025,-2.1536263331819154,0.0,0.0007030159410042423,0.029,14/45,9.06%,RPS4X;RPL26;RPS3;RPL13A;PAIP2;DDX6;CD28;EEF2;EIF3E;EIF3H;SOX4;MALSU1;ALKBH1;EIF4A2
gsea,protein modification by small protein removal (GO:0070646),0.4679586719002874,2.1407745541128476,0.0,0.0001471138662054705,0.017,40/94,24.43%,PSMB8;PSMB3;RHOA;TAF10;PSMA2;ARRB2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;OTUB1;OTULINL;PSMD9;SNX3;USP25;UBC;PSMB1;UBE2D1;COPS8;PSMF1;BECN1;TAF9B;PSMD8;ACTR5;NEDD8;PSMD4;TFPT;USP4;BABAM2;PSMD5;USP38;OTUB2;USP48;UFD1;RCE1;COPS6;PSMD10
gsea,regulation of macroautophagy (GO:0016241),0.5201446429032472,2.1404517824992464,0.0,0.00015488757997305768,0.018,33/52,28.87%,LAMTOR4;SH3GLB1;RHEB;ATP6V1G1;TBK1;LAMTOR3;LAMTOR1;LAMTOR5;CAPNS1;LAMTOR2;PAFAH1B2;SNX6;ATP6V1A;ATP6V0B;CAPN1;ATP6V1E1;GBA;RRAGC;VPS26A;ATP6V0D1;RRAGA;QSOX1;PRKAG1;ATP6V1H;CDK5;UBQLN2;ATP6V1C1;EXOC7;PRKAB1;PRKACA;TRIM13;EXOC1;ATP6V1D
gsea,establishment of protein localization to mitochondrion (GO:0072655),0.6861435995803119,2.1343383424718043,0.0,0.00018824351948036413,0.019,11/18,16.22%,AIP;DNAJC19;PAM16;TSPO;BCAP31;TIMM10B;TOMM22;TOMM7;TOMM40L;DNLZ;MFF
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.48589387114379456,2.1328612106428375,0.0,0.00018719187970673082,0.019,42/103,24.61%,PPP1CA;RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;ILK;PSMD13;PSMB4;EMD;PSMD9;MAD2L2;PPM1N;PSMB1;ZEB2;GSK3A;PSEN1;OTULIN;PSMF1;ZNRF3;TGFB1;PSMD8;AMFR;GID8;PSMD4;SLC9A3R1;NKD1;TRPM4;DAPK3;STK11;PSMD5;ANKRD6;CSNK1G2;TLE6;GNAQ;IGFBP6;PSMD10;LIMD1
gsea,cortical cytoskeleton organization (GO:0030865),0.6876195453854752,2.1312244179362,0.0,0.00018615192481947118,0.019,5/16,6.61%,RAC2;RHOA;FMNL1;RAC1;ARF6
gsea,negative regulation of translation (GO:0017148),-0.6311452380841963,-2.129581205878047,0.0,0.0010410839008695176,0.047,10/27,14.93%,RPS3;RPL13A;PAIP2;DDX6;EIF3E;MALSU1;PUM1;EIF4EBP2;EIF4EBP3;CPEB4
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.6360771406276627,2.1239592043132136,0.0,0.00020195286670520227,0.021,12/25,18.09%,CTSC;CTSB;PDCD6IP;CASP8;VPS4A;UBC;NEDD8;BAG6;CTSW;NGLY1;VPS4B;UBE2W
gsea,positive regulation of cellular protein metabolic process (GO:0032270),-0.579633909804057,-2.1169238169075997,0.001841620626151013,0.0011972932552677294,0.055,13/36,13.03%,RPS4X;RPL26;TBC1D10A;OGT;CD28;EEF2;EIF3E;CAPN3;VGLL4;SOX4;IST1;PTTG1IP;AMER1
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.5261979155905779,2.113753253343941,0.0,0.00022594864001564184,0.022,31/70,24.61%,RBX1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;EMD;PSMD9;MAD2L2;PSMB1;GSK3A;PSMF1;ZNRF3;CTNNBIP1;PSMD8;AMFR;PSMD4;SLC9A3R1;NKD1;STK11;PSMD5;ANKRD6;TLE6;IGFBP6;PSMD10;LIMD1
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.6758843613023693,2.111955976131319,0.0,0.00023303668680827987,0.022,4/20,9.33%,CALM1;YWHAB;RGS14;RGS3
gsea,protein targeting (GO:0006605),0.5093875032399307,2.1035760142386963,0.0,0.0002814352223061175,0.025,28/55,19.43%,SRP14;AIP;SEC61G;CDC37;SDCBP;DNAJC19;RABGEF1;TSPO;VPS37B;ATG3;BCAP31;TIMM10B;TOMM22;SPCS1;TOMM7;SPCS2;LAMP2;GOLGA7;ZFAND6;SORL1;ZDHHC18;ZFAND2B;YIF1B;ZDHHC3;MFF;PEX16;AP1S3;PEX19
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),-0.5446858250770595,-2.10241062560425,0.0,0.001303587045685674,0.063,10/42,9.44%,RPS20;RPL23;RPL37;RPL11;MAPK11;PRKAB2;NOP53;ING2;RAD9B;CDK5R1
gsea,cellular response to lectin (GO:1990858),0.5805087058388625,2.099645390478024,0.0,0.0003094990680032044,0.028,21/37,21.93%,KLRD1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4;PRKACB;PAK2;PSMD5;FBXW11;SRC
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5805087058388625,2.099645390478024,0.0,0.0003094990680032044,0.028,21/37,21.93%,KLRD1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4;PRKACB;PAK2;PSMD5;FBXW11;SRC
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5805087058388625,2.099645390478024,0.0,0.0003094990680032044,0.028,21/37,21.93%,KLRD1;PSMB8;PSMB3;PSMA2;PSMB10;PSMA1;PSMB9;PSMC3;PSMA7;PSMD13;PSMB4;PSMD9;PSMB1;PSMF1;PSMD8;PSMD4;PRKACB;PAK2;PSMD5;FBXW11;SRC
gsea,regulation of tumor necrosis factor production (GO:0032680),0.6048184684698344,2.0962668603525145,0.0,0.00033215696449895966,0.031,12/27,16.65%,IFNGR1;CD47;HMGB1;CYBA;STAT3;PYCARD;GSTP1;PSEN1;PTPN22;TRIM27;ILRUN;CD2
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5982586055049062,2.0959820148316273,0.0,0.0003384580451263113,0.032,10/27,13.26%,IFNGR1;CBFB;CDC37;PYCARD;CASP8;TRADD;CFLAR;OTULIN;SPPL2A;SHARPIN
gsea,regulation of organelle organization (GO:0033043),0.5610284525178165,2.090336064851789,0.0,0.00035270891018426126,0.033,15/39,19.91%,MAPK3;SURF4;TMED9;SAR1B;PDCD10;SCARB2;ZEB2;MARK2;SAR1A;MIEF2;MFF;MAPK1;PAK2;DNM1L;SIRT7
gsea,amide biosynthetic process (GO:0043604),0.6976289741034194,2.089739633503382,0.0,0.00035086226667544314,0.033,8/17,13.32%,CERS2;DEGS1;SPTLC2;CERS4;SPTSSA;ASAH1;CERS5;GBA
gsea,muscle contraction (GO:0006936),0.7079254612912634,2.0890740142007997,0.0,0.00034903485903650856,0.033,7/33,6.13%,MYL6;CALM1;MYL12A;TLN1;EMD;TMOD3;PXN
gsea,regulation of protein dephosphorylation (GO:0035304),0.6974523517858243,2.0850560028679386,0.002380952380952381,0.0003866839323852417,0.036,11/16,19.45%,CALM1;CALM3;ARPP19;YWHAB;PTPA;CAMTA1;TGFB1;GBA;CNEP1R1;NSMF;PPP1R16B
gsea,regulation of interferon-gamma production (GO:0032649),0.7202876882893708,2.084969315640778,0.0,0.000384690716238926,0.036,10/15,16.65%,CD47;HMGB1;LAPTM5;IL12RB1;IL12RB2;PYCARD;CEBPG;PTPN22;TRIM27;CD2
gsea,cellular response to organonitrogen compound (GO:0071417),0.6070777657784154,2.0819040897999592,0.0,0.00039052851360728226,0.036,13/28,19.12%,LAMTOR4;RAP1B;EGR1;LAMTOR3;LAMTOR1;LAMTOR5;LAMTOR2;PKD2;P2RY12;RRAGC;HCN2;RRAGA;NSMF
gsea,positive regulation of TOR signaling (GO:0032008),0.6478572424606205,2.081730565209012,0.0,0.0003885360211909186,0.036,9/22,17.73%,LAMTOR4;RHEB;LAMTOR3;LAMTOR1;LAMTOR5;LAMTOR2;SEC13;RRAGC;RRAGA
gsea,RNA splicing (GO:0008380),0.5951047007401006,2.0809034627431147,0.0,0.0003865637571239596,0.036,17/31,23.32%,ZCRB1;LSM6;LSM4;TRA2B;SF3B1;PPP2CA;PRPF18;USB1;PPP2R1A;ZRSR2;RRAGC;SLU7;SRSF11;WBP4;NOL3;BCAS2;SMNDC1
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.694159110283443,-2.078779828222159,0.0,0.0016739330973783875,0.085,7/17,4.34%,RPL23;RPS7;RPL11;OGT;FHIT;EIF3H;NOP53
gsea,membrane fusion (GO:0061025),0.711406199770198,2.078424284756377,0.0,0.0003999958715129133,0.038,12/15,25.19%,RABIF;VTI1B;VAMP3;SNAP29;VAPA;RABEP1;DNM2;NAPG;DNM1L;VAMP2;SNAP23;UBXN2A
gsea,protein targeting to membrane (GO:0006612),0.5410586645972522,2.0778726470842903,0.0,0.00039798584200782333,0.038,16/39,19.43%,SRP14;RAB8B;TRAM1;SRP19;SDCBP;RABGEF1;VPS37B;SSR1;ATG3;GOLGA7;ATAD1;ZDHHC18;YIF1B;ZDHHC3;PEX16;PEX19
gsea,organonitrogen compound biosynthetic process (GO:1901566),0.5374872668615368,2.0767629505106857,0.0,0.0003959959127977842,0.038,21/52,22.84%,CSNK2B;CERS2;ELOVL1;DEGS1;ESD;GSTP1;SPTLC2;CERS4;SPTSSA;AKR1A1;PHOSPHO1;CERS5;MOCS2;MOCOS;VAPA;PLA2G4C;CEPT1;MOCS3;CSNK1G2;VAPB;PCYT1B
gsea,receptor metabolic process (GO:0043112),0.6484494358289766,2.074909457131777,0.0,0.00041675804064060713,0.04,10/21,17.30%,ITGB2;ARRB2;SH3GLB1;GRB2;AP2M1;MVB12A;TGFB1;BECN1;RAB31;DNM2
gsea,cellular response to interferon-gamma (GO:0071346),0.6589811082403192,2.0739390060441547,0.002070393374741201,0.0004297746959153408,0.042,5/20,6.16%,IFNGR1;CD47;B2M;IL12RB1;SP100
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.5711582700584061,-2.073772926363283,0.0,0.001718770591058166,0.09,7/30,5.55%,RPS4X;RPL26;CD28;EEF2;EIF3E;INSR;SOX4
gsea,phosphate-containing compound metabolic process (GO:0006796),0.5116537663390822,2.0715787916604906,0.0,0.00042765757918669385,0.042,18/59,24.61%,CALM1;PLAAT3;PPP1CA;MAPK3;PPP3CA;STAT3;IMPA1;INPP5D;ITPK1;TGFB1;PLA2G15;INPP1;PLA2G4C;PAK2;CDK5;LPCAT4;PLCD4;LIMD1
gsea,positive regulation of catalytic activity (GO:0043085),0.6669969541980671,2.069465432549104,0.0,0.000433027204793957,0.042,7/18,17.69%,MAPK3;YWHAB;SSBP1;PSEN1;B3GAT3;NCSTN;CHTOP
gsea,canonical Wnt signaling pathway (GO:0060070),-0.6026492787063542,-2.069424659233698,0.0,0.0017443066112681727,0.095,5/23,8.47%,TCF7;LEF1;BCL9;CTNNB1;FRAT1
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.6085589851190476,2.06791066854148,0.0,0.00043834444380992996,0.043,9/23,14.72%,ELOB;POLR2K;POLR2G;POLR2J;CCNH;GTF2H5;CDK9;POLR2I;TCEA1
gsea,regulation of protein kinase activity (GO:0045859),0.5628885011334442,2.067345621303534,0.0,0.00043621655816036717,0.043,11/36,19.25%,THY1;IQGAP1;LAT;AGAP2;ITGB1BP1;GSTP1;TRIM27;SLC9A3R1;ANKRD54;PAK2;PRKAG1
gsea,regulation of fat cell differentiation (GO:0045598),0.6542200439985612,2.0634572877619934,0.0,0.00047089814974095486,0.046,7/20,14.33%,ID2;CCDC71L;SIRT2;LRP5;TGFB1;GPS2;SYAP1
gsea,regulation of actin cytoskeleton organization (GO:0032956),0.590503240690897,2.0596627514555745,0.0,0.0004979238548492848,0.049,12/29,24.24%,ARHGDIB;RAC2;RHOA;RAC1;IQGAP1;ARHGAP18;TWF2;RND1;RND2;DAPK3;TWF1;RAC3
gsea,neuron projection development (GO:0031175),0.5142139285892836,2.054827216377368,0.0,0.0005538404374794185,0.055,18/56,17.37%,CDC42;HMGB1;DOCK10;EHD1;DBNL;ATXN10;RAB11A;RAB35;MARK2;BLOC1S4;DBN1;SVBP;GBA;BLOC1S6;VAPA;BLOC1S3;DNM2;TAOK3
gsea,cellular response to lipopolysaccharide (GO:0071222),0.5932640923698431,2.0547560542623065,0.0,0.0005512031020628497,0.055,10/27,14.37%,HMGB2;RHOA;HMGB1;PYCARD;GSTP1;STAP1;CHMP5;TGFB1;PTPN22;TICAM1
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5655915664348294,2.05198304145511,0.0,0.0005702456637080741,0.057,10/39,11.89%,ZYX;RHOA;ARRB2;MAPK3;RUNX2;PXN;TGFBR2;UBC;FKBP1A;TGFB1
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.6165422787225244,2.051600853923286,0.0023752969121140144,0.0005675558256717153,0.057,9/22,14.72%,ELOB;POLR2K;POLR2G;POLR2J;CCNH;GTF2H5;CDK9;POLR2I;TCEA1
gsea,protein complex oligomerization (GO:0051259),0.5854432553072683,2.0488177356234094,0.0,0.0006006438547312003,0.059,15/31,24.15%,EHD1;PDCD6IP;PYCARD;LRRC8C;CHMP2A;G3BP2;NUDT21;PKD2;GSDMD;DNM1L;ELAVL1;NOL3;UGDH;SPAST;RNF135
gsea,positive regulation of intracellular transport (GO:0032388),0.6812741939966498,2.047545518594324,0.0,0.0005978371077464751,0.059,7/17,11.54%,EHD1;RAB29;OAZ1;PDCD10;TPR;B3GAT3;SORL1
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.6944985129644388,-2.0468729648003046,0.0,0.002266510669527252,0.119,5/15,5.96%,RPL26;CDKN1B;CNOT6L;SOX4;CNOT2
gsea,nucleotide-excision repair (GO:0006289),0.5639319642821344,2.046298223721483,0.0,0.0006092244812273603,0.06,17/30,25.41%,RBX1;ISY1;POLR2K;POLR2G;POLR2J;COMMD1;UBC;COPS8;CCNH;GTF2H5;POLR2I;TCEA1;AQR;ERCC1;XAB2;COPS6;POLR2D
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.6035789129318558,2.0406282188527194,0.0,0.0006628136717056929,0.064,16/21,25.41%,RBX1;ISY1;POLR2K;POLR2G;POLR2J;UBC;COPS8;CCNH;GTF2H5;POLR2I;TCEA1;AQR;ERCC1;XAB2;COPS6;POLR2D
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.6860289104795134,2.035138050714761,0.0,0.0006948528069298232,0.067,6/17,10.91%,RAC2;RAC1;GRB2;TGFBR2;FOXM1;SIRT2
gsea,positive regulation of cellular biosynthetic process (GO:0031328),-0.5035219749996714,-2.034742774567703,0.0,0.0024881250461032496,0.133,9/47,5.55%,RPS4X;RPL26;HIF1A;CD28;EEF2;EIF3E;KLF2;INSR;SOX4
gsea,iron ion transport (GO:0006826),0.6035589616561405,2.031752811748724,0.0,0.0007196114858534186,0.069,13/23,24.11%,FTH1;ATP6V1G1;ATP6V1A;ATP6V0B;ARHGAP1;ATP6V1E1;ATP6V0D1;DNM2;ATP6V1H;MCOLN1;ATP6AP1;ATP6V1C1;RAB11B
gsea,neuron differentiation (GO:0030182),0.6096285924666217,2.0232560384606497,0.0,0.0007858717623138322,0.075,8/34,14.88%,ID2;UGCG;RUNX3;MTPN;RUNX2;LDB1;DTNB;VAX2
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6983359416893158,2.0224233334789954,0.0,0.0007822996179396785,0.075,4/17,2.78%,GNG2;CALM1;GNB1;PPP3CA
gsea,positive regulation of protein ubiquitination (GO:0031398),0.5572351404838687,2.021472333464311,0.0,0.0007856514803158267,0.076,13/33,21.04%,RBX1;NDFIP2;LAPTM5;UBE2L3;CENPX;COMMD1;GSK3A;UBE2D1;FKBP1A;DERL1;NSMCE3;PDCD6;WFS1
gsea,T cell activation (GO:0042110),0.5974274706913953,2.021167489536426,0.0,0.0008095550538832039,0.078,15/26,18.53%,CD3G;SLA2;PPP3CA;LAT;RAB29;CASP8;LFNG;ITK;FKBP1A;ZAP70;LCK;PTPN22;CD2;CD3E;PTPN2
gsea,nitrogen compound transport (GO:0071705),0.5743734605897561,2.020221218639584,0.0,0.0008195845038933098,0.079,14/39,22.00%,CD3G;TMEM30A;SLC48A1;CHMP2A;SCARB2;RALBP1;SCAMP2;CHMP3;CHMP2B;SCAMP3;CHMP1B;SLC36A1;PPT1;VAMP2
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6515387851889709,2.0179030435095124,0.0020833333333333333,0.0008567219267259753,0.082,6/19,9.65%,IFNGR1;HMGB1;CYBA;STAT3;PYCARD;PSEN1
gsea,positive regulation of translation (GO:0045727),-0.5571253694951424,-2.0170231145362694,0.0018552875695732839,0.003002586991726102,0.159,7/34,5.55%,RPS9;RPS4X;RPL26;CD28;EEF2;EIF3E;SOX4
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5020703955787983,2.0167768509407376,0.0,0.0008596834346208305,0.083,16/47,21.86%,ID2;ARRB2;PYCARD;SP100;WWP2;EOMES;MAD2L2;COMMD1;PKD2;OTULIN;CEBPG;CTNNBIP1;COMMD7;WFS1;HES6;BRMS1
gsea,positive regulation of protein kinase activity (GO:0045860),0.5133790621919431,2.01666424348088,0.0,0.0008558795256180835,0.083,22/46,25.74%,CALM1;UNC119;CALM3;RHOA;EGR1;IQGAP1;LAT;AGAP2;PDCD10;TGFBR2;PPP2CA;MARK2;MAP2K2;SYAP1;TAOK3;PAK2;PRKAG1;STK11;SRC;PARP16;MTCP1;CAB39
gsea,protein homooligomerization (GO:0051260),0.6089453036348237,2.0143363118987585,0.0,0.0008655281726688268,0.083,14/29,24.15%,B2M;EHD1;PDCD6IP;PYCARD;CHMP2A;G3BP2;SSBP1;PKD2;GSDMD;TRPM4;ELAVL1;MCOLN1;SPAST;RNF135
gsea,regulation of neuron death (GO:1901214),0.6142800481249447,2.0137122875318467,0.0021321961620469083,0.0008617319964729108,0.083,7/22,13.32%,ITGB2;EGR1;RAB29;BTBD10;TBK1;SORL1;GBA
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.6747154156433102,2.0136796265429266,0.0017064846416382253,0.0008579689746542518,0.083,8/19,16.43%,MAPK3;GRB2;POLR2K;POLR2G;POLR2J;RAB14;POLR2I;MAPK1
gsea,regulation of cytoskeleton organization (GO:0051493),0.5469441429931778,2.0116075564857483,0.0,0.0008741046904566473,0.084,14/39,18.18%,RAC2;RHOA;RAC1;IQGAP1;MAPK3;MARK2;ARHGAP18;TWF2;RND1;PFDN2;KATNBL1;MAPK1;RND2;PAK2
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.6680536879074576,-2.0107482204165565,0.0,0.0031835356760486224,0.171,5/17,5.96%,RPL26;CDKN1B;CNOT6L;SOX4;CNOT2
gsea,cellular response to growth factor stimulus (GO:0071363),0.5248957246978008,2.0099786858174697,0.0,0.0008901007030919226,0.084,16/44,14.85%,EHD1;IQGAP1;ITGB1BP1;LIMS1;EMD;RUNX2;TGFBR2;RAB35;SIRT2;NTRK1;TWF2;NR3C1;TGFB1;CORO1B;SYAP1;RPS6KB1
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.6173713129294122,2.0040650908611335,0.0,0.0009322184949815211,0.088,7/20,10.72%,UNC119;RHOA;PDCD6IP;DCTN3;VPS4A;RAB35;ALKBH4
gsea,cytoplasmic microtubule organization (GO:0031122),0.6670310931228751,2.0005849280866768,0.0,0.0009739747607604794,0.092,8/17,23.91%,RHOA;CRIPT;RAB11A;KATNA1;KATNAL1;VPS4B;SPAST;TPPP
gsea,cell projection organization (GO:0030030),0.7034898223117585,1.9987339744489185,0.0,0.0009958477096985697,0.094,5/15,13.01%,CDC42;RAC2;RAC1;P2RY12;PARVG
gsea,circulatory system development (GO:0072359),0.6014601226464449,1.9965809081297423,0.0,0.001062902286396671,0.099,8/28,11.89%,ID2;CASP8;MEF2A;TGFBR2;PKD2;PDLIM2;TCF25;TGFB1
gsea,negative regulation of cellular amide metabolic process (GO:0034249),-0.5976216614733142,-1.9942123965790444,0.0,0.003692901384216402,0.194,7/24,11.56%,RPS3;RPL13A;PAIP2;DDX6;ORMDL1;MALSU1;RTN4
gsea,positive regulation of protein phosphorylation (GO:0001934),0.47063822540316635,1.9922198699199778,0.0,0.0011229349548046684,0.107,34/86,29.97%,CALM1;CALM3;SEMA4D;CSNK2B;RAC1;IQGAP1;MAPK3;HCLS1;ILK;LAT;SDCBP;AGAP2;PDCD10;TBK1;RPS6KA4;MAD2L2;RALBP1;DDRGK1;NTRK1;TGFB1;CDK9;MAPK1;PAK2;PRKAG1;SRC;AKT2;FNIP2;MTCP1;CAB39;UBE2K;IL11;HDAC3;CRKL;BRAF
gsea,toll-like receptor signaling pathway (GO:0002224),0.5764532103413269,1.9918517544332242,0.002053388090349076,0.0011181968326324967,0.107,9/25,14.37%,ITGB2;HMGB1;CTSB;CASP8;NMI;UBC;UBE2D1;UBE2D3;TICAM1
gsea,RNA processing (GO:0006396),0.4863995152711334,1.9898034001906768,0.002207505518763797,0.001139096193891493,0.109,24/59,22.65%,RBM3;RBMS1;HNRNPL;LSM5;ZCRB1;LSM6;LSM4;AURKAIP1;NUDT21;SF3B1;RNGTT;PPP2CA;PRPF18;USB1;PPP2R1A;ZRSR2;RRAGC;SLU7;KIN;SRSF11;WBP4;RBMS2;NOL3;BCAS2
gsea,negative regulation of cytokine production (GO:0001818),0.5041382950530503,1.986123706904069,0.0,0.0011916838701832256,0.114,18/52,17.26%,TBX21;HMGB1;LAPTM5;SRGN;RAC1;PYCARD;PPP1R11;N4BP1;TBK1;RPS6KA4;JAK3;RNF125;PTPN22;GBA;TRIM27;ILRUN;CUEDC2;ADCY7
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.5792506193232767,1.9855901132586922,0.002074688796680498,0.0011994106974163655,0.116,7/25,11.64%,DYNLL1;DCTN3;MAPRE1;RAB11A;SSNA1;PAFAH1B1;PPP2R1A
gsea,plasma membrane bounded cell projection assembly (GO:0120031),0.44744262872674484,1.9847252851106862,0.0,0.0011944338895432686,0.116,22/103,18.84%,ACTR3;FXYD5;RAP1B;EHD1;RAC1;DYNLL1;STK26;RAB8B;RAB1A;SDCBP;RAB8A;RAB11A;ARF6;ARHGEF6;CFAP20;P2RY12;EXOC5;SNAP29;ATP6V0D1;SLC9A3R1;EXOC6;BBIP1
gsea,positive regulation of intracellular signal transduction (GO:1902533),0.4228988638445895,1.9846808357320438,0.0,0.001189498212313751,0.116,59/151,22.98%,LITAF;S100A13;NDFIP2;RAC2;RHOA;HMGB1;LAMTOR4;LAPTM5;SEMA4D;RAC1;IQGAP1;RHEB;GRB2;HCLS1;ILK;HCST;TMEM9B;UBE2V1;CASP8;ITGB1BP1;GOLT1B;LIMS1;NMI;TRADD;PELI1;TBK1;LAMTOR3;LAMTOR1;LAMTOR5;BCAP31;IFI35;LAMTOR2;SEC13;CFLAR;SLC35B2;FKBP1A;NTRK1;TGFB1;LCK;BECN1;NOD1;P2RY12;SHARPIN;RRAGC;TICAM1;VAPA;TRIM27;SLC9A3R1;VAV1;RRAGA;ITGAV;DNM1L;RNF13;MYD88;ATP2C1;SRC;AKT2;LURAP1;BRD4
gsea,neuron projection morphogenesis (GO:0048812),0.5480682151310617,1.9815685775106964,0.0,0.0012034063826713288,0.116,13/41,24.01%,CDC42;DOCK10;IQGAP1;DBNL;MEF2A;RAB8A;DBN1;RAB3A;DNM2;TAOK3;CDK5;POU4F1;MAPK8IP2
gsea,synapse organization (GO:0050808),0.6259085458218566,1.981216195681895,0.0,0.0012047164434106613,0.117,11/26,26.11%,CDC42;DBNL;RAB29;CAST;PSEN1;CACNB4;LRFN4;CDK5;POU4F1;NRXN2;LRRC4C
gsea,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3916173148097278,1.9803380231556142,0.0,0.0012122323861156659,0.119,103/314,29.74%,ID2;LITAF;ACTR3;YWHAH;RPS6KA1;TBX21;HMGB2;HMGB1;RBPJ;EDF1;SSBP4;EGR1;RUNX3;MAPK3;PPP3CA;STAT3;PSMC3;HCLS1;FLI1;ILK;YAF2;UBE2V1;WAS;ITGB1BP1;GLMP;MEF2A;MLX;RUNX2;SP100;TBK1;EOMES;PSMD9;RPS6KA4;MAD2L2;FOXM1;UBC;RNF187;ZEB2;PSEN1;DDRGK1;PKD2;CDC5L;MED19;CEBPG;SIRT2;HTATIP2;PCBD2;SREBF1;MED10;NR3C1;LRP5;RNF4;TGFB1;LDB1;BCL2L12;CDK9;CCNC;SERTAD2;MAP2K2;MED6;ATF6B;GPS2;SETD3;HOXC4;AKIRIN1;RNF6;TCEA1;KMT2E;NR1H2;GALR3;TMF1;SFR1;LAGE3;MTF1;MED21;DNM2;RNF20;SIRT7;SERTAD1;USF1;CHCHD2;FOXD2;FBXW11;RYBP;PPARD;SERTAD3;POU4F1;BRD4;NCK1;SMARCD2;NR1I3;GALR2;NR4A2;DEAF1;TRIAP1;CEBPA;SMARCD3;IL11;LHX2;HDAC3;SMAD2;HEY1;PPP3R1
gsea,regulation of cell adhesion (GO:0030155),0.5734185676503869,1.9799582696413933,0.0,0.0012196872235954266,0.12,12/35,18.93%,ARHGDIB;RAC2;SEMA4D;PPP3CA;CD164;ITGB1BP1;SIPA1;PPP2CA;PPP2R1A;RND1;YTHDF2;ITGAV
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),0.5498058311786447,1.9792665961954998,0.00228310502283105,0.0012209154583301348,0.121,22/31,30.83%,UBXN8;SEC61B;UBE2J2;JKAMP;DERL1;AMFR;OS9;RNF121;BAG6;FBXO2;FBXO6;WFS1;UBQLN2;RNF185;EDEM2;UFD1;DNAJB9;TRIM13;UBE2J1;UBE2G2;SGTA;AUP1
gsea,regulation of GTPase activity (GO:0043087),0.5248614787248717,1.977896539776796,0.0,0.001222133787946015,0.121,10/45,17.40%,THY1;DOCK10;SEMA4D;MAPRE2;ITGB1BP1;LIMS1;RALBP1;NTRK1;CHN1;VAV1
gsea,modification-dependent protein catabolic process (GO:0019941),0.44081286421567273,1.9777817395042547,0.0,0.0012172256201229386,0.121,37/84,26.20%,RBX1;NDFIP2;ANAPC11;NTAN1;UBE2I;PSMD13;UBE2L3;PPP1R11;PTTG1;UBE2A;RNF166;PSMD9;UBC;UBE2D1;RNF125;ANAPC2;PSMF1;ZNRF3;UBL7;NEDD8;AMFR;RNF6;OS9;FBXO22;BAG6;ARIH2;KCTD6;FEM1C;RNF20;RNF13;UBQLN2;RNF185;RNF7;UFD1;KCTD10;SMURF1;UBE2K
gsea,negative regulation of immune response (GO:0050777),0.5579310676600642,1.9752642028173413,0.0,0.0012610946761406358,0.123,20/45,26.09%,GNG2;CD3G;GNB1;PDCD1;NMI;PRKAR1A;SIRT2;ADCY3;TRIM27;TYRO3;ILRUN;ADCY7;SAMSN1;PRKACB;GPR176;SRC;GGT1;HRH2;AVPR2;PRKACA
gsea,regulation of gene silencing by miRNA (GO:0060964),0.6485746420917954,1.9734802870501795,0.0,0.00127427431332416,0.125,12/17,25.41%,STAT3;POLR2K;POLR2G;TPR;POLR2J;SEC13;TGFB1;POLR2I;ELAVL1;NUP50;LIMD1;POLR2D
gsea,regulation of interleukin-6 production (GO:0032675),0.647723128780456,1.9708892568417824,0.0,0.0013296566058533655,0.132,7/20,13.32%,CD47;HMGB1;CYBA;STAT3;PYCARD;PTPN22;GBA
gsea,"transcription, DNA-templated (GO:0006351)",0.4512540808903874,1.970769486020208,0.0,0.0013244010461464352,0.132,32/69,25.57%,ELOB;TAF10;ARRB2;CBFB;POLR2K;MEF2A;POLR2G;POLR2J;RNGTT;GTF2B;CCNH;GTF2H5;TAF12;KLF13;TRIP11;TAF13;CDK9;TAF9B;RRAGC;POLR2I;TCEA1;TBPL1;CRCP;GCM2;PIR;GTF3C6;XAB2;ABT1;NR4A2;DEAF1;POLR2D;NELFB
gsea,anterograde trans-synaptic signaling (GO:0098916),0.5542795531234505,1.969443347978594,0.0,0.001343172084595755,0.135,18/43,27.54%,CALM1;RPS6KA1;UNC119;SDCBP;PAFAH1B1;PRKAR1A;CNP;CACNB4;GALR3;BSN;MAPK1;PRKACB;GPR176;CDK5;HRH2;NRXN2;PRKACA;CHRNB2
gsea,positive regulation of GTPase activity (GO:0043547),0.49594369840358515,1.9670667573552332,0.0,0.0013498503211508178,0.135,12/57,12.19%,THY1;DOCK10;SEMA4D;MAPRE2;LIMS1;SIPA1;TBC1D10C;RALBP1;TBC1D9B;NTRK1;TBC1D16;TBC1D2B
gsea,protein ubiquitination (GO:0016567),0.3875042528084087,1.9665221477791934,0.0,0.0013505269261583084,0.135,78/206,28.29%,RBX1;PSMB8;ELOB;PSMB3;PSMA2;ANAPC11;ARRB2;PSMB10;PSMA1;CBFB;PSMB9;PSMC3;PSMA7;PSMD13;UBE2L3;UBE2V1;PSMB4;DDA1;PELI1;UHRF2;UBE2A;TPP2;RNF166;MKRN1;WWP2;PSMD9;ATG3;COMMD1;UBC;RNF187;PSMB1;PCNP;UBE2D1;OTULIN;UBE2J2;RNF125;DERL1;PSMF1;RNF4;ZNRF3;UBE2D3;PSMD8;NEDD8;AMFR;RNF6;OS9;FBXO22;PSMD4;TRIM27;FBXO2;ARIH2;FBXW2;RRAGA;RNF181;UBE2W;FBXO6;RNF20;RNF115;RNF13;CUL2;PSMD5;FBXW11;RNF185;RNF7;FBXO9;RNF135;KCTD10;PSMD10;RNF139;KLHL18;SMURF1;UBE2K;ZNRF2;UBOX5;CCDC22;TRIM2;TRIM13;UBE2J1
gsea,cellular response to chemical stress (GO:0062197),0.5897082164660793,1.9662447205974998,0.0,0.0013511982657571804,0.135,8/24,10.91%,NCF4;CYBA;PRDX6;GSTP1;MGAT3;PRDX5;PKD2;SIRT2
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.5765722167311398,1.9650824223170689,0.00186219739292365,0.0013931877671478393,0.14,13/30,21.09%,CAPZB;SEMA4D;SP100;RNH1;LFNG;MARK2;HTATIP2;TGFB1;CHN1;PAK2;NSMF;FITM2;CDK5
gsea,peptide metabolic process (GO:0006518),0.5792381686592062,1.9650478086217364,0.0,0.001387808663799778,0.14,10/26,10.52%,SEC11C;GSTP1;MGAT3;SEC11A;SPCS1;ETHE1;PSEN1;SPCS2;GLRX2;LTA4H
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.6631220616885262,-1.964697440650652,0.0,0.004942455524517491,0.247,3/17,0.68%,RPL23;RPS7;RPL11
gsea,negative regulation of cell adhesion (GO:0007162),0.6191129256827511,1.9632924761058803,0.0,0.001411760576690325,0.144,8/23,13.43%,ARHGDIB;RHOA;SEMA4D;CD164;ITGB1BP1;SIPA1;TGFB1;RND1
gsea,receptor-mediated endocytosis (GO:0006898),0.5926199496601354,1.9626397676657878,0.0,0.0014238579829451714,0.146,15/30,20.20%,ITGB2;ARRB2;GRB2;CLTA;AP2S1;SCARB2;AP2M1;SORL1;AP2A1;AP1S1;RAB31;DNM2;GPR107;FCHO1;PPT1
gsea,regulation of cell growth (GO:0001558),0.4656750673200281,1.9619055415577227,0.0,0.0014358630425873851,0.147,21/55,25.22%,CDC42;RPS6KA1;MTPN;NDUFA13;SDCBP;LAMTOR1;MAD2L2;LAMTOR2;SIPA1;PPP2CA;PPP2R1A;TGFB1;SERTAD2;TAF9B;MINAR1;PPT1;STK11;SERTAD3;ADAM10;PSMD10;EGLN2
gsea,negative regulation of apoptotic process (GO:0043066),0.4297097497393379,1.9598855576159613,0.0,0.0014883145596523914,0.152,52/128,24.90%,IL2RB;RPS6KA1;YWHAZ;SEMA4D;MAPK3;UFM1;DNAJB6;BEX3;BAG1;HCLS1;NAA38;TMBIM6;BNIP2;AGAP2;MIEN1;GSTP1;PDCD10;PRDX5;LAMTOR5;PRKCH;UBC;CIAPIN1;TMBIM4;PSEN1;DDRGK1;SNX6;DNAJC3;CFLAR;NTRK1;HTATIP2;ZFAND6;TAF9B;LTK;MAEA;RPS6KB1;TRIM27;TYRO3;MAPK1;PAK2;MYD88;PPT1;BABAM2;WFS1;NOL3;SRC;AKT2;POU4F1;ADAM10;MAPK8IP2;PSMD10;HYPK;NR4A2
gsea,mitochondrial translational termination (GO:0070126),0.5439203531599694,1.9536846371502636,0.0,0.0015576762304108642,0.162,18/39,14.30%,MRPL33;MRPS18C;MRPS14;MRPL54;MRPS36;MRPS24;MRPL57;MRPL4;MRPS21;MRPS15;AURKAIP1;MRPS16;MRPL58;MTRF1L;MRPS26;MRPS33;MRPS23;MRPL27
gsea,regulation of interleukin-1 beta production (GO:0032651),0.6207203706633205,1.9501993838506133,0.0,0.0015862826114976549,0.165,7/18,11.04%,EGR1;STAT3;PYCARD;CASP8;GSTP1;PANX1;GSDMD
gsea,cellular protein-containing complex assembly (GO:0034622),0.4827438875402411,1.9496128256302776,0.0,0.0015860449370298758,0.166,29/56,25.00%,CYBA;CSNK2B;CLTA;POMP;AP2S1;PSMD13;SRP19;CHMP2A;PXN;RAB5IF;BIN1;TPR;AP2M1;GTF2B;FKBP1A;CHMP3;TGFB1;VAMP3;PSMD4;TBCC;TBCA;CD3E;FCHO1;SRC;VAMP2;TBCD;NCK1;MAPK8IP2;CHMP4B
gsea,negative regulation of programmed cell death (GO:0043069),0.4315111641734089,1.9494707407384004,0.0,0.0015858090428951886,0.166,39/97,24.73%,IL2RB;RPS6KA1;YWHAZ;LAPTM5;SEMA4D;UFM1;BAG1;NAA38;TMBIM6;BNIP2;MIEN1;GSTP1;PDCD10;PRDX5;UBC;CIAPIN1;TMBIM4;PSEN1;DDRGK1;DNAJC3;CFLAR;NTRK1;HTATIP2;ZFAND6;TAF9B;LTK;RPS6KB1;PAK2;MYD88;PPT1;BABAM2;WFS1;NOL3;SRC;AKT2;POU4F1;ADAM10;PSMD10;HYPK
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.659223355264267,1.9472865652956126,0.0,0.0016083071659267066,0.169,6/15,11.64%,DYNLL1;DCTN3;MAPRE1;SSNA1;PAFAH1B1;PPP2R1A
gsea,mitochondrial translation (GO:0032543),0.5338415219541832,1.9471111844599696,0.0,0.001602328328878652,0.169,20/41,20.14%,MRPL33;MRPS18C;MRPS14;MRPL54;MRPS36;MRPS24;MRPL57;MRPL4;MRPS21;MRPS15;AURKAIP1;MRPS16;MRPL58;MTRF1L;MRPS26;MRPS33;MRPS23;MRPL27;MRPL10;MRPL21
gsea,mitochondrial transport (GO:0006839),0.5985189823101329,1.9470412910221067,0.0,0.0015963937795124346,0.169,12/21,21.60%,AIP;DNAJC19;TSPO;TMEM14C;BCAP31;TIMM10B;TOMM22;TOMM7;MFF;STARD3;SLC25A16;SLC25A4
gsea,regulation of cell division (GO:0051302),0.6062915674312607,1.9452304056799503,0.0,0.0016410843959260995,0.172,6/21,12.45%,CALM1;CALM3;SH3GLB1;RAB11A;SIRT2;BECN1
gsea,regulation of cellular catabolic process (GO:0031329),0.5756477229807737,1.9451306674901576,0.0,0.0016350509974116655,0.172,9/26,19.85%,VPS29;RAB8A;SCARB2;DRAM2;RRAGC;RMC1;RRAGA;DAPK3;PIP4K2C
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.518036816191762,1.9433307222628378,0.0,0.0016681146509796771,0.176,14/34,27.37%,RBX1;ELOB;LAPTM5;DDA1;GSK3A;DDRGK1;SIRT2;FBXO22;ARIH2;PSMD10;RNF139;SMURF1;CEBPA;CCDC22
gsea,negative regulation of transport (GO:0051051),0.6249552556630177,1.942891597091593,0.0,0.0016731438763634623,0.177,9/19,20.42%,NDFIP2;WWP2;SNX3;PIP4P2;NR1H2;MTMR2;SNX12;ITGAV;RUBCN
gsea,regulation of heart contraction (GO:0008016),0.6651293604626786,1.9416796964300196,0.0,0.001705828547436609,0.179,9/19,26.09%,CALM1;CALM3;GSK3A;SRI;PDE4D;FKBP1B;ATP2A1;GJA5;PRKACA
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5445222355042332,1.9397364144510996,0.0,0.0017162030222980893,0.182,12/29,12.48%,HMGB1;LAPTM5;BEX3;NDUFA13;PYCARD;CASP8;TRADD;MTCH1;BCAP31;CFLAR;LCK;NOD1
gsea,protein dephosphorylation (GO:0006470),0.4784486252582967,1.9347533488535416,0.0,0.0018254740773238594,0.194,24/57,24.37%,PPP1CA;PTPN18;PPP3CA;PPP1CC;PPM1H;PPP1R15B;PPP6C;EYA2;SSU72;PPP2CA;PTPRA;PPP2R1A;PTPN22;PPP3CC;ILKAP;MTMR2;TNS2;PTPN2;FAM220A;STK11;FBXW11;NCK1;MTMR6;PTPRR
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4905412692208849,1.934149353689212,0.0,0.001835343536071634,0.195,21/49,31.70%,YWHAZ;HMGB1;ARRB2;MAPK3;PYCARD;ITGB1BP1;GSTP1;RGS14;NTRK1;TGFB1;PTPN22;SLC9A3R1;PTPN2;ATP6AP1;PTPRR;FGFR3;LGALS9;CRKL;BRAF;AGER;DUSP9
gsea,ERBB signaling pathway (GO:0038127),0.6716759589190882,1.9339479510720334,0.0,0.0018342242445554934,0.196,6/15,16.43%,IQGAP1;PTPN18;GRB2;CDC37;TGFB1;MAPK1
gsea,regulation of TOR signaling (GO:0032006),0.5695520267200321,1.9336342604805596,0.0,0.001827673443682081,0.196,14/30,18.77%,LAMTOR4;RHEB;LAMTOR3;LAMTOR1;LAMTOR5;LAMTOR2;SEC13;GSK3A;GBA;NPRL2;RRAGC;MINAR1;RRAGA;PDCD6
gsea,Wnt signaling pathway (GO:0016055),-0.5097643694541054,-1.9303391456597738,0.0,0.007083790221718299,0.338,13/34,25.22%,TCF7;LEF1;UBA52;BCL9;CSNK1G3;CTNNB1;FRAT1;AMER1;DVL2;DVL1;APC;ZRANB1;WNT16
gsea,regulation of MAPK cascade (GO:0043408),0.5439342579501664,1.923795889885989,0.0,0.0020000341065204265,0.217,12/34,18.18%,YWHAZ;HMGB1;LAPTM5;IQGAP1;MAPK3;GSTP1;LAMTOR1;NTRK1;MAP2K2;MAPK1;TAOK3;PAK2
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.5052727829501467,1.922906810146554,0.0,0.0020037436394977895,0.218,14/43,16.58%,HMGB1;EHD1;RAC1;ATXN10;RAB11A;RAB35;PKD2;BLOC1S4;CORO1B;GBA;BLOC1S6;VAPA;BLOC1S3;SLC9A3R1
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6148093756648956,1.9226087633161524,0.0,0.001994995660357201,0.219,14/30,27.59%,GNG2;CD3G;GNB1;PRKAR1A;ADCY3;ADCY7;PRKACB;GPR176;SRC;GGT1;HRH2;AVPR2;PRKACA;GPR150
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6148093756648956,1.9226087633161524,0.0,0.001994995660357201,0.219,14/30,27.59%,GNG2;CD3G;GNB1;PRKAR1A;ADCY3;ADCY7;PRKACB;GPR176;SRC;GGT1;HRH2;AVPR2;PRKACA;GPR150
gsea,mitochondrial translational elongation (GO:0070125),0.5439912302114924,1.9221902815206464,0.0,0.001993339749980749,0.219,19/37,20.14%,MRPL33;MRPS18C;MRPS14;MRPL54;MRPS36;MRPS24;MRPL57;MRPL4;MRPS21;MRPS15;AURKAIP1;MRPS16;MRPL58;MRPS26;MRPS33;MRPS23;MRPL27;MRPL10;MRPL21
gsea,RNA metabolic process (GO:0016070),0.5065029999671344,1.9220394059195454,0.004219409282700422,0.001986370030575222,0.219,12/39,19.16%,RBM3;RBMS1;RNASEH2C;HNRNPL;POLR2K;POLR2G;POLR2J;RNGTT;POLR2I;LAGE3;SKIV2L;RBMS2
gsea,regulation of ion transport (GO:0043269),0.6376078369521982,1.9217468389756152,0.0033783783783783786,0.001990062547563241,0.22,5/19,12.42%,YWHAH;B2M;WWP2;SNX6;VAMP3
gsea,heart development (GO:0007507),0.5285463158607789,1.9199033722492245,0.0,0.0020148830498925717,0.224,9/39,11.89%,ID2;CASP8;MEF2A;TGFBR2;PKD2;FKBP1A;PDLIM2;TCF25;TGFB1
gsea,mitotic nuclear membrane organization (GO:0101024),0.5956843724194641,1.918489335916611,0.0,0.0020272469806358715,0.226,11/20,14.17%,UBE2I;CHMP2A;EMD;CHMP6;VPS4A;SEC13;PPP2CA;SIRT2;CHMP3;PPP2R1A;CHMP2B
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.5956843724194641,1.918489335916611,0.0,0.0020272469806358715,0.226,11/20,14.17%,UBE2I;CHMP2A;EMD;CHMP6;VPS4A;SEC13;PPP2CA;SIRT2;CHMP3;PPP2R1A;CHMP2B
gsea,response to metal ion (GO:0010038),0.6028381934516758,1.9181292408904522,0.0,0.0020255143834620997,0.227,9/23,18.77%,CALM1;PPP1CA;ANXA11;CALM3;PPP3CA;PPP2CA;MTF1;SLC25A12;PDCD6
gsea,sphingolipid biosynthetic process (GO:0030148),0.5904577416251828,1.915791462639038,0.0018181818181818182,0.0020498734685132926,0.232,10/24,14.59%,CERS2;ELOVL1;DEGS1;SPTLC2;CERS4;SPTSSA;ASAH1;CERS5;GBA;VAPA
gsea,actomyosin structure organization (GO:0031032),0.6557201991364329,1.914892490513253,0.0,0.002058471796638521,0.235,6/20,10.72%,ZYX;RHOA;WDR1;TMOD3;PDCD10;ALKBH4
gsea,positive regulation of binding (GO:0051099),0.559604209016647,1.9139423631503054,0.0,0.002077372593300778,0.238,11/26,13.92%,HMGB2;HMGB1;B2M;EDF1;DPH3;PSEN1;FKBP1A;CEBPG;SIRT2;DERL1;AMFR
gsea,nuclear membrane reassembly (GO:0031468),0.5814692384637428,1.9132609854829348,0.002207505518763797,0.002075493571638973,0.238,11/21,14.17%,UBE2I;CHMP2A;EMD;CHMP6;VPS4A;SEC13;PPP2CA;SIRT2;CHMP3;PPP2R1A;CHMP2B
gsea,inflammatory response (GO:0006954),0.5554670029055278,1.9090953977285636,0.0,0.002166245832742556,0.245,14/39,19.55%,ITGB2;HMGB1;CYBA;RAC1;STAT3;LAT;ITGAL;TBK1;PRDX5;TGFB1;NOD1;XCR1;PLA2G4C;TAC4
gsea,intra-Golgi vesicle-mediated transport (GO:0006891),0.5849586245084303,1.907078267397836,0.0,0.002241002510912091,0.252,15/20,34.73%,COPE;VTI1B;COPB1;GOSR1;RAB6A;NAPG;TRAPPC3;COPZ1;GABARAPL2;GOSR2;COG6;VTI1A;COG1;TRAPPC3L;TRAPPC10
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4149040605902197,1.9043753659842035,0.0,0.0023357012409471784,0.266,38/140,22.98%,ID2;YWHAH;RPS6KA1;TBX21;HMGB2;EDF1;EGR1;RUNX3;STAT3;FLI1;ILK;YAF2;UBE2V1;RUNX2;SP100;EOMES;PSMD9;MAD2L2;FOXM1;RNF187;PSEN1;PCBD2;LRP5;RNF4;TGFB1;MAP2K2;SETD3;RNF6;KMT2E;NR1H2;SFR1;DNM2;RNF20;FBXW11;RYBP;PPARD;SERTAD3;BRD4
gsea,membrane lipid biosynthetic process (GO:0046467),0.6224278625963312,1.897977012888992,0.0,0.0025316435382106857,0.28,8/18,14.59%,CERS2;ELOVL1;DEGS1;SPTLC2;CERS4;SPTSSA;CERS5;VAPA
gsea,regulation of apoptotic process (GO:0042981),0.3803784834771993,1.8912957528732113,0.0,0.002741510165523121,0.295,92/188,36.19%,IL2RB;IKZF3;RPS6KA1;YWHAZ;HMGB1;CTSB;SEMA4D;STK26;UFM1;BAG1;NAA38;TMBIM6;PYCARD;IER3IP1;BNIP2;CASP8;MIEN1;GSTP1;TRADD;PDCD10;MTCH1;BIN1;ARHGEF6;SAP18;PRDX5;JAK3;PTPA;CALHM2;UBC;CIAPIN1;TMBIM4;PSEN1;DDRGK1;DNAJC3;CFLAR;NTRK1;HTATIP2;ZFAND6;SRA1;TAF9B;LTK;RPS6KB1;APH1B;NCSTN;LCMT1;DNM2;VAV1;ARHGEF1;TFPT;PAK2;CD3E;DNM1L;NSMF;DAPK3;MYD88;PPT1;BABAM2;WFS1;CDK5;PIP5KL1;NOL3;RYBP;BRMS1;SRC;AKT2;ARHGEF16;ADAM10;PSMD10;HYPK;EGLN2;TRIAP1;RABGGTA;TRIM2;HDAC3;ARL6IP5;CASP9;BRAF;KRT18;APH1A;DUSP9;CITED1;SUDS3;CASP2;TOPORS;FGD4;STK17B;IRF3;TAX1BP1;PDCD2;PDCD5;NCKAP1L;EVI2B
gsea,neuron development (GO:0048666),0.5122024121427731,1.8904867561449643,0.0016722408026755853,0.0027830021982977416,0.298,17/43,23.21%,UGCG;HMGB1;EHD1;RUNX3;ATXN10;RAB11A;RAB35;BLOC1S4;GBA;BLOC1S6;VAPA;BLOC1S3;PPT1;CDK5;POU4F1;TBCD;UGDH
gsea,protein polymerization (GO:0051258),0.6193265660324428,1.8897755575692197,0.005747126436781609,0.0028040464533312273,0.302,5/18,11.18%,PSTPIP1;RAC1;WAS;CHMP2A;CHMP3
gsea,selective autophagy (GO:0061912),0.5803756775025526,1.8885035253172475,0.002403846153846154,0.0028299784070214837,0.306,9/20,15.80%,DYNLL1;UFM1;UBE2V1;ATG5;UBC;DDRGK1;BECN1;UFC1;DYNC1LI1
gsea,intracellular protein transmembrane transport (GO:0065002),0.6027381276581082,1.887991806491127,0.002150537634408602,0.002860749825500187,0.311,8/18,16.88%,SEC61G;DNAJC19;PAM16;SEC61B;TOMM40L;ZFAND2B;DNLZ;PEX16
gsea,cytosolic transport (GO:0016482),0.46455584640247033,1.8877039464331242,0.0,0.0028613576044530936,0.312,29/48,32.82%,LAPTM5;SNF8;RAB29;VPS29;GGA1;VPS54;RAB14;TBC1D10C;VTI1B;YKT6;SNX6;AP2A1;SYS1;VAMP3;BECN1;GOSR1;ARFRP1;VPS26A;TRIM27;RAB6A;SNX2;VPS51;SNX1;VPS53;BET1L;GOSR2;STX8;VTI1A;WASHC1
gsea,negative regulation of cell motility (GO:2000146),0.6035714265677722,1.8867484456364454,0.001483679525222552,0.0028768933835736457,0.315,5/24,10.59%,THY1;STK24;STK26;WAS;ARHGAP4
gsea,negative regulation of protein modification process (GO:0031400),0.5848556841070144,1.886084492386551,0.0,0.002887366840996121,0.316,6/24,11.89%,ARPP19;FKBP8;YWHAB;PPP1R15B;PTPA;TGFB1
gsea,chemical synaptic transmission (GO:0007268),0.4920086325959457,1.885039377254134,0.0,0.002922497308485145,0.319,25/66,27.54%,CALM1;RPS6KA1;UNC119;SDCBP;PAFAH1B1;PRKAR1A;CNP;STXBP2;CACNB4;GALR3;BSN;MAPK1;RAB3A;FCHSD1;PRKACB;NQO1;GPR176;CDK5;VAMP2;SLC17A7;HRH2;NRXN2;PRKACA;LIN7C;CHRNB2
gsea,regulation of intracellular signal transduction (GO:1902531),0.4037060001726036,1.8837716733321357,0.0,0.002957400394307574,0.324,50/137,24.24%,CDC42;ARHGDIB;RAC2;RHOA;TAF10;PRDM1;CSNK2B;RAC1;MAPK3;LIME1;PYCARD;ARHGEF6;RALBP1;TMBIM4;PRKAR1A;ARHGAP4;ARHGAP18;NTRK1;TAF12;ZFAND6;DEPDC7;ARHGAP1;TAF13;ARHGAP30;PTPN22;TAF9B;GBA;RRAGC;ARHGAP33;CHN1;MAPK1;ANKRD54;TAOK3;VAV1;ARHGEF1;PAK2;ITGAV;PRKAG1;PPP1R16B;ARAP3;PIP4K2C;STARD8;STK11;CDK5;POU4F1;ARHGEF16;MEAF6;FBXO9;RMI1;RAC3
gsea,mitotic metaphase plate congression (GO:0007080),0.6026221175711759,1.8836360588799954,0.0,0.0029527734936906735,0.324,11/18,18.99%,PDCD6IP;CHMP2A;RAB11A;CHMP6;VPS4A;CHMP5;CHMP3;BECN1;CHMP2B;VPS4B;CHMP1B
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.5012358356751401,1.8828130567856813,0.001610305958132045,0.0029677655596766902,0.327,23/53,24.24%,CDC42;ARHGDIB;RAC2;RHOA;RAC1;ARHGEF6;FOXM1;RALBP1;ARHGAP4;ARHGAP18;DEPDC7;ARHGAP1;ARHGAP30;ARHGAP33;CHN1;VAV1;ARHGEF1;ITGAV;ARAP3;STARD8;SRC;ARHGEF16;RAC3
gsea,negative regulation of cellular protein metabolic process (GO:0032269),-0.5570658426423214,-1.8820049050018512,0.0,0.012119192808292384,0.476,6/26,6.67%,RPS3;RPL13A;PAIP2;DDX6;RIC1;MALSU1
gsea,positive regulation of cytokine production (GO:0001819),0.4442351613815329,1.876762596405909,0.0,0.0031437545345386216,0.345,30/72,22.93%,S100A13;HMGB1;CRLF2;CYBA;LAPTM5;EGR1;IL12RB1;IL12RB2;STAT3;POLR2K;PYCARD;LRRFIP1;RAB1A;PNP;TMED10;TBK1;LAMTOR5;ITK;CEBPG;SORL1;TGFB1;NOD1;PTPN22;TICAM1;TRIM27;CD2;CRCP;MYD88;PDE4D;LURAP1
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.5794730748101384,-1.8752988878358674,0.0019120458891013384,0.01269868154334739,0.498,7/21,9.46%,RPL26;CDKN1B;BATF;CNOT6L;SOX4;CNOT2;ING4
gsea,plasma membrane organization (GO:0007009),0.6840737158986832,1.8719328328798757,0.0,0.0032748248871087337,0.361,4/16,6.55%,ANXA6;UGCG;DEGS1;BIN1
gsea,cellular response to cytokine stimulus (GO:0071345),0.42950722250343704,1.8719125749690246,0.0,0.0032692460218729366,0.361,37/108,19.54%,IL2RB;ITGB2;IFNGR1;SLA2;CD47;YWHAZ;RHOA;CRLF2;EGR1;IL12RB1;IL12RB2;PTPN18;STAT3;GRB2;HCLS1;NDUFA13;PYCARD;TRADD;INPP5D;TBK1;TPR;JAK3;IL2RG;UBC;GSK3A;ASAH1;ZFAND6;TGFB1;IL20RA;LCK;CDK9;IL3RA;GBA;SELPLG;VAV1;PTPN2;DAPK3
gsea,regulation of DNA binding (GO:0051101),0.6355619822017794,1.8718298640113415,0.0,0.00325886746307334,0.361,8/18,11.89%,HMGB2;HMGB1;EDF1;CSNK2B;SP100;CEBPG;SIRT2;TGFB1
gsea,double-strand break repair (GO:0006302),0.48894047841909727,1.871170323975833,0.002,0.0032726536610235574,0.365,22/43,31.37%,HMGB2;HMGB1;SEM1;RAD21;MAD2L2;PAXX;NSMCE2;SWI5;ACTR5;MORF4L1;SFR1;SMARCAD1;BABAM2;ERCC1;MEIOB;RMI1;XRCC3;UBXN1;SWSAP1;EYA1;UIMC1;EXD2
gsea,positive regulation of gene expression (GO:0010628),-0.38416685336175965,-1.8652514148039532,0.0,0.013503222994566359,0.526,0/120,0.01%,
gsea,translational termination (GO:0006415),0.5141187644640669,1.8633412507394267,0.002398081534772182,0.003584238667157814,0.392,21/41,20.14%,MRPL33;MRPS18C;MRPS14;MRPL54;MRPS36;MRPS24;MRPL57;MRPL4;MRPS21;MRPS15;AURKAIP1;MRPS16;MRPL58;MTRF1L;MRPS26;MRPS33;MRPS23;MRPL27;APEH;MRPL10;MRPL21
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.5155441933105198,1.8633162502496536,0.0,0.003572967476380588,0.392,11/35,17.30%,ARPP19;DYNLL1;DCTN3;MAPRE1;SSNA1;PAFAH1B1;FOXM1;CCNH;PPP2R1A;LCMT1;DNM2
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.5520324538486068,1.8629226865193471,0.0022675736961451248,0.003569674694691564,0.394,13/22,28.51%,POLR2K;POLR2G;SNAPC5;POLR2J;SNAPC1;GTF2B;TAF13;CDK9;POLR2I;PHAX;POLR2D;TAF11;INTS12
gsea,snRNA transcription (GO:0009301),0.5520324538486068,1.8629226865193471,0.0022675736961451248,0.003569674694691564,0.394,13/22,28.51%,POLR2K;POLR2G;SNAPC5;POLR2J;SNAPC1;GTF2B;TAF13;CDK9;POLR2I;PHAX;POLR2D;TAF11;INTS12
gsea,sterol homeostasis (GO:0055092),0.6105397587228102,1.8583697627260283,0.003316749585406302,0.0037556229665723917,0.407,8/18,15.25%,EHD1;NPC2;RALY;LAMTOR1;LRP5;SOAT2;TTC39B;NR1H2
gsea,cholesterol homeostasis (GO:0042632),0.6105397587228102,1.8583697627260283,0.003316749585406302,0.0037556229665723917,0.407,8/18,15.25%,EHD1;NPC2;RALY;LAMTOR1;LRP5;SOAT2;TTC39B;NR1H2
gsea,regulation of cellular component organization (GO:0051128),0.5104288505379916,1.8552193189011008,0.008016032064128256,0.0038948871632647026,0.421,13/33,25.22%,RAP1B;SEMA4D;RAB5C;AP2S1;RAB4B;LAMTOR1;MAD2L2;LAMTOR2;ALKBH4;SNX12;STK11;SNX17;EGLN2
gsea,positive regulation of MAPK cascade (GO:0043410),0.5092972043850128,1.8545121218300986,0.001594896331738437,0.003911070743681819,0.423,13/47,17.37%,HMGB1;LAPTM5;ARRB2;IQGAP1;MAPK3;PYCARD;PDCD10;LAMTOR1;NTRK1;TGFB1;PTPN22;KLHDC10;TAOK3
gsea,endocytic recycling (GO:0032456),0.51691977415592,1.8543458782060975,0.007009345794392523,0.003913095706344968,0.425,15/28,24.20%,EHD1;DENND1B;SNF8;VPS29;ARF6;SNX3;RAB14;RAB35;VPS26A;SNX12;ENTR1;VPS51;CCDC93;RAB11B;SNX17
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5124804822581706,1.8530509339749146,0.00205761316872428,0.003961827914730073,0.434,9/30,15.84%,RBX1;ELOB;DDA1;BCAP31;GSK3A;DDRGK1;SIRT2;FBXO22;ARIH2
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.5096960336625268,1.852291302828399,0.0019880715705765406,0.003996289028234519,0.437,10/35,15.84%,RBX1;ELOB;PSMC3;DDA1;GSK3A;DDRGK1;SIRT2;FBXO22;BAG6;ARIH2
gsea,regulation of signal transduction (GO:0009966),0.44995420970923916,1.8501928560878629,0.0017035775127768314,0.00405840088866397,0.441,29/73,24.01%,UGCG;CBFB;ILK;ITGB1BP1;PXN;SP100;MTCH1;SNX3;RGS14;LFNG;RGS3;PPP2CA;GLRX2;PPP2R1A;TGFB1;SHARPIN;ZFAND2B;AMFR;ZDHHC3;ANKRD54;CD3E;PTPN2;VWA2;SRC;NCK1;INTU;IGFBP6;MFNG;MAPK8IP2
gsea,negative regulation of neuron projection development (GO:0010977),0.6414310766613895,1.848301135717451,0.0017241379310344827,0.004147911361547985,0.445,3/15,4.11%,THY1;RHOA;RAB29
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5832502506728686,1.8472241676698549,0.0017123287671232876,0.004186110639948604,0.447,9/23,16.43%,MAPK3;GRB2;POLR2K;ITGB1BP1;POLR2G;POLR2J;RAB14;POLR2I;MAPK1
gsea,histone H4 acetylation (GO:0043967),-0.6351268105978742,-1.8469363724069323,0.007366482504604052,0.015790863779435976,0.584,9/16,17.20%,LEF1;OGT;EPC1;ING4;MSL2;KANSL3;NAA60;ATF2;MSL3
gsea,transferrin transport (GO:0033572),0.5719279745007968,1.846363193463529,0.008547008547008548,0.00423328189372486,0.451,12/20,24.11%,ATP6V1G1;ATP6V1A;ATP6V0B;ARHGAP1;ATP6V1E1;ATP6V0D1;DNM2;ATP6V1H;MCOLN1;ATP6AP1;ATP6V1C1;RAB11B
gsea,positive regulation of T cell activation (GO:0050870),0.5653426475097443,1.8445274264489253,0.004056795131845842,0.004293931584554287,0.456,7/21,12.28%,THY1;CD47;PYCARD;PNP;JAK3;ZAP70;LCK
gsea,myeloid cell differentiation (GO:0030099),-0.5913653262119758,-1.8405683008714873,0.0024630541871921183,0.016287839917734217,0.604,5/17,19.22%,RPS14;RPS19;SLC25A38;ACIN1;RASGRP4
gsea,mitotic nuclear division (GO:0140014),0.6239967149028944,1.8394998490187924,0.0041753653444676405,0.004505151006073196,0.472,8/15,26.52%,RHOA;CHMP2A;RAB11A;MZT1;SPAST;CHMP4B;ABRAXAS2;ARHGEF10
gsea,polyol metabolic process (GO:0019751),0.6088909466471568,1.838709980217407,0.003883495145631068,0.004537358449738101,0.476,5/18,16.16%,CALM1;IMPA1;INPP5D;ITPK1;INPP1
gsea,inositol phosphate metabolic process (GO:0043647),0.6088909466471568,1.838709980217407,0.003883495145631068,0.004537358449738101,0.476,5/18,16.16%,CALM1;IMPA1;INPP5D;ITPK1;INPP1
gsea,negative regulation of cell differentiation (GO:0045596),0.5026836759766223,1.8380995692953648,0.0,0.004546519007969064,0.477,14/42,18.93%,ID2;SEMA4D;MAD2L2;PPP2CA;SIRT2;LRP5;SRA1;TGFB1;GPS2;NR1H2;YTHDF2;EID2B;TRPM4;ITGAV
gsea,negative regulation of multicellular organismal process (GO:0051241),0.4900110137787261,1.835717824994181,0.0,0.004655053528666032,0.49,14/52,15.25%,IFNGR1;ARHGDIB;RBPJ;SRGN;RHEB;PPP1R11;N4BP1;RPS6KA4;MAD2L2;GSK3A;PPP2CA;TGFB1;PLCL2;NR1H2
gsea,phagosome maturation (GO:0090382),0.584384081753974,1.827540533530551,0.0045871559633027525,0.005073866611405382,0.523,12/17,29.51%,ATP6V1G1;RAB14;ATP6V1A;ATP6V0B;ATP6V1E1;ATP6V0D1;RAB31;ATP6V1H;MCOLN1;ATP6V1C1;ATP6V1D;RAB43
gsea,positive regulation of protein modification process (GO:0031401),0.46339149786650324,1.8252284696435566,0.0,0.005220640465974872,0.536,18/53,22.36%,CALM1;CALM3;SEMA4D;RAC1;MAPK3;ILK;PTPA;RALBP1;CAMTA1;NTRK1;TGFB1;GBA;CNEP1R1;NSMF;PPP1R16B;ASPSCR1;BRMS1;AKT2
gsea,positive regulation of cellular process (GO:0048522),0.407838358613508,1.825092270312267,0.0,0.005205285641074946,0.536,56/134,30.76%,IL2RB;CDC42;GNAI2;S100A13;CD47;RPS6KA1;CRLF2;CYBA;MTPN;RAC1;IL12RB2;PPP3CA;HCLS1;PYCARD;SDCBP;ITGB1BP1;PDCD10;UBE2A;COPS9;CST7;TGFBR2;POFUT2;SSR1;CAPNS1;FOXM1;IL2RG;RNF187;DDRGK1;SIRT2;LRP5;CAPN1;TGFB1;TAF9B;GID8;CHTOP;TULP1;TRPM4;ITGAV;SERTAD1;CNOT6;AKT2;EAPP;ADAM10;TPPP;FKBP1B;PSMD10;FGFR3;CNOT7;FRMD5;EPHA1;IL11;TRIM13;MCTS1;CRKL;ROMO1;RTKN2
gsea,cellular transition metal ion homeostasis (GO:0046916),0.5334510198567873,1.8238482073478168,0.00404040404040404,0.005270417066336401,0.542,10/28,14.27%,FTH1;ATP6V1G1;ARF1;BOLA2;ATOX1;ATP6V1A;LCK;NEDD8;SLC31A2;ATP6V0D1
gsea,organelle assembly (GO:0070925),0.3685770955703507,1.8234302870567232,0.0,0.005286180257433309,0.543,66/169,30.96%,ACTR3;EHD1;PDCD6IP;MAPRE2;DYNLL1;BSCL2;DBNL;RAB8B;STX7;MAPRE1;SNF8;RAB1A;VPS28;CHMP2A;ATG5;TMOD3;VMP1;LSM4;RAB8A;RAB11A;VPS37B;VPS36;CHMP6;RAB1B;TSG101;ATG3;VPS4A;STX12;RAB19;CDS2;TMEM41B;CHMP5;MVB12A;CHMP3;VTA1;BECN1;CFAP20;EXOC5;SNAP29;CHMP2B;ATP6V0D1;WDR45B;HPS1;VPS4B;PLA2G4C;YTHDF2;EXOC6;BBIP1;CHMP1B;FITM2;UBQLN2;EXOC7;SSTR3;INTU;LIMD1;CHMP4B;UBXN2A;GABARAPL2;HDAC3;EXOC1;ATP6V1D;RAB43;STK36;AUP1;MAP1LC3B;ARL6
gsea,regulation of cellular response to stress (GO:0080135),0.5715155375897005,1.8213059518392236,0.002079002079002079,0.005364017298270052,0.552,10/20,20.92%,MAPK3;DNAJB6;BAG1;TPR;SEC13;HSBP1;AMFR;MAPK1;CHCHD2;NUP50
gsea,cellular protein catabolic process (GO:0044257),0.5553205127025318,1.81974271147617,0.01160541586073501,0.005450256805166282,0.555,8/20,15.51%,CTSC;CTSB;CLTA;AP2S1;CASP8;AP2M1;AP2A1;CTSW
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.4698439815492176,1.8146017362996256,0.0,0.0056905098282758505,0.573,25/39,29.45%,RAB29;SURF4;TMED9;VPS29;GGA1;VPS54;SNX3;TBC1D10C;VTI1B;YKT6;SNX6;VAMP3;GOSR1;ARFRP1;VPS26A;TRIM27;RAB6A;SNX12;SNX2;VPS51;SNX1;SNX8;VPS53;BET1L;GOSR2
gsea,cellular response to organic cyclic compound (GO:0071407),0.4993243903280984,1.8117700012788789,0.0,0.0058237282417904455,0.582,12/38,17.15%,GNG2;GNB1;RAP1B;EGR1;UBE2L3;PKD2;NR3C1;TGFB1;P2RY12;ADCY3;RIOK3;HCN2
gsea,regulation of Notch signaling pathway (GO:0008593),0.5262416809284964,1.8106600794550902,0.001669449081803005,0.005877172769189015,0.588,14/33,33.59%,RBPJ;STAT3;ITGB1BP1;PDCD10;WWP2;LFNG;YTHDF2;SRC;MFNG;HEY1;NOS3;JAG1;LLGL2;HIF1AN
gsea,epithelial cell differentiation (GO:0030855),0.641735054139638,1.8089751532230427,0.0031746031746031746,0.005965323045351236,0.595,2/16,1.40%,CTSB;EDF1
gsea,protein import (GO:0017038),0.5225044942255065,1.8089084605957166,0.001976284584980237,0.005956958573605636,0.595,15/28,28.25%,STAT3;RAB8B;TPR;TOMM22;SEC13;LAMP2;ATAD1;PEX16;PEX19;NUP50;NXT2;RANBP17;PXMP4;NUP62CL;PEX11B
gsea,chromatin remodeling (GO:0006338),-0.5298171583112941,-1.8079971212339687,0.006060606060606061,0.021152509048451174,0.69,8/26,14.24%,MYB;SATB1;DR1;CHRAC1;RSF1;KDM5A;ESR1;EZH1
gsea,positive regulation of cell-substrate adhesion (GO:0010811),0.5734909520988162,1.8076237501685266,0.0018050541516245488,0.00604872877790022,0.601,4/22,5.06%,CDC42;RAC1;ILK;LIMS1
gsea,regulation of MAP kinase activity (GO:0043405),0.5726513238835274,1.805895082623854,0.0,0.006144315280754573,0.608,9/22,13.32%,LIME1;SNF8;GSTP1;PDCD10;TSG101;RGS14;SORL1;TGFB1;GBA
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5019550239994337,1.804611842860567,0.0022271714922048997,0.006196089894300994,0.611,12/31,24.43%,NDFIP2;LAPTM5;UBE2L3;CENPX;COMMD1;GSK3A;UBE2D1;FKBP1A;DERL1;NSMCE3;WFS1;PSMD10
gsea,protein processing (GO:0016485),0.5329508707257943,1.804500200631066,0.006666666666666667,0.006178537231710906,0.611,15/27,23.92%,SEC11C;SRGN;SEC11A;TMEM208;SPCS1;PSEN1;SPCS2;APH1B;NCSTN;HGFAC;PCSK7;GGT1;ECE2;ADAM10;RCE1
gsea,translational elongation (GO:0006414),0.5021917574660768,1.8044589733347294,0.0049504950495049506,0.006161083736706072,0.611,19/40,20.14%,MRPL33;MRPS18C;MRPS14;MRPL54;MRPS36;MRPS24;MRPL57;MRPL4;MRPS21;MRPS15;AURKAIP1;MRPS16;MRPL58;MRPS26;MRPS33;MRPS23;MRPL27;MRPL10;MRPL21
gsea,autophagosome maturation (GO:0097352),0.5716881060635042,1.8042192819444065,0.008350730688935281,0.006160889824242882,0.611,7/18,13.68%,CALM1;VMP1;TSG101;VTI1B;LAMP2;CHMP3;SNAP29
gsea,iron ion homeostasis (GO:0055072),0.5735365040804388,1.8033127269701892,0.002044989775051125,0.006186366572013784,0.615,7/19,14.27%,FTH1;B2M;ATP6V1G1;BOLA2;ATP6V1A;NEDD8;ATP6V0D1
gsea,negative regulation of cellular process (GO:0048523),0.3919310794370359,1.8010498867482891,0.0,0.00630129242838103,0.622,59/143,28.18%,ARHGDIB;ANXA6;FTH1;SEMA4D;CSNK2B;RUNX3;BTG3;CD164;NDUFA13;TMBIM6;ITGB1BP1;CHMP2A;ATG5;NMI;SP100;SNX3;IFI35;FOXM1;SIPA1;PPP2CA;PKD2;COPS8;SIRT2;NTRK1;PPP2R1A;TGFB1;PIP4P2;VAMP3;BECN1;SERTAD2;RND1;NR1H2;MINAR1;SLC9A3R1;TMEM115;VPS4B;TNS2;PTPN2;LRPAP1;SIRT7;PPT1;STK11;WFS1;SERTAD3;PDE12;CTBP1;NCK1;ADAM10;SSTR3;IGFBP6;PARP16;RNF139;CHMP4B;AVPR2;COL18A1;CNOT7;CEBPA;TXNDC12;PPP2R5C
gsea,regulation of protein secretion (GO:0050708),0.547719913858854,1.7994370328267884,0.0,0.006394304436345827,0.628,9/29,19.07%,UQCC2;IER3IP1;DPH3;TMED10;ARF6;DNAJC1;TGFB1;SLC8B1;DNM1L
gsea,positive regulation of developmental growth (GO:0048639),0.6136963277047609,1.798021222946099,0.003395585738539898,0.006452858189044673,0.63,6/16,12.03%,SEMA4D;DBNL;PPIB;ITSN2;TWF2;DBN1
gsea,cellular response to insulin stimulus (GO:0032869),0.4669870509465026,1.7893327303329012,0.002028397565922921,0.0070314658874991165,0.662,20/45,24.87%,GRB2;RAB8B;ATP6V1G1;RAB8A;GSK3A;ATP6V1A;ATP6V0B;ATP6V1E1;ATP6V0D1;SYAP1;RPS6KB1;RAB31;PTPN2;USF1;ATP6V1H;ATP6AP1;VAMP2;AKT2;ATP6V1C1;RAB12
gsea,innate immune response (GO:0045087),0.46881320467621884,1.787744187534791,0.003355704697986577,0.007100587270814733,0.665,20/50,32.36%,KLRD1;HMGB1;B2M;CYBA;CAPZA1;SP100;TBK1;RNF187;OTULIN;ZAP70;LCK;TRIM27;MYD88;SRC;RNF135;TRIM13;TRIM11;AGER;CYLD;CITED1
gsea,regulation of cytokine production (GO:0001817),0.521647306315961,1.7875275971942206,0.0053285968028419185,0.0070851797402408465,0.665,9/31,10.13%,S100A13;CD47;SRGN;CASP8;PPP1R11;N4BP1;TBK1;RPS6KA4;ITK
gsea,protein phosphorylation (GO:0006468),0.36738378336205857,1.7860349786318415,0.0,0.0071705553610024704,0.668,68/164,31.05%,RPS6KA1;YWHAZ;STK24;CSNK2B;RUNX3;STK26;MAPK3;ILK;HCST;GMFG;MAPK9;TGFBR2;TBK1;PKN2;RPS6KA4;JAK3;PRKCH;GSK3A;MORC3;COPS8;MARK2;CCNH;GTF2H5;NTRK1;HTATIP2;ZAP70;TGFB1;LCK;INSRR;CDK9;LTK;LIPE;RPS6KB1;TYRO3;MAPK1;MAP3K6;TAOK3;PRKACB;PAK2;PRKAG1;DAPK3;STK11;CDK5;SRC;AKT2;CSNK1G2;CTBP1;ADAM10;CDC42BPG;FNIP2;STK16;NEK3;CDC42BPA;PXK;FGFR3;UHMK1;PRKAB1;CAB39;PRKACA;RPS6KB2;MAP4K5;EPHA1;SMAD2;STK36;BRAF;PRKX;CLK3;PKN1
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5132916233581665,1.7855496336174244,0.0018315018315018315,0.007188514139756901,0.67,10/28,13.03%,RHOA;LAPTM5;LIME1;ILK;LIMS1;NMI;TRADD;IFI35;NOD1;PTPN22
gsea,regulation of DNA metabolic process (GO:0051052),0.6089329062057441,1.7822478492787766,0.0,0.007410840264793095,0.683,5/16,19.91%,SUB1;UBE2V1;CDK9;SMARCAD1;SIRT7
gsea,"DNA-templated transcription, termination (GO:0006353)",0.5752282380652665,1.7807172678943455,0.0022222222222222222,0.007536239996603479,0.689,7/18,19.62%,POLR2K;NUDT21;SSU72;CCNH;GTF2H5;LSM10;MED18
gsea,positive regulation of Ras protein signal transduction (GO:0046579),0.6303216247001763,1.7799398595200229,0.008488964346349746,0.007577955740607356,0.69,4/15,10.97%,MAPRE2;RAC1;GRB2;NTRK1
gsea,positive regulation of cell adhesion (GO:0045785),0.5981441784177737,1.7778885715703199,0.0030534351145038168,0.0077270523536106086,0.698,4/21,5.06%,CD47;RAC1;PPP3CA;LIMS1
gsea,regulation of nucleic acid-templated transcription (GO:1903506),-0.37454096078189564,-1.7771285151965912,0.002347417840375587,0.026623945331380117,0.769,49/107,29.52%,TCF7;RPL6;HIF1A;MYB;PFDN5;PRKCQ;BTG1;BHLHE40;INSR;RHOH;TGFBRAP1;SOX4;NFIA;ING2;CREBL2;GPBP1L1;TCF3;GPBP1;PHF1;PQBP1;NR2C2;IRF2;DRAP1;ESR1;SLC39A8;RFX3;NSD1;CASZ1;VHL;ATF2;ARNTL2;EZH2;MSL3;DVL2;SOX12;TEAD2;NSD3;DVL1;ACVR1B;DMTF1;PHF12;NR1D2;RELA;PLAG1;SPIN1;ACVR2B;RBAK;SP3;WWC2
gsea,positive regulation of interleukin-8 production (GO:0032757),0.6007309226017251,1.776324818399247,0.004073319755600814,0.007854703169211833,0.702,8/15,19.80%,HMGB1;STAT3;PYCARD;RAB1A;LAMTOR5;NOD1;CD2;MYD88
gsea,ERAD pathway (GO:0036503),0.47929121593299145,1.7762591340075322,0.0,0.007841707004987306,0.702,22/35,30.83%,UBXN8;SEC61B;UBE2J2;JKAMP;DERL1;AMFR;OS9;RNF121;BAG6;FBXO2;FBXO6;WFS1;UBQLN2;RNF185;UFD1;DNAJB9;RNF139;TRIM13;UBE2J1;UBE2G2;SGTA;AUP1
gsea,transcription by RNA polymerase II (GO:0006366),0.3888513495696574,1.7755195119431604,0.0,0.007836991473470558,0.702,43/103,28.74%,ELOB;RBPJ;TAF10;ARRB2;CBFB;POLR2K;POLR2G;SNAPC5;NUDT21;POLR2J;RNGTT;SSU72;SNAPC1;GTF2B;CCNH;GTF2H5;TAF12;NR3C1;KLF13;TRIP11;TAF13;CDK9;TAF9B;POLR2I;TCEA1;NR1H2;TBPL1;MED27;LSM10;MED18;GCM2;PHAX;PPARD;PIR;NR1I3;ABT1;NR4A2;DEAF1;POLR2D;NELFB;TAF11;INTS12;HDAC3
gsea,amyloid fibril formation (GO:1990000),0.5788791528568041,1.7736995457912446,0.008547008547008548,0.008004259817200867,0.711,8/16,16.04%,ITM2B;B2M;GGA1;UBC;FKBP1A;SORL1;APH1B;NCSTN
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5652931447301118,1.7724830188561644,0.004,0.008125715265700046,0.718,8/17,21.93%,NDUFA13;PYCARD;BCAP31;LCK;BECN1;SLC9A3R1;DNM1L;SRC
gsea,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5769793028638022,1.770885350887431,0.006211180124223602,0.008279100069085716,0.726,9/15,22.10%,UNC119;RAC1;SDCBP;ARF6;PSEN1;MTMR2;LRPAP1;ITGAV;UBQLN2
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5288927208738482,1.768207023090538,0.005016722408026756,0.008439789813269698,0.733,7/30,13.03%,HMGB1;ARRB2;MAPK3;PYCARD;NTRK1;TGFB1;PTPN22
gsea,positive regulation of protein metabolic process (GO:0051247),0.4764382468315057,1.7666605576865804,0.001890359168241966,0.008587472740704812,0.739,20/42,25.98%,MTPN;NDUFA13;SNF8;RAB1A;OAZ1;VPS28;WWP2;RAB1B;GSK3A;PSEN1;SORL1;TGFB1;LDB1;SEC22B;GBA;NR1H2;NKD1;WFS1;EGLN2;SMURF1
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.566821994709014,1.7639489692380024,0.010845986984815618,0.008904050110246035,0.749,6/18,20.93%,HMGB2;HMGB1;PAXX;NSMCE2;BABAM2;ERCC1
gsea,phosphorylation (GO:0016310),0.37196517774007837,1.7627700913022695,0.0,0.00896913819584725,0.752,49/139,26.42%,YWHAZ;STK24;RUNX3;STK26;MAPK3;STAT3;ILK;HCST;GMFG;MAPK9;TGFBR2;TBK1;PKN2;RPS6KA4;JAK3;GNPTG;PRKCH;GSK3A;MORC3;COPS8;MARK2;NTRK1;ZAP70;TGFB1;LCK;CDK9;LTK;LIPE;MAPK1;MAP3K6;TAOK3;PRKACB;PAK2;PRKAG1;DAPK3;STK11;CDK5;CSNK1G2;CTBP1;ADAM10;CDC42BPG;FNIP2;LIMD1;NEK3;CDC42BPA;PXK;PRKAB1;PRKACA;MAP4K5
gsea,regulation of protein localization to plasma membrane (GO:1903076),0.5418727941258451,1.7610072516247013,0.005671077504725898,0.009130329956125081,0.758,7/24,11.89%,STX7;ARF6;PRKCH;VPS4A;VTI1B;AP2M1;TGFB1
gsea,regulation of interleukin-8 production (GO:0032677),0.551387608390303,1.7527015690629295,0.005859375,0.00993997837792009,0.781,9/20,19.80%,HMGB1;STAT3;PYCARD;RAB1A;LAMTOR5;NOD1;PTPN22;CD2;MYD88
gsea,vesicle organization (GO:0016050),0.5795151056407774,1.7523566152177883,0.007920792079207921,0.00994986701952034,0.782,5/16,14.17%,SRGN;SAR1B;LAMTOR1;SAR1A;CHMP2B
gsea,positive regulation of secretion by cell (GO:1903532),0.5792099904913116,1.7513624271245505,0.005050505050505051,0.009995587529037907,0.784,9/19,20.86%,IER3IP1;TMED10;ARF6;UNC13D;TGFB1;NMB;RAB3A;DNM1L;ATP6AP1
gsea,extracellular matrix organization (GO:0030198),0.5149020085082437,1.7505248215807503,0.0024875621890547263,0.010068905916890837,0.787,17/50,27.04%,ITGB2;CD47;PPIB;ITGAL;CAPNS1;ITGA2;ADAMTS10;CAPN1;TGFB1;LAMB3;QSOX1;ITGAV;ADAM10;ADAMTSL5;COL18A1;MMP17;MMP11
gsea,positive regulation of immune response (GO:0050778),0.5725755398400183,1.7493497723907125,0.008403361344537815,0.010153741353789339,0.791,8/16,16.64%,ITGB2;CYBA;IL12RB1;PYCARD;NMI;IFI35;SASH3;RIOK3
gsea,regulation of axonogenesis (GO:0050770),0.6195824060937568,1.748804343330683,0.005934718100890208,0.010186708046496446,0.793,6/17,18.18%,THY1;RHOA;MARK2;AMIGO1;CHN1;PAK2
gsea,cellular response to organic substance (GO:0071310),0.48053457900637564,1.7432211191037295,0.0,0.010744289264132786,0.804,12/36,18.53%,RHOA;PTPN18;STAT3;HCLS1;EMD;TGFBR2;TBK1;TWF2;TGFB1;CDK9;RPS6KB1;PTPN2
gsea,glucose homeostasis (GO:0042593),-0.4951869271989492,-1.7415245645958122,0.010101010101010102,0.03489595377159808,0.847,9/27,18.93%,HIF1A;RPS6;INSR;ADIPOR2;IGF1R;SOX4;FOXO1;CRTC2;FOXK1
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3568407157723565,1.7407625350768934,0.0,0.01097627311461956,0.812,89/242,36.86%,SUB1;LITAF;ACTR3;RPS6KA1;HMGB2;HMGB1;RBPJ;SSBP4;EGR1;MAPK3;PPP3CA;STAT3;PSMC3;HCLS1;WAS;ITGB1BP1;GLMP;MEF2A;MLX;RUNX2;TBK1;EOMES;RPS6KA4;FOXM1;UBC;ZEB2;DDRGK1;PKD2;CDC5L;MED19;CEBPG;SIRT2;HTATIP2;SREBF1;MED10;NR3C1;LRP5;RNF4;TGFB1;LDB1;BCL2L12;CDK9;CCNC;MED6;ATF6B;GPS2;SETD3;HOXC4;AKIRIN1;TCEA1;NR1H2;GALR3;TMF1;LAGE3;MTF1;MED21;SIRT7;USF1;CHCHD2;FOXD2;PPARD;POU4F1;EAPP;BRD4;NCK1;SMARCD2;NR1I3;GALR2;NR4A2;TRIAP1;CEBPA;SMARCD3;IL11;HDAC3;SMAD2;HEY1;PPP3R1;CITED1;JAG1;KLF14;SMARCD1;IRF3;TFR2;ELF1;POU5F1;ETS1;MOSPD1;PITX2;SIX1
gsea,positive regulation of supramolecular fiber organization (GO:1902905),0.5329679527556628,1.7403913221498852,0.010810810810810811,0.01099116332111217,0.812,8/23,9.65%,VASP;WDR1;RAC1;MAPRE1;PYCARD;BIN1;ARF6;PSEN1
gsea,cell cycle G2/M phase transition (GO:0044839),0.4720713359997569,1.734496672374948,0.006134969325153374,0.01161285225784287,0.823,12/36,21.15%,ARPP19;DYNLL1;DCTN3;MAPRE1;SSNA1;PAFAH1B1;FOXM1;CCNH;PPP2R1A;LCMT1;DNM2;FBXW11
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3633953623702177,1.7333512764055847,0.0018450184501845018,0.011684613127129885,0.828,67/175,29.66%,ID2;SLA2;TBX21;HMGB1;RBPJ;PRDM1;SEMA4D;RUNX3;UBE2I;STAT3;CBFB;GATAD2A;EID1;LRRFIP1;SDCBP;MEF2A;CREM;MLX;CGGBP1;ZGPAT;MTA3;SIN3B;SP100;MBD2;WWP2;TPR;EOMES;MAD2L2;FOXM1;UBC;ZFP69;ZEB2;HSBP1;PSEN1;UBE2D1;NKAP;SIRT2;TCF25;NR3C1;LDB1;UBE2D3;TAF9B;GPS2;UXT;TRIM27;NR1H2;LIN37;THAP7;FAM220A;SIRT7;KCNIP3;WFS1;BRMS1;PPARD;POU4F1;CTBP1;TLE6;NR1I3;PSMD10;FNIP2;NR4A2;DEAF1;HSF4;HDAC3;SMAD2;SCRT1;HEY1
gsea,positive regulation of autophagy (GO:0010508),0.5112670810710109,1.733296119214221,0.004347826086956522,0.011662519800477727,0.828,9/24,20.37%,HMGB1;SH3GLB1;TBK1;PAFAH1B2;GSK3A;NPRL2;TICAM1;TRIM27;STK11
gsea,mitotic sister chromatid segregation (GO:0000070),0.5070241726279756,1.7329590557590988,0.00816326530612245,0.011671622076575192,0.828,13/26,18.99%,CSNK2B;PDCD6IP;CHMP2A;RAD21;RAB11A;CHMP6;VPS4A;CHMP5;CHMP3;BECN1;CHMP2B;VPS4B;CHMP1B
gsea,positive regulation of cellular amide metabolic process (GO:0034250),-0.5218621085199238,-1.7288206696670354,0.009345794392523364,0.0376189175776689,0.87,8/24,10.71%,RPS4X;RPL26;CD28;EEF2;EIF3E;SOX4;PRKCD;NSMAF
gsea,positive regulation of defense response (GO:0031349),0.5574942622846838,1.7275728835874997,0.011029411764705883,0.012300753838521892,0.842,7/18,16.64%,CD47;CYBA;NMI;TRADD;IFI35;GPSM3;RIOK3
gsea,negative regulation of developmental process (GO:0051093),0.6815780661244895,1.7268444554407651,0.0026702269692923898,0.012373905865537946,0.846,3/15,11.89%,THY1;FOXM1;TGFB1
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.524470087240369,1.7264612546557931,0.009569377990430622,0.012377282181897634,0.846,5/28,11.89%,RBPJ;CSNK2B;SDCBP;ZEB2;TGFB1
gsea,regulation of cell-matrix adhesion (GO:0001952),0.5929581362808604,1.7260066376627363,0.005145797598627788,0.012396025902751151,0.848,6/18,19.54%,THY1;RHOA;PTPRA;LDB1;CD3E;DAPK3
gsea,response to cytokine (GO:0034097),0.4731145496223465,1.7255248872714237,0.011764705882352941,0.012410838770595154,0.85,15/38,23.34%,RHOA;PTPN18;STAT3;HCLS1;CASP8;SP100;TBK1;JAK3;CDK9;PTPN2;MYD88;SRC;GGT1;POU4F1;ADAM10
gsea,endoplasmic reticulum organization (GO:0007029),0.4870250761748892,1.725448971360153,0.002079002079002079,0.012391136119435884,0.85,16/29,23.50%,REEP5;SEC61G;TRAM1;EMD;SEC61B;TOR1AIP2;RAB18;WDR83OS;UBE2J2;VAPA;DNM1L;VAMP2;VAPB;TLE6;TRAM2;STX18
gsea,positive regulation of cell motility (GO:2000147),0.45983489432092095,1.7253798604208546,0.00303951367781155,0.012379166620428128,0.85,15/50,16.02%,SEMA4D;PPP3CA;STAT3;MAPRE1;SDCBP;MIEN1;TRADD;PDCD10;FERMT3;DDRGK1;TGFB1;CCDC25;CFAP20;FAM89B;FAM83H
gsea,apical junction assembly (GO:0043297),0.5783844413685316,1.7232199174281508,0.009708737864077669,0.01257667788433732,0.854,4/19,7.40%,RHOA;WDR1;PDCD6IP;PKN2
gsea,regulation of protein phosphorylation (GO:0001932),0.4171697465514854,1.722783644804579,0.0,0.012617479592501812,0.855,26/68,33.26%,ITGB2;SEMA4D;FKBP8;RAC1;MAPK3;ILK;PDCL3;PPP1R15B;NDUFS4;RALBP1;PPP2CA;NTRK1;TGFB1;SLC9A3R1;ANKRD54;PIP5KL1;TWF1;AKT2;BRD4;FNIP2;PPP2R5C;HDAC3;CRKL;AGER;F2;FGF23
gsea,negative regulation of kinase activity (GO:0033673),0.5054229573206617,1.7212915218052331,0.0034904013961605585,0.012817204104428855,0.858,6/26,18.18%,THY1;ITGB1BP1;GSTP1;NPRL2;TRIM27;PAK2
gsea,protein localization to organelle (GO:0033365),0.4098938418834634,1.7167722026513035,0.0019267822736030828,0.013337178624388053,0.869,29/59,30.96%,TMEM30A;EHD1;TOR1AIP1;SEC61G;TRAM1;EMD;RAB11A;ARF6;SEC61B;RAB35;DDRGK1;WDR83OS;LAMP2;UBE2J2;SORL1;SYS1;ARFRP1;VAPA;CNEP1R1;FAM83H;RAB6A;TULP1;VAMP2;TRAM2;GABARAPL2;ATP6V1D;SGTA;AUP1;ARL6
gsea,regulation of transcription by RNA polymerase II (GO:0006357),0.32780487422557414,1.7162712824793473,0.0,0.013379564875469688,0.872,210/490,43.24%,ID2;SUB1;LITAF;ACTR3;IKZF3;SLA2;RPS6KA1;TBX21;HMGB2;HMGB1;RBPJ;PRDM1;SSBP4;SEMA4D;EGR1;RUNX3;UBE2I;MAPK3;PPP3CA;STAT3;CBFB;LIME1;PSMC3;GATAD2A;HCLS1;FLI1;SNF8;EID1;LRRFIP1;SDCBP;WAS;ITGB1BP1;GLMP;MEF2A;PURB;RAD21;CREM;MLX;CGGBP1;RUNX2;ZGPAT;MTA3;SIN3B;SP100;MBD2;TBK1;MAFG;SAP18;WWP2;TPR;ZBTB8A;EOMES;RPS6KA4;MAD2L2;MED29;FOXM1;UBC;ZFP69;ZEB2;HSBP1;PSEN1;DDRGK1;SSU72;PRKAR1A;CAMTA1;UBE2D1;PKD2;CDC5L;MED19;NKAP;CEBPG;CCNH;SIRT2;GTF2H5;HTATIP2;TCF25;CREBZF;SREBF1;MED10;NR3C1;KLF13;LRP5;SRA1;RNF4;TGFB1;LDB1;MYNN;BCL2L12;CDK9;UBE2D3;CCNC;TAF9B;MED6;ATF6B;GPS2;SETD3;HOXC4;MED12L;AKIRIN1;UXT;TCEA1;VAX2;MED31;TRIM27;NR1H2;GALR3;TMF1;LAGE3;MTF1;LIN37;MED21;TADA1;HOXC9;THAP7;MED27;MED18;FAM220A;SIRT7;KCNIP3;GCM2;GBX1;USF1;CHCHD2;FOXD2;WFS1;ZFP92;HES6;PHF20L1;BRMS1;PPARD;ZFP3;POU4F1;CTBP1;TLE6;BRD4;NCK1;SMARCD2;NR1I3;PSMD10;GALR2;FNIP2;NR4A2;ONECUT3;DEAF1;TBR1;TRIAP1;DMRTA2;CEBPA;SMARCD3;HSF4;IL11;AGO3;LHX2;HDAC3;SMAD2;SCRT1;HEY1;PPP3R1;NKX2-2;PKN1;CITED1;KLF12;RCOR2;SUDS3;JAG1;ELF2;ZBTB7B;KLF14;BRD9;SMARCD1;IRF3;CBX8;CBX2;TFR2;HMX3;ELF1;POU5F1;ETS1;DMRT2;MOSPD1;PITX2;SIX1;PPP1R13L;MAFK;PAF1;RTF1;RFXAP;N4BP2L2;FOXJ1;CCNL1;WBP2;FSTL3;EFCAB7;TCF7L1;IKBKB;DGKQ;ZFP14;YEATS4;VPS72;SQSTM1;MEF2B;SIX5;DPF3;HES7;SNAI1;LCOR;GRHL2;HMGA2;KAT5;YY1
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.615515989872484,1.7145897740435994,0.002785515320334262,0.013560885674727536,0.876,7/18,23.10%,GNG2;GNB1;ADCY3;ADGRB2;ADCY7;GNAS;GNAQ
gsea,Rho protein signal transduction (GO:0007266),0.5645601883947696,1.7073889842302141,0.0017452006980802793,0.01453660631007402,0.883,6/19,12.23%,CDC42;ARHGDIB;RHOA;WAS;ARHGAP4;ARHGAP1
gsea,regulation of organelle assembly (GO:1902115),0.47562167201905703,1.7072600675347231,0.0020964360587002098,0.014515858493126109,0.883,15/31,26.46%,PDCD6IP;ATG5;RAB1B;TSG101;ATG3;TBC1D10C;TBC1D9B;RNF4;TBC1D16;TBC1D2B;NPRL2;RABEP2;UBQLN2;STX18;TBC1D19
gsea,positive regulation of response to external stimulus (GO:0032103),0.5033260193743782,1.703651744746333,0.00641025641025641,0.014894642647654213,0.89,11/31,20.27%,CD47;CYBA;NMI;TRADD;IFI35;THBD;TGFB1;P2RY12;GPSM3;RIOK3;USF1
gsea,protein lipidation (GO:0006497),0.4945203655308884,1.701567658165936,0.008492569002123142,0.015063038059686258,0.891,10/26,20.59%,UGCG;ATG5;SELENOK;DPM3;ZDHHC18;PIGO;WDR45B;ZDHHC3;PIGM;DPM2
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5741782107059481,1.701047481281418,0.0087527352297593,0.015100594610909875,0.892,5/16,6.77%,LSM5;LSM6;LSM4;NT5C3B;POLR2G
gsea,protein tetramerization (GO:0051262),0.5604527354037058,1.7005720241821254,0.003952569169960474,0.015130556915153965,0.894,6/16,20.68%,B2M;SSBP1;NUDT21;PKD2;TRPM4;MCOLN1
gsea,cellular response to DNA damage stimulus (GO:0006974),-0.39788578236771444,-1.7000121905415497,0.0066555740432612314,0.04627351354538638,0.917,28/75,21.05%,RPS3;FOXP1;USP3;BATF;SUSD6;UBE2B;NIPBL;NOP53;USP28;SUMO1;ALKBH1;PHF1;FOXO1;XPA;RAD9B;UVRAG;MCL1;VCPIP1;TNFRSF1B;USP16;TRIP12;ZBTB40;ATF2;CEP63;WAC;POLB;STXBP4;APC
gsea,defense response to bacterium (GO:0042742),-0.5083819306429596,-1.6980305061189436,0.011594202898550725,0.04580038258059581,0.918,4/21,5.83%,RPL30;RPS19;RPL39;PRKCD
gsea,regulation of autophagosome assembly (GO:2000785),0.5756355287865099,1.696997376112025,0.022494887525562373,0.015481991064200151,0.896,8/15,25.00%,SH3GLB1;RAB1B;SEC22B;NPRL2;PIP4K2C;FEZ2;UBQLN2;CHMP4B
gsea,regulation of gene expression (GO:0010468),-0.3189069422822837,-1.6939698500929952,0.0,0.046527343116904436,0.918,1/258,0.01%,TCF7
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5847440699989095,1.6921202925009131,0.0064516129032258064,0.016060366923396813,0.899,7/19,18.18%,ITGB2;SEMA4D;HCLS1;PDCL3;TGFB1;SAMSN1;PAK2
gsea,protein insertion into membrane (GO:0051205),0.5774039123725426,1.6904678513789189,0.010460251046025104,0.01624598616606294,0.902,9/15,22.91%,SEC61G;TRAM1;EMD;SEC61B;WDR83OS;UBE2J2;VAPA;VAMP2;TRAM2
gsea,organic substance transport (GO:0071702),0.5027696896418259,1.689081213447597,0.006482982171799027,0.016416030750180617,0.907,16/33,29.07%,CD3G;TAP1;SLC48A1;CHMP2A;SCAMP2;CHMP3;CHMP2B;SCAMP3;CHMP1B;PEX19;PPT1;VAMP2;CLN8;SPNS2;ARL6IP5;MFSD12
gsea,regulation of Wnt signaling pathway (GO:0030111),0.48784989445200216,1.6886571878348842,0.008319467554076539,0.01647176046299215,0.908,10/33,18.57%,PPP1CA;CBFB;EMD;SNX3;PSEN1;PPP2CA;OTULIN;PPP2R1A;CTNNBIP1;NKD1
gsea,second-messenger-mediated signaling (GO:0019932),0.61355662836069,1.6884322895131383,0.009244992295839754,0.01646878408785472,0.908,6/15,18.70%,LAT;PPP2CA;PPP2R1A;P2RY12;XCR1;TRPM4
gsea,regulation of vesicle-mediated transport (GO:0060627),0.453802895902618,1.688170451926824,0.015350877192982455,0.016454890892480617,0.908,19/37,24.97%,RAB5C;MAPK3;RAB8B;AP2S1;RAB4B;RAB8A;RAB11A;CHMP3;MAP2K2;MAPK1;RAB3A;SNX12;ITGAV;SRC;VAMP2;RAB11B;SNX17;RAB12;RNF139
gsea,positive regulation of mitochondrion organization (GO:0010822),0.5706277942161343,1.6881183586095188,0.012072434607645875,0.01643015904026055,0.908,6/16,19.07%,PYCARD;RALBP1;GSK3A;MIEF2;MFF;DNM1L
gsea,nucleic acid metabolic process (GO:0090304),0.527367158575176,1.6854602718442995,0.014989293361884369,0.01681894728531248,0.912,9/19,31.37%,HNRNPL;POLR2K;POLR2G;POLR2J;POLR2I;PDE12;POLR2D;WTAP;EXD2
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.49026374437298914,1.6838091356522296,0.00851063829787234,0.017028620149270694,0.915,9/25,27.37%,ARRB2;PYCARD;G3BP2;COMMD1;OTULIN;COMMD7;BRMS1;PSMD10;CCDC22
gsea,regulation of innate immune response (GO:0045088),0.5570517034272088,1.6821073813208625,0.016605166051660517,0.017197598655499833,0.916,8/16,16.64%,CDC37;CASP8;NMI;N4BP1;IFI35;PTPN22;TYRO3;RIOK3
gsea,positive regulation of cellular metabolic process (GO:0031325),0.4906806542891551,1.6820158592759957,0.01616161616161616,0.017174945481409624,0.916,12/26,21.89%,ARRB2;GRB2;RAB29;RAB1A;TGFBR2;RAB1B;TGFB1;ATAD1;VAMP3;NR1H2;CHCHD2;PPARD
gsea,regulation of cell motility (GO:2000145),0.47742936033666944,1.6810035208668626,0.009508716323296355,0.01726016292628223,0.917,11/39,12.54%,RHOA;DOCK10;RAC1;WAS;MGAT3;PKN2;ARHGAP18;TGFB1;CCDC25;LDB1;CFAP20
gsea,positive regulation of catabolic process (GO:0009896),0.5035696418382593,1.6795731281040436,0.01060070671378092,0.017409485469426566,0.919,11/28,25.98%,NDUFA13;SNF8;OAZ1;VPS28;WWP2;GSK3A;SORL1;SEC22B;NKD1;EGLN2;SMURF1
gsea,regulation of viral transcription (GO:0046782),0.5561717330418288,1.6782093082440028,0.011312217194570135,0.017558106967767405,0.922,10/16,29.75%,POLR2K;POLR2G;POLR2J;CDK9;POLR2I;TRIM27;POLR2D;NELFB;TRIM13;TRIM11
gsea,positive regulation of type I interferon production (GO:0032481),0.5458278128129127,1.6759795892398537,0.006787330316742082,0.017848707869213762,0.926,8/16,24.15%,POLR2K;LRRFIP1;TBK1;PTPN22;RIOK3;CRCP;MYD88;RNF135
gsea,regulation of cellular localization (GO:0060341),0.5864123527391135,1.6756559127170747,0.016474464579901153,0.017846149377074835,0.927,5/16,13.09%,REEP5;UNC13D;LRP5;STXBP2;GOSR1
gsea,proteolysis (GO:0006508),0.4036779839612192,1.6751149122355729,0.0031397174254317113,0.017903957219286584,0.928,33/75,23.39%,CTSC;CTSB;SRGN;CTSA;CASP8;CNDP2;USP25;SPCS1;PSEN1;SPPL2A;CAPN1;SVBP;NEDD8;APH1B;FBXO2;CTSW;APEH;CAPN5;NCSTN;HGFAC;FBXW2;PCSK7;FBXO6;CPA5;ADAM33;XPNPEP1;ATG4B;ATG4D;GGT1;ECE2;PM20D2;ADAM10;CELA1
gsea,regulation of cell population proliferation (GO:0042127),0.3629740153198432,1.6735723661406074,0.0,0.0180854662857378,0.929,83/168,37.21%,ID2;GNAI2;S100A13;CD47;FTH1;HMGB2;RHOA;CRLF2;CSNK2B;IL12RB2;STAT3;BTG3;CD164;HCLS1;SDCBP;ITGB1BP1;LIMS1;NMI;PDCD10;UBE2A;COPS9;TSPO;TGFBR2;SSR1;CAPNS1;IFI35;FOXM1;RNF187;DDRGK1;PKD2;COPS8;SIRT2;NTRK1;LRP5;CAPN1;TGFB1;LTK;GID8;MINAR1;SLC9A3R1;TMEM115;CHTOP;TNS2;PTPN2;TRPM4;ITGAV;SERTAD1;STK11;CNOT6;AKT2;CTBP1;EAPP;ADAM10;SSTR3;IGFBP6;RNF139;AVPR2;FGFR3;COL18A1;CNOT7;CEBPA;EPHA1;IL11;AGO3;PPP2R5C;MCTS1;CRKL;KCNH1;ROMO1;RTKN2;TGFB1I1;NOS3;FGF23;JAG1;PDCD5;ETS1;CNOT8;CNTF;MEAK7;CSNK2A1;SIX1;MYO16;CIB1
gsea,regulation of response to external stimulus (GO:0032101),0.4930227838669328,1.672234289069903,0.00505902192242833,0.018248464159269655,0.931,11/30,24.56%,CALM1;STK24;CASP8;N4BP1;P2RY12;PTPN22;MYD88;GGT1;BRD4;RNF135;DAGLB
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.5031116780373635,1.672095132854148,0.009174311926605505,0.018220324762633088,0.931,9/26,12.48%,RPS6KA1;HMGB1;DNAJB6;BEX3;NDUFA13;PYCARD;LAMTOR5;BCAP31;NOD1
gsea,cilium assembly (GO:0060271),0.3746285413261302,1.671663812907098,0.0030864197530864196,0.018238042350830617,0.931,44/108,43.20%,ACTR3;EHD1;DYNLL1;RAB8B;DCTN3;MAPRE1;RAB1A;DYNLRB1;RAB8A;RAB11A;SSNA1;PAFAH1B1;TRIP11;PPP2R1A;CFAP20;EXOC5;SNAP29;ATP6V0D1;EXOC6;BBIP1;EXOC7;SSTR3;INTU;PRKACA;CETN2;EXOC1;ATP6V1D;STK36;ARL6;RILPL1;CCDC39;IFT52;FAM161A;TTLL3;CPLANE2;FOXJ1;CEP131;INPP5E;DCTN2;ZMYND10;UNC119B;TUBB4A;TTC36;EXOC3
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3366015669542605,1.6715544394737094,0.0,0.018213565999827187,0.932,114/247,44.05%,ID2;SLA2;TBX21;HMGB2;HMGB1;RBPJ;PRDM1;SEMA4D;RUNX3;UBE2I;STAT3;CBFB;GATAD2A;YWHAQ;NDUFA13;EID1;YAF2;LRRFIP1;SDCBP;MEF2A;LIMS1;CREM;MLX;CGGBP1;RUNX2;ZGPAT;MTA3;SIN3B;SP100;MBD2;SAP18;WWP2;PRDX5;TPR;EOMES;MAD2L2;FOXM1;UBC;ZFP69;ZEB2;HSBP1;PSEN1;UBE2D1;SNX6;NKAP;SIRT2;TCF25;CREBZF;NR3C1;TGFB1;LDB1;UBE2D3;TAF9B;GPS2;UXT;TRIM27;NR1H2;LIN37;THAP7;EID2B;COMMD7;FAM220A;SIRT7;KCNIP3;WFS1;CDK5;FBXW11;BRMS1;PPARD;POU4F1;CTBP1;TLE6;NR1I3;PSMD10;MPHOSPH8;FNIP2;LIMD1;NR4A2;DEAF1;TBR1;CNOT7;CEBPA;HSF4;HDAC3;SMAD2;SCRT1;HEY1;SAMD11;UIMC1;CITED1;KLF12;RCOR2;SUDS3;ZBTB7B;CBX8;CBX2;POU5F1;MOSPD1;INPP5K;MAFK;PAF1;RTF1;N4BP2L2;FOXJ1;VPS72;MTERF3;DPF3;SNAI1;LCOR;HMGA2;KAT5;YY1;ZFHX3;TFAP2A
gsea,negative regulation of response to external stimulus (GO:0032102),0.4828549321249497,1.668698404432402,0.014953271028037384,0.01858134667743449,0.935,12/27,21.89%,CERS2;NMI;OTULIN;SIRT2;SHARPIN;GBA;GPS2;TYRO3;ILRUN;PTPN2;RTN4RL1;PPARD
gsea,calcium-mediated signaling (GO:0019722),0.5816534197873038,1.6679087468838318,0.0065040650406504065,0.018685445814708428,0.937,9/18,26.09%,PPP3CA;LAT;BCAP31;P2RY12;PPP3CC;XCR1;TRPM4;FKBP1B;PRKACA
gsea,dephosphorylation (GO:0016311),0.40815211944617574,1.665262001171552,0.00375234521575985,0.019130624584994167,0.938,29/59,40.83%,PPP1CA;PTPN18;PPP3CA;PPP1CC;PPM1H;PPP6C;PPP2CA;PTPRA;PPP2R1A;PTPN22;PPP3CC;ILKAP;MTMR2;FAM220A;STK11;FBXW11;MTMR6;PTPRR;PPP2R5C;SDHAF2;PPM1B;DUSP9;PPP2R2A;INPP5K;PDP2;EPHX2;CTTNBP2NL;PNKP;PLPP6
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3630977213550722,1.6619895428497404,0.0017889087656529517,0.01966418060125983,0.944,49/133,33.04%,ID2;TBX21;HMGB2;RBPJ;UBE2I;GATAD2A;YWHAQ;NDUFA13;EID1;YAF2;LIMS1;MLX;RUNX2;ZGPAT;MTA3;MBD2;SAP18;WWP2;FOXM1;SNX6;NKAP;SIRT2;CREBZF;NR3C1;TGFB1;LDB1;NR1H2;THAP7;EID2B;COMMD7;CDK5;FBXW11;BRMS1;PPARD;CTBP1;MPHOSPH8;LIMD1;DEAF1;TBR1;CNOT7;CEBPA;HDAC3;SMAD2;HEY1;SAMD11;UIMC1;CITED1;RCOR2;SUDS3
gsea,protein stabilization (GO:0050821),-0.41144390169932193,-1.661329108400569,0.007220216606498195,0.05760227738312015,0.945,20/55,31.60%,RPL23;RPS7;RPL11;RAB21;STK4;UBE2B;NOP53;SOX4;PRKCD;CREBL2;SUMO1;RTN4;VHL;HPS4;STXBP4;DVL1;PER3;DVL3;A1CF;SEL1L
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.5128522501814697,-1.658372334320638,0.013133208255159476,0.05763112520974163,0.949,6/21,6.02%,RPS3;RPL11;OGT;CAPN3;SOX4;CTNNB1
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3462260743786656,-1.6558327930727035,0.002347417840375587,0.05744977640045119,0.95,53/112,34.71%,TCF7;RPL6;HIF1A;MYB;PFDN5;PRKCQ;BTG1;BHLHE40;INSR;RHOH;TGFBRAP1;SOX4;NFIA;ING2;CREBL2;GPBP1L1;TCF3;GPBP1;PHF1;PQBP1;NR2C2;IRF2;DRAP1;ESR1;SLC39A8;RFX3;NSD1;CASZ1;VHL;ESCO1;ATF2;ARNTL2;EZH2;MSL3;DVL2;SOX12;TEAD2;NSD3;DVL1;ACVR1B;DMTF1;PHF12;NR1D2;RELA;PLAG1;SPIN1;ACVR2B;RBAK;SP3;WWC2;CXXC1;ZKSCAN5;SUFU
gsea,cellular response to peptide (GO:1901653),-0.5204335494452043,-1.654315515874862,0.01977401129943503,0.05682582958912783,0.954,3/18,5.12%,RPL23;FYN;IGF1R
gsea,positive regulation of endocytosis (GO:0045807),0.5952893496813065,1.6517612869773075,0.011532125205930808,0.02127081602736302,0.956,5/16,15.50%,CDC42;B2M;VPS28;STAP1;RAB31
gsea,peroxisome organization (GO:0007031),0.5545264611036738,1.650462164514068,0.03282275711159737,0.02142324042225075,0.957,8/15,28.25%,PLAAT3;ACOT8;MFF;PEX16;DNM1L;PEX19;TMEM135;PEX11B
gsea,protein maturation (GO:0051604),0.47788751713866884,1.648152836247974,0.017953321364452424,0.0218063683359952,0.958,14/29,23.34%,SRGN;CIAO2B;BOLA2;ISCA1;PSEN1;CIAO2A;SORL1;NFU1;GALNT2;APH1B;NCSTN;PCSK7;ECE2;ADAM10
gsea,protein N-linked glycosylation (GO:0006487),0.4836667504061882,1.6471152918793637,0.01639344262295082,0.02197412057006152,0.96,14/25,25.67%,KRTCAP2;MGAT2;MGAT3;ALG5;DPM3;OSTC;OST4;B4GALT7;TMEM258;PMM2;DPM2;SRD5A3;ALG1;GAL3ST1
gsea,autophagosome organization (GO:1905037),0.44228075242876946,1.6462659560528254,0.01598173515981735,0.022065478106756197,0.96,16/31,33.56%,RAB1A;ATG5;VMP1;RAB1B;ATG3;STX12;RAB19;TMEM41B;BECN1;WDR45B;UBQLN2;UBXN2A;GABARAPL2;RAB43;MAP1LC3B;ATG16L1
gsea,positive regulation of cell death (GO:0010942),0.5787115879856011,1.645089751936603,0.022263450834879406,0.022207878893389245,0.962,4/15,10.99%,ITGB2;EGR1;NTRK1;HTATIP2
gsea,establishment of protein localization to extracellular region (GO:0035592),0.556058491287933,1.6444033401761018,0.016697588126159554,0.0223085683631457,0.963,6/17,28.70%,RAB8B;RAB8A;SVBP;RAB3A;RAB12;TANGO2
gsea,regulation of protein binding (GO:0043393),0.43015553285009317,1.6414741361826997,0.014613778705636743,0.02278444920823401,0.964,14/38,18.89%,PPP1CA;B2M;TMBIM6;ITGB1BP1;PSEN1;PPP2CA;MARK2;FKBP1A;DERL1;SORL1;CTNNBIP1;AMFR;MITD1;LRPAP1
gsea,negative regulation of intracellular signal transduction (GO:1902532),0.40408283650052,1.638913958839719,0.00546448087431694,0.023241164353757407,0.968,28/63,32.61%,SLA2;ARRB2;NDUFA13;PYCARD;CASP8;GSTP1;NMI;CARD19;IFI35;PPM1N;GSK3A;NPRL2;MINAR1;SLC9A3R1;RIOK3;PDCD6;SRC;PDE4D;PSMD10;LIMD1;CCDC22;PPP2R5C;PPM1B;RNF34;RTKN2;CYLD;MUL1;ADIPOR1
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5759414110507941,1.6365598493994187,0.02146690518783542,0.02360744864756021,0.968,6/16,16.64%,PYCARD;CASP8;GSTP1;CARD19;PPM1N;RIOK3
gsea,positive regulation of metabolic process (GO:0009893),-0.49970207883191475,-1.6360338739001765,0.020618556701030927,0.06341912711496255,0.967,9/20,26.71%,OGT;IL18;INSR;PRKAB2;ADIPOR2;IGF1R;APC;PER2;THRA
gsea,chromatin organization (GO:0006325),-0.4477389995119116,-1.6355894187104196,0.008676789587852495,0.06230788931241716,0.967,16/33,27.27%,MYB;SATB1;DR1;CHRAC1;RSF1;PHF1;KDM5A;ESR1;HDAC11;EZH1;EZH2;MYSM1;HDAC8;KDM6A;KDM4C;SETD5
gsea,"regulation of transcription, DNA-templated (GO:0006355)",0.311461832457778,1.6324853481742336,0.0,0.024294352642262554,0.969,209/483,45.97%,ID2;SUB1;LITAF;YWHAH;IKZF3;RPS6KA1;TBX21;HMGB2;HMGB1;RBPJ;PRDM1;EDF1;EGR1;RUNX3;UBE2I;STAT3;CBFB;LIME1;POLR2K;GATAD2A;HCLS1;FLI1;YWHAQ;NDUFA13;ILK;SNF8;EID1;YAF2;UBE2L3;LRRFIP1;UBE2V1;MEF2A;LIMS1;PURB;RAD21;CREM;MLX;RUNX2;ZGPAT;MTA3;SAP30L;SP100;MBD2;MAFG;SAP18;WWP2;TRAPPC2;ZBTB8A;EOMES;PSMD9;RGS14;RPS6KA4;MAD2L2;MED29;FOXM1;RNF187;ZFP69;ZEB2;MLF2;PSEN1;PRKAR1A;CAMTA1;SNX6;PPP2CA;GLRX2;CDC5L;NKAP;CEBPG;CCNH;SIRT2;HTATIP2;CREBZF;PCBD2;SREBF1;NR3C1;KLF13;LRP5;PPP2R1A;SRA1;RNF4;TGFB1;LDB1;MYNN;CCNC;MAP2K2;MED6;ATF6B;SETD3;HOXC4;ACTR5;MED12L;RNF6;UXT;VAX2;MED31;SBNO1;KMT2E;NR1H2;SFR1;MTF1;MED21;DNM2;TADA1;HOXC9;THAP7;EID2B;MED27;RNF20;ZFPL1;COMMD7;DAPK3;MED18;GCM2;GBX1;USF1;FOXD2;ZFP92;CDK5;FBXW11;HES6;RYBP;PHF20L1;BRMS1;PPARD;ZFP3;SERTAD3;POU4F1;CTBP1;BRD4;SMARCD2;MPHOSPH8;LIMD1;NR4A2;ONECUT3;DEAF1;TBR1;CNOT7;DMRTA2;CEBPA;SMARCD3;HSF4;LHX2;HDAC3;SMAD2;SCRT1;HEY1;NKX2-2;TGFB1I1;PKN1;SAMD11;UIMC1;GPATCH3;CITED1;KLF12;RCOR2;SUDS3;TESMIN;ELF2;CDK11B;ZBTB7B;KLF14;BRD9;SMARCD1;IRF3;HMX3;ELF1;POU5F1;ETS1;DMRT2;PITX2;SIX1;PPP1R13L;INPP5K;MAFK;RFXAP;APBB2;MAP3K12;FOXJ1;CCNL1;WBP2;FSTL3;TCF7L1;IKBKB;DGKQ;ZFP14;YEATS4;MTERF3;MEF2B;SIX5;DPF3;HES7;SNAI1;LCOR;GRHL2;HMGA2;KAT5;YY1;ZFHX3;TFAP2A;POLR3C;TRIM16;CELSR2;ACTR8;CRLF3;TIAL1;ZBTB24;UBP1;MECP2;ZIK1
gsea,regulation of glycolytic process (GO:0006110),-0.4982176706093634,-1.6296621060167726,0.0225,0.06346644660942624,0.968,6/20,11.73%,HIF1A;OGT;INSR;PRXL2C;JMJD8;NCOR1
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.5456682141700266,1.6284326618546,0.01282051282051282,0.025005280373931873,0.972,7/17,26.09%,PSMC3;COMMD1;DDRGK1;PSMF1;TMF1;GABARAPL2;PRKACA
gsea,negative regulation of response to stimulus (GO:0048585),0.5469172976065632,1.6269996980312393,0.02608695652173913,0.025297675104623923,0.973,2/17,2.64%,THY1;PDCD1
gsea,regulation of protein targeting to membrane (GO:0090313),0.5548072019655341,1.6249125640753903,0.01775147928994083,0.02569323379070034,0.974,4/15,16.22%,ITGB2;ITGB1BP1;MIEF2;MFF
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.52853670602646,1.623962936971616,0.021367521367521368,0.025804624135871906,0.976,5/17,11.89%,HCLS1;TPR;LAMTOR5;PSEN1;TGFB1
gsea,autophagosome assembly (GO:0000045),0.4299528618066461,1.619476212316871,0.024390243902439025,0.026643506772619466,0.978,17/32,33.56%,RAB1A;ATG5;VMP1;RAB1B;ATG3;STX12;RAB19;TMEM41B;BECN1;WDR45B;UBQLN2;UBXN2A;GABARAPL2;SMURF1;RAB43;MAP1LC3B;ATG16L1
gsea,positive regulation of MAP kinase activity (GO:0043406),-0.4940113807360784,-1.6168466947038216,0.026755852842809364,0.067866884481211,0.972,5/18,19.64%,RPS3;MAP3K10;EZH2;DVL2;FGFR1
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4780752458003715,1.6120963673028856,0.01956521739130435,0.02815152685231923,0.982,8/24,18.61%,SUB1;CBFB;RUNX2;MED10;CCNC;MED6;MED31;MED27
gsea,regulation of protein ubiquitination (GO:0031396),0.4137135683070437,1.6103680172835664,0.020224719101123594,0.028500616767067243,0.982,21/45,28.74%,NDFIP2;LAPTM5;ARRB2;UBE2L3;VPS28;N4BP1;CENPX;COMMD1;GSK3A;UBE2D1;FKBP1A;DERL1;SVBP;MINAR1;NSMCE3;USP4;SIRT7;WFS1;PSMD10;UBXN1;HDAC3
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.40600092432267715,1.6101233845879093,0.006837606837606838,0.028488243246889908,0.982,21/57,29.55%,ID2;SUB1;NDFIP2;SDCBP;PDCD10;WWP2;PSEN1;DDRGK1;TGFB1;PTPN22;MAP2K2;MTMR2;SNX12;CD3E;LRPAP1;POU4F1;ADAM10;CNOT7;LGALS9;AGO3;CRKL
gsea,brain development (GO:0007420),0.4436203629504658,1.609979658385009,0.010752688172043012,0.028465947376125563,0.982,17/38,21.15%,UFM1;IER3IP1;NDUFS4;UGP2;TGFBR2;PAFAH1B1;EOMES;RAB18;PAFAH1B2;UFC1;TMX2;AMIGO1;BAG6;DNAJC30;PPT1;VPS51;FBXW11
gsea,negative regulation of inflammatory response (GO:0050728),0.4505271815082519,1.6063438006548139,0.005471956224350205,0.02915384690666442,0.982,22/46,27.59%,GNG2;CD3G;GNB1;GSTP1;PRKAR1A;OTULIN;ADCY3;SHARPIN;GBA;GPS2;TYRO3;ADCY7;PRKACB;PTPN2;GPR176;PPARD;SRC;GGT1;HRH2;AVPR2;PRKACA;GPR150
gsea,nervous system development (GO:0007399),0.3907142852632827,1.6057799454334252,0.004016064257028112,0.029232842091067194,0.982,28/100,24.79%,ITM2B;UNC119;COX7B;DBNL;STAT3;ATXN10;RAB29;GSTP1;ZEB2;PKD2;TGFB1;LDB1;MAB21L2;VAX2;MTF1;ADGRB2;TYRO3;GJB1;PPT1;SH3GL1;CDK5;FEZ2;NDUFS2;POU4F1;INTU;SEMA6B;DAGLB;NRXN2
gsea,mitotic cell cycle phase transition (GO:0044772),0.40185137033933965,1.6042858314314326,0.012552301255230125,0.029569192554147906,0.982,20/51,28.45%,ARPP19;DYNLL1;DCTN3;MAPRE1;CHMP2A;SSNA1;PAFAH1B1;PPP6C;FOXM1;CCNH;PPP2R1A;RPS6KB1;LCMT1;DNM2;CUL2;FBXW11;SPAST;CHMP4B;PRKACA;CETN2
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5115480866361489,1.6015132002712467,0.017985611510791366,0.030055733741070585,0.982,8/21,12.48%,RHOA;LAPTM5;ILK;LIMS1;NMI;TRADD;IFI35;NOD1
gsea,regulation of BMP signaling pathway (GO:0030510),0.5279696778615919,1.59920091774934,0.029565217391304348,0.030487540453645656,0.983,4/19,12.93%,RBPJ;UBE2D1;SORL1;UBE2D3
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.49039302317638833,1.5987764839240894,0.014953271028037384,0.03053343817013419,0.983,14/24,24.60%,SH3GLB1;PDCD6IP;SNF8;SDCBP;CHMP2A;TSG101;TPR;VPS4A;TGFB1;VPS4B;ERCC1;STX18;TPPP;FNIP2
gsea,establishment of protein localization to organelle (GO:0072594),0.5247539923817016,1.5986732703702597,0.015332197614991482,0.03049725346617178,0.983,11/20,26.53%,STAT3;RAB11A;TPR;SEC13;LAMP2;PEX19;NEURL1B;NUP50;NXT2;RANBP17;NUP62CL
gsea,regulation of neurogenesis (GO:0050767),0.5336849974646072,1.596370388006886,0.022968197879858657,0.030964553300150275,0.983,6/17,21.48%,HMGB2;B2M;RGS14;SORL1;YTHDF2;HES6
gsea,protein secretion (GO:0009306),0.5311907644073781,1.5956053941154267,0.01773049645390071,0.0310678394441747,0.983,7/19,28.70%,RAB8B;RAB8A;SVBP;CYB5R4;RAB3A;RAB12;TANGO2
gsea,"DNA-templated transcription, initiation (GO:0006352)",0.3921713591051448,1.5956039985882753,0.0019083969465648854,0.03100145517185809,0.983,25/57,28.74%,RBPJ;TAF10;MAPK3;POLR2K;POLR2G;POLR2J;GTF2B;CCNH;GTF2H5;TAF12;NR3C1;TAF13;CDK9;TAF9B;POLR2I;NR1H2;TBPL1;CRCP;MED27;PPARD;NR1I3;NR4A2;POLR2D;TAF11;HDAC3
gsea,cell-cell junction assembly (GO:0007043),0.536707482917842,1.59390789582858,0.02147239263803681,0.031243863187038555,0.984,9/22,28.93%,RHOA;TLN1;WDR1;PKN2;PAK2;GJB1;TBCD;GJA5;GJC1
gsea,positive regulation of protein secretion (GO:0050714),0.5589875482140271,1.5908957006399447,0.026981450252951095,0.03181901692112474,0.985,6/16,19.07%,IER3IP1;TMED10;ARF6;PSMD9;TGFB1;DNM1L
gsea,positive regulation of JNK cascade (GO:0046330),0.5559938593404105,1.5878215981143629,0.0265625,0.03248227130535474,0.987,3/17,4.39%,HMGB1;PYCARD;SDCBP
gsea,positive regulation of organelle assembly (GO:1902117),0.5258538691093336,1.5867277540402023,0.022964509394572025,0.03269095984806349,0.988,8/15,23.50%,SH3GLB1;PDCD6IP;SDCBP;G3BP2;ENTR1;PIP4K2C;CNOT6;STX18
gsea,positive regulation of neuron projection development (GO:0010976),0.4706495959919835,1.5854610835438885,0.009784735812133072,0.032934186014764485,0.988,8/26,13.98%,DBNL;SNX3;SCARB2;MARK2;NTRK1;TWF2;DBN1;LTK
gsea,regulation of cellular component movement (GO:0051270),-0.4835163103762261,-1.5825005475729301,0.02608695652173913,0.08376852377163702,0.989,6/21,19.68%,RPS19;RAF1;IGBP1;MYCBP2;NRG4;CADM4
gsea,cellular response to oxidative stress (GO:0034599),0.421931441305718,1.5822492102672108,0.023157894736842106,0.033674433350541856,0.988,18/35,31.42%,NCF4;CYBA;MAPK3;PRDX6;GSTP1;MAPK9;MGAT3;PXN;PRDX5;PKD2;SIRT2;MAPK1;NUDT2;CHCHD2;RBM11;MSRA;ROMO1;SLC4A11
gsea,response to UV (GO:0009411),-0.46294015937941246,-1.5817340858467417,0.026615969581749048,0.08254463968739027,0.99,8/26,16.53%,RPL26;UBE2B;USP28;PRKCD;XPA;TMEM161A;BMF;MAP2K7
gsea,regulation of myeloid cell differentiation (GO:0045637),-0.542071624406796,-1.5800609970758903,0.03648068669527897,0.08205812592239464,0.991,4/15,5.74%,NR4A3;PRKCQ;TNRC6B;TNRC6C
gsea,negative regulation of cell population proliferation (GO:0008285),0.38234836900822256,1.5794917991587412,0.005383580080753701,0.03435384785194704,0.99,35/92,28.18%,FTH1;B2M;CSNK2B;RUNX3;BTG3;CD164;ITGB1BP1;GSTP1;NMI;EMD;IFI35;MORC3;PKD2;COPS8;SIRT2;NTRK1;TGFB1;CTNNBIP1;B4GALT7;MINAR1;SLC9A3R1;TMEM115;TNS2;PTPN2;STK11;CTBP1;SSTR3;IGFBP6;RNF139;AVPR2;COL18A1;CNOT7;CEBPA;OGN;PPP2R5C
gsea,extracellular structure organization (GO:0043062),0.5087080114088404,1.5785846482232928,0.014687882496940025,0.03450565549136477,0.99,15/37,33.98%,ITGB2;CD47;ITGAL;ITGA2;ADAMTS10;LAMB3;ITGAV;ADAMTSL5;COL18A1;MMP17;MMP11;MMP28;COL8A2;COL5A1;F11R
gsea,positive regulation of vasculature development (GO:1904018),-0.4999975015845353,-1.5781700783023336,0.0345821325648415,0.0815398799178329,0.991,2/17,1.62%,HIF1A;BTG1
gsea,response to reactive oxygen species (GO:0000302),0.4656732817982422,1.5776341969416092,0.021231422505307854,0.03468237062416974,0.99,11/24,16.43%,STK24;STK26;MAPK3;GSTP1;MAPK9;PDCD10;PXN;PRDX5;PKD2;GLRX2;MAPK1
gsea,cellular amide metabolic process (GO:0043603),0.4530978252555656,1.577547885714721,0.028846153846153848,0.034625744965992286,0.99,11/28,28.50%,PLAAT3;ACOT7;ORMDL2;PPP2CA;PPP2R1A;PLA2G15;ACOT8;NAPEPLD;CLN8;MTHFS;SLC46A1
gsea,cellular iron ion homeostasis (GO:0006879),0.5065105822871541,1.575464277373377,0.034552845528455285,0.035052665349949996,0.991,6/18,14.27%,FTH1;ATP6V1G1;BOLA2;ATP6V1A;NEDD8;ATP6V0D1
gsea,JNK cascade (GO:0007254),0.47954181077787944,1.5750482904886831,0.02912621359223301,0.035090695509861346,0.991,6/21,13.74%,UBE2V1;MAPK9;ARHGEF6;UBC;NOD1;GPS2
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.49579314694285,1.5724333137363014,0.027303754266211604,0.03573652544247395,0.992,11/23,21.93%,PYCARD;CASP8;GSTP1;TRADD;SP100;CFLAR;BCL2L12;PAK2;ITGAV;NOL3;SRC
gsea,mesenchymal cell differentiation (GO:0048762),-0.49290629953346915,-1.5717489701470224,0.024657534246575342,0.08341077370620922,0.992,8/19,19.64%,HIF1A;LEF1;DDX5;CTNNB1;FBXL17;DDX17;HGF;FGFR1
gsea,negative regulation of protein kinase activity (GO:0006469),0.447611321885616,1.5700551128436457,0.022263450834879406,0.03622168168210182,0.993,8/31,18.18%,THY1;PYCARD;ITGB1BP1;GSTP1;SORL1;LRP5;TRIM27;PAK2
gsea,central nervous system development (GO:0007417),0.39352741666324303,1.5685139103348142,0.006153846153846154,0.036515628843751716,0.993,26/66,25.54%,COX7B;UFM1;STAT3;IER3IP1;GSTP1;NDUFS4;UGP2;TGFBR2;EOMES;RAB18;PAFAH1B2;PKD2;UFC1;TMX2;AMIGO1;BAG6;VAX2;MTF1;DNAJC30;PPT1;SH3GL1;CDK5;TPPP;SEMA6B;NR4A2;TBR1
gsea,sterol metabolic process (GO:0016125),0.5302256297143116,1.5679203403787179,0.04238921001926782,0.0365660561563116,0.993,9/16,29.81%,EBP;LIPA;SOAT2;GBA;OSBPL1A;STARD3;PPARD;CLN8;INSIG2
gsea,external encapsulating structure organization (GO:0045229),0.5095476818016313,1.5675788393992531,0.0170316301703163,0.03659115286217114,0.993,15/36,33.98%,ITGB2;CD47;ITGAL;ITGA2;ADAMTS10;LAMB3;ITGAV;ADAMTSL5;COL18A1;MMP17;MMP11;MMP28;COL8A2;COL5A1;F11R
gsea,regulation of exocytosis (GO:0017157),0.5314739908882864,1.5640018406623843,0.026365348399246705,0.03766599300345495,0.994,9/16,24.87%,RAB8B;RAB8A;CHMP6;UNC13D;CHMP3;RAB3A;ATP6AP1;VAMP2;RAB12
gsea,fatty acid biosynthetic process (GO:0006633),0.5434757137206181,1.563792336254487,0.043824701195219126,0.03764494394524505,0.994,6/15,22.05%,ACOT7;ELOVL1;DEGS1;LTA4H;ACSBG1;ABHD2
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),0.507231968025816,1.5635855811733406,0.021035598705501618,0.0376583124512773,0.994,8/24,21.69%,HMGB1;PYCARD;SDCBP;PDCD10;EMC10;KLHDC10;TAOK3;ANKRD6
gsea,regulation of epithelial cell migration (GO:0010632),-0.5325151593993795,-1.5635162451722182,0.037267080745341616,0.08651088862658085,0.993,4/15,12.36%,HIF1A;BMPR2;RTN4;CAPN7
gsea,negative regulation of metabolic process (GO:0009892),0.5133937850806549,1.5620274571171915,0.030821917808219176,0.03799554931744666,0.994,6/19,20.37%,RBPJ;RHEB;GSTP1;PLCL2;NR1H2;STK11
gsea,response to lipopolysaccharide (GO:0032496),0.41506219428118896,1.5607617946222585,0.024475524475524476,0.038309651689424566,0.994,20/42,38.81%,HMGB2;RHOA;HMGB1;PYCARD;GSTP1;PELI1;STAP1;CHMP5;PTPN22;TICAM1;MYD88;GGT1;LGALS9;NOS3;CITED1;IL12A;TIRAP;GIT1;PAF1;CD6
gsea,establishment of protein localization to membrane (GO:0090150),0.44632045222259037,1.5594458418100496,0.021505376344086023,0.03857904721499327,0.994,13/27,30.96%,SDCBP;RABGEF1;RAB11A;VPS37B;ATG3;GOLGA7;ZDHHC18;YIF1B;ZDHHC3;RAB11B;BRAF;ZDHHC4;ARL6
gsea,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5092765975304323,-1.5575120396692612,0.03488372093023256,0.08841389213780272,0.993,6/17,16.06%,RPL11;OGT;FHIT;EIF3H;NOP53;WAC
gsea,protein modification by small protein conjugation (GO:0032446),0.3130271266478531,1.556525206279108,0.004866180048661801,0.03942623472007958,0.995,65/143,38.00%,RBX1;ELOB;ANAPC11;ARRB2;UBE2I;UFM1;UBE2L3;UHRF2;UBE2A;MKRN1;WWP2;TPR;ATG3;COMMD1;UBC;RNF187;PCNP;DDRGK1;UBE2D1;OTULIN;UBE2J2;DERL1;NSMCE2;ZNRF3;UBE2D3;UFC1;NEDD8;AMFR;RNF6;OS9;TRIM27;FBXO2;ARIH2;RRAGA;RNF181;UBE2W;TRPM4;RNF20;CUL2;NUP50;MOCS3;FBXW11;RNF7;FBXO9;RNF135;KCTD10;RNF139;KLHL18;SMURF1;UBE2K;CCDC22;TRIM13;UBE2G2;TRIM11;RNF34;EYA1;MUL1;RNF220;UBA5;TOPORS;CBLL1;TRIM47;TRAF7;PAF1;RTF1
gsea,cell-cell junction organization (GO:0045216),0.5398863615209067,1.5553756143235398,0.029745042492917848,0.039676825620704806,0.995,4/20,11.89%,TLN1;LIMS1;TJP3;TGFB1
gsea,monocarboxylic acid metabolic process (GO:0032787),-0.4353410000073328,-1.5547055151615443,0.03044496487119438,0.08839391611156282,0.993,13/28,25.64%,LDHB;PANK2;ACOT2;GLO1;ACOT6;AMACR;SCP2;ACSF3;BCO2;HAGH;PCCB;PER2;CPT1C
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5364230551442677,1.5539851892879186,0.035940803382663845,0.03995723318171351,0.995,6/15,20.83%,LSM5;LSM6;LSM4;NT5C3B;SKIV2L;CNOT6
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.3607217411228987,1.5536668286464754,0.00463678516228748,0.039981125803375345,0.995,48/101,36.43%,ID2;IFNGR1;RBPJ;LAPTM5;EGR1;ARRB2;MTPN;MAPK3;STAT3;SNF8;RAB29;LIMS1;MAPK9;PDCL3;PDCD10;LAMTOR5;GSK3A;PSEN1;DDRGK1;STAP1;TGFB1;ATAD1;VAMP3;PTPN22;GBA;TICAM1;MAPK1;CD3E;PRKAG1;MYD88;WFS1;POU4F1;MPHOSPH8;AVPR2;PRKAB1;LGALS9;AGO3;HEY1;BRAF;DTNBP1;NOS3;CITED1;FGF23;ZBTB7B;MBIP;PDCD5;ETS1;CNTF
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5382971164997921,1.551348772942521,0.030874785591766724,0.04059756485033735,0.997,8/15,31.54%,GSTP1;STAP1;GPS2;NR1H2;YTHDF2;PTPN2;CNOT7;MUL1
gsea,positive regulation of cell population proliferation (GO:0008284),0.3541143776413721,1.5471353328379196,0.006546644844517185,0.041818296130928356,0.997,49/102,40.54%,ID2;GNAI2;S100A13;CD47;RBPJ;CRLF2;IL12RB2;HCLS1;SDCBP;ITGB1BP1;PDCD10;UBE2A;COPS9;NDUFS4;TGFBR2;SSR1;CAPNS1;PRKCH;FOXM1;RNF187;DDRGK1;LRP5;CAPN1;TGFB1;GID8;CHTOP;TRPM4;ITGAV;SERTAD1;CNOT6;AKT2;EAPP;ADAM10;FGFR3;CNOT7;EPHA1;IL11;MCTS1;CRKL;ROMO1;RTKN2;FGF23;CNOT8;CNTF;CSNK2A1;CIB1;PDF;CEP131;CRLF1
gsea,phosphatidylcholine metabolic process (GO:0046470),0.4697971903207981,1.5356613219606445,0.034926470588235295,0.045217790938486546,0.998,9/23,22.84%,PLAAT3;CSNK2B;PHOSPHO1;NR1H2;PLA2G15;PLA2G4C;CEPT1;LPCAT4;PCYT1B
gsea,tRNA processing (GO:0008033),0.5015857608799099,1.5353916452509828,0.04592901878914405,0.04519432311389541,0.998,5/16,25.34%,RPP21;POP7;ZBTB8OS;DTWD2;PTCD1
gsea,cellular response to nutrient levels (GO:0031669),0.47229099001211045,1.5350317287920596,0.03361344537815126,0.04521359487428855,0.998,7/20,17.73%,STK24;STK26;LAMP2;SREBF1;RRAGC;WDR45B;RRAGA
gsea,negative regulation of phosphorylation (GO:0042326),0.48596150708628316,1.534208015370084,0.0328719723183391,0.04537567169061666,0.998,6/22,13.53%,FKBP8;DYNLL1;PPP1R15B;STAP1;TGFB1;NPRL2
gsea,regulation of protein kinase B signaling (GO:0051896),0.39468911208578983,1.5338335599359392,0.02486678507992895,0.045385403459562164,0.998,21/49,37.21%,RAC2;ARRB2;RAC1;GRB2;HCLS1;ITGB1BP1;NTRK1;TGFB1;LCK;P2RY12;SLC9A3R1;VAV1;PDCD6;SRC;AKT2;FGFR3;PPP2R5C;MUL1;FGF23;INPP5K;CIB1
gsea,positive regulation of multicellular organismal process (GO:0051240),-0.3407661145109023,-1.533768790551559,0.023121387283236993,0.09877577350841814,0.995,29/76,26.71%,RPS19;LEF1;OGT;TAPT1;CD28;IL18;BATF;PRKAB2;ADIPOR2;IGF1R;SOX5;CTNNB1;TERT;NR2C2;BMPR2;RTN4;RFX3;SMO;EZH2;SHLD3;SYDE1;SMAD4;MDK;ACVR1B;APC;IL15;PER2;BMP1;THRA
gsea,positive regulation of protein catabolic process (GO:0045732),0.4310222356283228,1.5320476347285368,0.03531598513011153,0.045873513372736124,0.998,11/33,25.98%,NDUFA13;SNF8;OAZ1;VPS28;WWP2;GSK3A;SORL1;SEC22B;NKD1;EGLN2;SMURF1
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.44529505963588395,1.5313960229254102,0.033386327503974564,0.045991008828369026,0.998,12/32,21.93%,SEMA4D;MAPK3;LIME1;HCLS1;HCST;NTRK1;BECN1;MAPK1;SLC9A3R1;PPP1R16B;PIP4K2C;SRC
gsea,axon guidance (GO:0007411),0.4326096199680928,1.5299479519398533,0.01747311827956989,0.046379475605516564,0.998,17/49,29.00%,RAC2;VASP;SEMA4D;RAC1;MAPK3;GRB2;LYPLA2;PTPRA;CHN1;SH3KBP1;MAPK1;FEZ2;SRC;DOK4;SEMA6B;EPHA1;DOK1
gsea,regulation of insulin receptor signaling pathway (GO:0046626),-0.48511405310098676,-1.5147405111780405,0.05473684210526316,0.10892411598263547,0.996,4/18,5.83%,PTPN1;PRKCQ;OGT;PRKCD
gsea,positive regulation of epithelial cell proliferation (GO:0050679),-0.43577119638945533,-1.513585249844495,0.03537735849056604,0.10809936760451086,0.996,10/24,21.19%,NR4A3;HIF1A;NR4A1;AKT3;BMPR2;RTN4;PTPRN;STXBP4;MDK;ANG
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.45133394586481296,1.513362579228381,0.050880626223091974,0.052088091144463784,0.999,11/23,29.45%,TLN1;SSR1;GSK3A;DNAJC3;ATP6V0D1;YIF1A;WFS1;VAPB;DNAJB9;PARP16;GOSR2
gsea,hemopoiesis (GO:0030097),0.46851630102172515,1.512649453512274,0.023064250411861616,0.05225271512065437,0.999,15/26,36.14%,RUNX3;CD164;RUNX2;TGFBR2;TGFB1;LCK;SELPLG;ARIH2;YTHDF2;CEBPA;PRKX;RTKN2;JAG1;FUT10;TIRAP
gsea,negative regulation of neuron death (GO:1901215),0.46123924193175464,1.5120913115524368,0.028708133971291867,0.05233274271566719,0.999,12/30,25.00%,AGAP2;BTBD10;SNX6;NTRK1;SORL1;GBA;TYRO3;PPT1;WFS1;CDK5;POU4F1;CHMP4B
gsea,positive regulation of angiogenesis (GO:0045766),-0.4597137971881866,-1.5115729287897819,0.03485254691689008,0.10766870059700083,0.997,7/20,35.93%,HIF1A;BTG1;JMJD8;MDK;RAPGEF3;HYAL1;RRAS
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.380749874569086,1.5046622509295688,0.022058823529411766,0.054875087235896666,0.999,22/50,28.74%,RBPJ;TAF10;POLR2K;POLR2G;POLR2J;GTF2B;CCNH;GTF2H5;TAF12;NR3C1;TAF13;CDK9;TAF9B;POLR2I;NR1H2;MED27;PPARD;NR1I3;NR4A2;POLR2D;TAF11;HDAC3
gsea,cellular response to UV (GO:0034644),-0.4436085416293373,-1.5029925427335344,0.03248259860788863,0.11161507342442602,0.997,6/24,14.82%,RPL26;USP28;PRKCD;XPA;TMEM161A;BMF
gsea,negative regulation of cellular component organization (GO:0051129),0.46793749245092225,1.5029837734277403,0.06077348066298342,0.05540060466298412,0.999,10/21,21.93%,CDC42;DNAJB6;SORL1;GBA;MTMR2;LCMT1;RIOK3;DNM2;RUBCN;SRC
gsea,phospholipid metabolic process (GO:0006644),0.4836791461179177,1.5012008122568596,0.046822742474916385,0.055995598477585215,0.999,7/22,22.15%,PLAAT3;AGPAT3;PLA2G15;PLA2G4C;FITM2;LPCAT4;PLBD2
gsea,mitochondrion organization (GO:0007005),0.36748201267251546,1.498285625573528,0.029535864978902954,0.056936311380330444,0.999,24/53,31.55%,AIP;RAB29;DNAJC19;MEF2A;SSBP1;RAB5IF;TSPO;BCAP31;TIMM10B;TOMM22;TOMM7;GBA;SLIRP;MIEF2;MFF;DNM2;DNM1L;CHCHD2;SLC25A4;CXADR;ATP2A1;MIGA2;MUL1;NOS3
gsea,cellular response to metal ion (GO:0071248),0.47577338004058034,1.4958376168154262,0.032590051457975985,0.05770412776381567,0.999,9/23,20.68%,B2M;IQGAP1;MAPK3;MEF2A;MAPK9;PKD2;MAPK1;ADCY7;MCOLN1
gsea,phospholipid transport (GO:0015914),0.493407417308509,1.4931368265929086,0.04954128440366973,0.058623040547675566,0.999,5/17,11.28%,TMEM30A;NPC2;SCARB2;PITPNA;PITPNC1
gsea,generation of neurons (GO:0048699),0.42001394152946164,1.4931144916770247,0.026706231454005934,0.05852103900255828,0.999,17/44,29.66%,HMGB2;RUNX3;MTPN;RAC1;RUNX2;PAFAH1B1;MARK2;LDB1;DTNB;VAX2;YTHDF2;CDK5;HES6;NR4A2;LHX2;TAFA3;HEY1
gsea,protein autophosphorylation (GO:0046777),0.3905689526252776,1.4875026436479166,0.03169014084507042,0.0606656529198931,0.999,19/46,27.57%,STK24;STK26;MAPK3;ITK;MARK2;NTRK1;HTATIP2;INSRR;MAP2K2;TYRO3;TAOK3;PAK2;DAPK3;STK11;SRC;STK16;FGFR3;UHMK1;EPHA1
gsea,epithelial to mesenchymal transition (GO:0001837),-0.4633029663959627,-1.4874965379554357,0.04838709677419355,0.12027525043435948,0.998,7/19,19.64%,HIF1A;LEF1;DDX5;CTNNB1;DDX17;HGF;FGFR1
gsea,mitotic cytokinesis (GO:0000281),0.5061500753583549,1.4864190474907635,0.05991735537190083,0.06094896176070047,0.999,6/15,25.00%,UNC119;PDCD6IP;RAB35;MITD1;SPAST;CHMP4B
gsea,positive regulation of mRNA catabolic process (GO:0061014),-0.508671229419724,-1.482484963154615,0.08061420345489444,0.12223280764587985,0.998,4/15,6.69%,TNRC6B;ZC3HAV1;TNRC6C;PUM1
gsea,protein K48-linked ubiquitination (GO:0070936),0.40458201778923686,1.4816148733819783,0.0593607305936073,0.06287184885175987,1.0,16/31,33.46%,RBX1;PELI1;UBE2A;RNF187;UBE2D1;RNF4;UBE2D3;AMFR;RNF6;ARIH2;RNF115;UBE2K;UBE2G2;RNF34;KBTBD7;TOPORS
gsea,protein localization to cell periphery (GO:1990778),0.3923149331026283,1.4800076908073754,0.037096774193548385,0.06337284524135282,1.0,26/49,41.16%,EHD1;RAB8B;RAB29;ITGB1BP1;RAB8A;RAB11A;RABEP1;ZDHHC3;SLC9A3R1;RAB3A;KCNIP3;RAB12;SLC9A3R2;SMURF1;EFR3B;RAB40C;LIN7C;PRAM1;FCHO2;F11R;PIGW;INPP5K;EFR3A;RAB3B;IKBKB;CRB3
gsea,positive regulation of macroautophagy (GO:0016239),0.5005488130122971,1.4775084925719868,0.06832298136645963,0.06434347790193581,1.0,6/15,21.60%,SH3GLB1;SPTLC2;TBK1;PAFAH1B2;PIP4K2C;SLC25A4
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4782436603492127,1.4737722211182858,0.03286978508217446,0.06581612269842989,1.0,10/33,26.11%,ITGB2;CD164;ITGAL;TGFBR2;AMIGO1;LRFN4;ATP2C1;CXADR;TRO;LRRC4C
gsea,lipid transport (GO:0006869),0.46888570643360405,1.4731817909031977,0.053156146179401995,0.0659322107389591,1.0,12/23,30.54%,UGCG;NPC2;GLTP;PITPNA;PITPNC1;PLEKHA3;PEX19;PPARD;TRIAP1;CLN8;SPNS2;ABCC3
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35127579013251253,1.472744398822248,0.03436426116838488,0.06597796293827474,1.0,27/70,37.21%,MTPN;STAT3;HCLS1;PYCARD;UBE2V1;TRADD;LAMTOR5;RPS6KA4;PRKCH;UBC;DDRGK1;CFLAR;CEBPG;NTRK1;TAF12;NOD1;LPAR5;TICAM1;TRIM27;MYD88;LGALS9;TRIM13;STK36;RTKN2;AGER;TIRAP;CIB1
gsea,ion transport (GO:0006811),0.44359037246845434,1.4706232631792042,0.050434782608695654,0.06670949937332607,1.0,9/25,27.54%,LASP1;PANX1;TSPO;SLC8B1;SLC36A1;MCOLN1;SLC17A7;SLC9A6;CHRNB2
gsea,regulation of cell cycle (GO:0051726),0.33828548068045067,1.4693798318821545,0.027833001988071572,0.0670669121762577,1.0,35/83,36.85%,ID2;RASSF1;RUNX3;IQGAP1;STAT3;SDCBP;UHRF2;BIN1;FOXM1;SIPA1;PKD2;SIRT2;SRA1;TGFB1;CDK9;MAEA;LIN37;RNF20;DAPK3;STK11;CDK5;AKT2;POU4F1;CTBP1;ADAM10;UHMK1;PRKACA;CYLD;USP51;IL12A;CDK11B;EVI2B;LIN52;TMEM8B;CSNK2A1
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.37037493501710045,1.4692846981374397,0.030418250950570342,0.06699731961330162,1.0,22/50,37.21%,MTPN;STAT3;PYCARD;UBE2V1;TRADD;LAMTOR5;RPS6KA4;PRKCH;UBC;DDRGK1;CFLAR;NTRK1;NOD1;TICAM1;TRIM27;MYD88;LGALS9;TRIM13;RTKN2;AGER;TIRAP;CIB1
gsea,stress-activated MAPK cascade (GO:0051403),0.4128182816683755,1.4677872617870529,0.0395010395010395,0.06749444276368013,1.0,12/29,31.70%,MAPK3;UBE2V1;MAPK9;ARHGEF6;UBC;NOD1;GPS2;MAPK1;FBXW11;LGALS9;CRKL;DUSP9
gsea,regulation of ATP metabolic process (GO:1903578),-0.5025524438601856,-1.467728013567325,0.0631163708086785,0.13095587558828722,0.998,6/15,15.99%,HIF1A;COX7A2L;OGT;JMJD8;COX7A2;FIS1
gsea,negative regulation of autophagy (GO:0010507),0.49546782963073077,1.4648049356498554,0.0773286467486819,0.06866756049061226,1.0,8/17,20.42%,CTSA;STAT3;SIRT2;PTPN22;MTMR9;RRAGA;QSOX1;RUBCN
gsea,regulation of intracellular protein transport (GO:0033157),0.494754343383585,1.4645208332559192,0.0499001996007984,0.06866443597727465,1.0,9/16,25.44%,RAB29;OAZ1;PDCD10;TPR;B3GAT3;TGFB1;SIRT7;VAMP2;UHMK1
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),0.4575144807193287,1.4641118931743988,0.053929121725731895,0.06873891316489839,1.0,10/27,26.09%,CD52;HMGB1;BCAP31;SLC8B1;XCR1;SELENOT;TRPM4;TAC4;FKBP1B;PRKACA
gsea,positive regulation of programmed cell death (GO:0043068),0.3383236726045322,1.4640646663004788,0.019157088122605363,0.0686209345051006,1.0,36/81,35.67%,HMGB1;LAPTM5;PYCARD;CASP8;TRADD;MTCH1;BIN1;ARHGEF6;SAP18;PTPA;CALHM2;UBC;PSEN1;NTRK1;HTATIP2;APH1B;NCSTN;DNM2;VAV1;ARHGEF1;TFPT;DNM1L;DAPK3;PIP5KL1;RYBP;ARHGEF16;ARL6IP5;CASP9;APH1A;DUSP9;SUDS3;CASP2;FGD4;STK17B;PDCD2;PDCD5
gsea,phosphatidylinositol metabolic process (GO:0046488),0.4002314234457694,1.46119087290651,0.03207547169811321,0.06976307405332854,1.0,23/38,37.30%,PLAAT3;IMPA1;ARF1;INPP5D;RAB14;PIP4P2;MTMR9;MTMR2;PLEKHA3;PLA2G4C;PIP4K2C;MTMR6;ARF3;MTMR11;PLEKHA4;PLCB3;MTMR10;PIP5K1B;PIP4K2A;PIK3C2B;PIGW;INPP5K;PIP4P1
gsea,insulin receptor signaling pathway (GO:0008286),0.4120454275110954,1.4592845795567753,0.058577405857740586,0.07056659739169635,1.0,15/30,34.12%,GRB2;ATP6V1G1;GSK3A;ATP6V1A;ATP6V0B;ATP6V1E1;ATP6V0D1;PTPN2;ATP6V1H;ATP6AP1;AKT2;ATP6V1C1;ATP6V1D;SOGA1;GRB14
gsea,positive regulation of protein polymerization (GO:0032273),0.46380312615595587,1.4574572112282504,0.05862068965517241,0.07129010256684395,1.0,9/22,23.91%,VASP;RAC1;MAPRE1;PYCARD;BIN1;ARF6;FCHSD1;NCK1;TPPP
gsea,negative regulation of defense response (GO:0031348),0.4582727749133595,1.4566906439855907,0.054474708171206226,0.07148139018288686,1.0,13/20,34.90%,NMI;OTULIN;SIRT2;SHARPIN;GBA;GPS2;TYRO3;ILRUN;PTPN2;PPARD;PPM1B;MUL1;LPCAT3
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30680823607406776,1.4559188962620733,0.020146520146520148,0.07175721000202671,1.0,65/154,44.26%,ID2;TBX21;HMGB2;RBPJ;UBE2I;GATAD2A;YWHAQ;NDUFA13;EID1;YAF2;LIMS1;MLX;RUNX2;ZGPAT;MTA3;MBD2;SAP18;WWP2;FOXM1;GSK3A;SNX6;NKAP;SIRT2;CREBZF;NR3C1;TGFB1;LDB1;NR1H2;PCIF1;THAP7;EID2B;COMMD7;DAPK3;CDK5;FBXW11;BRMS1;PPARD;CTBP1;TERF1;MPHOSPH8;LIMD1;RNF139;DEAF1;EIF4E2;TBR1;CNOT7;CEBPA;HDAC3;SMAD2;HEY1;SAMD11;UIMC1;CITED1;RCOR2;SUDS3;CNOT8;INPP5K;RBM4;EIF2AK1;MTERF3;DPF3;HMGA2;KAT5;TFAP2A;SAMD4B
gsea,negative regulation of binding (GO:0051100),0.4322775073562433,1.4543848384586686,0.05084745762711865,0.07235817022845631,1.0,10/25,19.43%,PPP1CA;TMBIM6;ITGB1BP1;SP100;SORL1;CTNNBIP1;ILRUN;MITD1;LRPAP1;PEX19
gsea,regulation of Ras protein signal transduction (GO:0046578),0.42400646697204886,1.4529706863217489,0.05514705882352941,0.07293707962054696,1.0,12/29,31.47%,ARHGDIB;GRB2;PDCD10;ARF6;RASAL3;FOXM1;NTRK1;VAV1;STARD8;LRRD1;CRKL;KBTBD7
gsea,regulation of cation channel activity (GO:2001257),0.4889422878973678,1.4516845219693004,0.058919803600654665,0.0734036379816472,1.0,12/19,30.44%,CALM1;FKBP1A;CAPN1;CACNB4;CACNG8;VAMP2;PDE4D;FKBP1B;MAPK8IP2;PRKACA;CACNG7;DMD
gsea,protein localization to plasma membrane (GO:0072659),0.38707908903655425,1.4484497790116326,0.049099836333878884,0.07490640635387144,1.0,25/46,43.46%,EHD1;RAB8B;ITGB1BP1;RAB8A;RAB11A;ZDHHC3;SLC9A3R1;RAB3A;KCNIP3;RAB12;SLC9A3R2;SMURF1;EFR3B;RAB40C;PRAM1;FCHO2;F11R;PIGW;INPP5K;EFR3A;RAB3B;IKBKB;CRB3;KCNB1;RAP1A
gsea,apoptotic process (GO:0006915),0.3578337538561322,1.4484438028588893,0.03171641791044776,0.07477357773289597,1.0,31/56,37.21%,ITGB2;PYCARD;RFK;BNIP2;CASP8;TRADD;ARHGEF6;TGFBR2;PPP2CA;GLRX2;CFLAR;PPP2R1A;RRAGC;BAG6;CD2;NUDT2;DAPK3;MYD88;STK11;CDK5;PPARD;CYFIP2;ATP2A1;MAGEH1;CASP9;CASP2;CDK11B;IRF3;KREMEN1;TRAF7;CIB1
gsea,regulation of cellular metabolic process (GO:0031323),0.48031030221625765,1.4477954077980972,0.06451612903225806,0.0749278670085163,1.0,8/17,22.97%,NPC2;ARF1;LAMTOR1;FOXM1;TBC1D16;GBA;MKLN1;PM20D2
gsea,organonitrogen compound catabolic process (GO:1901565),-0.4939710734623199,-1.4450774539711535,0.10191082802547771,0.14691894436990446,0.999,5/15,9.58%,CPQ;CAPN3;USE1;MPST;LNPEP
gsea,regulation of phosphorylation (GO:0042325),0.38987730692693745,1.4431247426935918,0.04460966542750929,0.07694404221468208,1.0,15/36,24.60%,DYNLL1;ILK;SDCBP;BTBD10;NDUFS4;TPR;SEC13;PSEN1;STAP1;PPP2CA;SIRT2;LDB1;PRKAG1;NUP50;FNIP2
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),0.5047647874576118,1.44269559296735,0.08814102564102565,0.07700698233528744,1.0,5/16,20.37%,RBPJ;RHEB;PLCL2;NR1H2;STK11
gsea,negative regulation of signal transduction (GO:0009968),0.36052265539378464,1.4422860802591138,0.02158273381294964,0.07708086991382133,1.0,37/79,37.05%,CD47;PTPN18;YWHAB;TMBIM6;LEPROT;WWP2;RGS14;GPR108;GSK3A;GBA;CTNNBIP1;GPS2;RPS6KB1;MTMR2;TYRO3;SLC9A3R1;YTHDF2;TNS2;KCTD6;PTPN2;NKD1;PDCD6;LRPAP1;PIP4K2C;MOSMO;NCK1;MAPK8IP2;NR4A2;MPIG6B;HEY1;CITED1;IL12A;HIF1AN;GRB14;PIP4K2A;CSNK2A1;INPP5K
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.45304102480268527,1.437778988565366,0.08423326133909287,0.07915455072943028,1.0,9/19,28.99%,HMGB1;NDUFA13;PYCARD;CASP8;BCAP31;NOD1;PDCD6;CYFIP2;ARL6IP5
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4700854550077052,1.4334540971442409,0.07167832167832168,0.0812484934287677,1.0,14/18,39.47%,DBNL;DBN1;DNM2;TAOK3;SNX2;SNX1;SLC9A6;NYAP1;DTNBP1;NCKAP1L;GAS7;MYO16;MAP1S;ATP7A
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),-0.4624505496298845,-1.4314802215837221,0.0718562874251497,0.15574727403250668,0.999,8/18,26.71%,OGT;IL18;PRKAB2;ADIPOR2;IGF1R;APC;PER2;THRA
gsea,positive regulation of cell migration (GO:0030335),0.36390614716031017,1.426795990752612,0.0391566265060241,0.08442706234600147,1.0,27/64,37.24%,SEMA4D;PPP3CA;STAT3;MAPRE1;SDCBP;MIEN1;TRADD;PDCD10;FERMT3;RAB11A;DDRGK1;TGFB1;FAM89B;FAM83H;NSMF;SRC;AKT2;ADAM10;SEMA6B;EPHA1;CRKL;MYLK;WASHC1;CBLL1;NCKAP1L;CIB1;SPAG9
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),-0.4781599418345118,-1.4261770789451338,0.060324825986078884,0.15824032631977925,0.999,6/15,16.79%,NOP53;RAD9B;NEK11;ATF2;WAC;CDK5RAP3
gsea,positive regulation of protein kinase B signaling (GO:0051897),0.40754898327355477,1.423166205839776,0.06403940886699508,0.08617086343990454,1.0,12/33,25.26%,RAC2;RAC1;GRB2;HCLS1;ITGB1BP1;TGFB1;LCK;P2RY12;VAV1;SRC;AKT2;FGFR3
gsea,cellular calcium ion homeostasis (GO:0006874),0.42317011357956785,1.4231223009597196,0.06484641638225255,0.08603357355805286,1.0,14/28,26.09%,ANXA6;SELENOK;TMCO1;SMDT1;PSEN1;SLC10A7;SLC8B1;GCM2;WFS1;ATP2C1;VAPB;FKBP1B;ATP2A1;PRKACA
gsea,regulation of protein localization (GO:0032880),0.4505201748738933,1.419600902863518,0.08955223880597014,0.08769073249753528,1.0,6/18,15.02%,DNAJB6;TPR;RAB14;VPS4A;FKBP1A;TRIM27
gsea,protein autoubiquitination (GO:0051865),0.40480331877832587,1.4191142476915717,0.07407407407407407,0.08778847517758571,1.0,11/28,22.31%,UHRF2;UBE2A;WWP2;RNF187;RNF4;UBE2D3;AMFR;RNF181;RNF115;RNF13;RNF185
gsea,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4742372084006938,1.4155877039513767,0.07095343680709534,0.08949705930146053,1.0,5/15,12.48%,UBE2V1;CASP8;UBC;OTULIN;NOD1
gsea,Golgi to plasma membrane transport (GO:0006893),0.41245263658420955,1.4131024564288464,0.061895551257253385,0.09058365267130096,1.0,14/27,28.75%,GGA1;COMMD1;GOLGA7;SYS1;EXOC5;ARFRP1;RAB31;RABEP1;EXOC6;VAMP2;GOPC;CCDC93;CCDC22;EXOC1
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.48893133871192623,1.4082047170005176,0.08856088560885608,0.09306041163468924,1.0,6/16,8.41%,RPS6KA1;DNAJB6;BEX3;CST7;LAMTOR5;CAST
gsea,histone deacetylation (GO:0016575),0.4717593936614876,1.4068866101060997,0.10429447852760736,0.09357786647125833,1.0,10/16,33.04%,MTA3;SIN3B;SIRT2;MORF4L1;SMARCAD1;SIRT7;BRMS1;HDAC3;RCOR2;SUDS3
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4559729988518221,1.406307672918631,0.0701219512195122,0.09376260081367227,1.0,7/24,19.55%,CD52;HMGB1;BCAP31;XCR1;SELENOT;TRPM4;TAC4
gsea,negative regulation of cell death (GO:0060548),0.4029830446961082,1.4059008517229061,0.07074569789674952,0.09382930451017804,1.0,16/27,27.66%,CHMP2A;ATG5;BTBD10;SORL1;BECN1;GBA;VPS4B;LRPAP1;WFS1;CDK5;PDE12;POU4F1;NCK1;PARP16;CHMP4B;TXNDC12
gsea,positive regulation of apoptotic process (GO:0043065),-0.3130762265351995,-1.4039921167740994,0.0420353982300885,0.17610578040127714,1.0,91/91,99.00%,RPS3;GNA13;BTG1;RPS6;STK4;BCL10;BNIP3L;UBA52;SRPK2;SOX4;RBM5;CTNNB1;FOXO1;FLCN;CDK5R1;ING4;PRDM11;BMF;DIABLO;MAP3K10;ARHGEF4;TRIO;RASGRF2;CRADD;APC;BACE1;RNF122;TIAM2;ING3;CTNNBL1;MCF2L;TRAF6;SLC27A4;GPLD1;FGD1;MOAP1;PSENEN;TNFRSF8;TPD52L1;TNFRSF12A;BAD;TGFBR1;AKAP13;RPS6KA2;PLEKHG5;SOD1;ARHGEF7;UBE2Z;TFAP2A;SIK1;HMGA2;SQSTM1;FZD9;USP27X;TRAF7;PDCD5;PDCD2;STK17B;FGD4;CASP2;SUDS3;DUSP9;APH1A;CASP9;ARL6IP5;ARHGEF16;BRMS1;RYBP;PIP5KL1;CDK5;DAPK3;DNM1L;TFPT;ARHGEF1;VAV1;DNM2;NCSTN;APH1B;SIRT2;PSEN1;UBC;CALHM2;PTPA;SAP18;ARHGEF6;BIN1;MTCH1;TRADD;CASP8;PYCARD;HMGB1
gsea,regulation of Rho protein signal transduction (GO:0035023),0.48168807616754306,1.401407959074689,0.07550644567219153,0.09611088361044336,1.0,6/16,24.28%,ARHGDIB;RAC1;PDCD10;RALBP1;STARD8;KCTD10
gsea,mitotic spindle organization (GO:0007052),0.40330514737768636,1.3990337616397792,0.06092436974789916,0.09730185285888411,1.0,14/27,26.52%,RHOA;DYNLL1;MAPRE1;PPP1CC;RAB11A;PAFAH1B1;PTPA;SEC13;DYNC1LI1;DCTN6;MZT1;SPAST;ABRAXAS2;ARHGEF10
gsea,positive regulation of transferase activity (GO:0051347),0.4027233013012597,1.3984806690411404,0.06591639871382636,0.09741618910606123,1.0,12/35,16.43%,UBE2I;MAPK3;UBE2L3;GSK3A;SERINC1;NTRK1;SORL1;TGFB1;INSRR;LTK;TYRO3;MAPK1
gsea,negative regulation of cellular catabolic process (GO:0031330),0.4494109529270743,1.3968780683193835,0.09523809523809523,0.09813988495856939,1.0,9/20,20.42%,STAT3;GSK3A;SIRT2;SORL1;PTPN22;MTMR9;MTMR2;RRAGA;RUBCN
gsea,negative regulation of gene expression (GO:0010629),0.315956124688942,1.3965040823409998,0.03949730700179533,0.09817928451466855,1.0,44/88,46.78%,ID2;NDFIP2;SRGN;LSM5;TMBIM6;PTBP3;LSM6;PPP1R11;PDCD10;N4BP1;RNH1;WWP2;RPS6KA4;PSEN1;DDRGK1;CREBZF;TGFB1;PTPN22;MAP2K2;TRIM27;PCIF1;SNX12;YTHDF2;CD3E;DAPK3;POU4F1;ADAM10;MPHOSPH8;RNF139;EIF4E2;CNOT7;LGALS9;AGO3;CRKL;DCP2;CNOT8;RBM4;MAPT;DGKQ;YY1;SAMD4B;MECP2;STOX1;BMPR1A
gsea,cilium organization (GO:0044782),0.3218486536233285,1.3958614536857674,0.04227642276422764,0.09832116195481809,1.0,35/82,43.20%,ACTR3;EHD1;DYNLL1;RAB8B;RAB1A;RAB8A;RAB11A;PKD2;CFAP20;EXOC5;SNAP29;ATP6V0D1;SLC9A3R1;EXOC6;BBIP1;EXOC7;SSTR3;INTU;EXOC1;ATP6V1D;STK36;ARL6;RILPL1;ARMC2;IFT52;FAM161A;FAM161B;TTLL3;CPLANE2;FOXJ1;CEP131;INPP5E;UNC119B;TTC36;EXOC3
gsea,positive regulation of viral process (GO:0048524),0.4177962130644742,1.389625486002305,0.09843400447427293,0.10168927037760934,1.0,13/21,26.68%,POLR2K;POLR2G;PKN2;POLR2J;VPS4A;CDK9;POLR2I;TYRO3;PDE12;VAPB;POLR2D;NELFB;CNOT7
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3902516043902982,1.3869662313454205,0.07159353348729793,0.10300306842942092,1.0,10/30,28.11%,RBM3;HNRNPL;PRDX6;SAP18;TRA2B;PUF60;SF1;NSRP1;RBM11;WTAP
gsea,intracellular pH reduction (GO:0051452),0.4581551970893946,1.3854621095271855,0.1,0.1037105290816012,1.0,8/15,28.87%,ATP6V1G1;ATP6V1A;ATP6V0B;ATP6V1E1;ATP6V0D1;ATP6V1H;ATP6V1C1;ATP6V1D
gsea,regulation of RNA splicing (GO:0043484),-0.42755319860866453,-1.3853065481349802,0.10526315789473684,0.19168967415389684,1.0,12/23,22.98%,RPS13;CLK1;MBNL2;SRPK2;YTHDC1;SON;PQBP1;CLK4;TIA1;RBM39;HNRNPH2;KHDRBS1
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.357928434197231,1.3828458402175279,0.06935123042505593,0.1050510013250189,1.0,16/40,27.10%,RBX1;ELOB;SDCBP;DDA1;N4BP1;COMMD1;GSK3A;DDRGK1;SIRT2;FBXO22;BAG6;ARIH2;RYBP;PSMD10;CEBPA;UBXN1
gsea,positive regulation of proteolysis (GO:0045862),0.44494609210956243,1.3820141476135013,0.11042944785276074,0.10534015920132485,1.0,7/16,25.45%,CTSC;NDUFA13;CASP8;AURKAIP1;GBA;FBXW11;CYFIP2
gsea,regulation of type I interferon production (GO:0032479),0.3756622938996253,1.3769981202004262,0.06728538283062645,0.10807054448789731,1.0,15/32,36.14%,POLR2K;LRRFIP1;TBK1;RNF125;PTPN22;ILRUN;CRCP;MYD88;UFD1;RNF135;CYLD;GPATCH3;IRF3;TAX1BP1;TIRAP
gsea,positive regulation of cell projection organization (GO:0031346),0.3806694077002203,1.374372003900114,0.08214285714285714,0.10942301179242557,1.0,17/36,46.54%,RHOA;SNX3;SCARB2;MARK2;NTRK1;TWF2;LTK;AMIGO1;TWF1;CDKL5;CARMIL1;GPC2;RAP1A;STYXL1;OBSL1;MAGI2;EP300
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.42856098098455686,1.3723967828199521,0.07706422018348624,0.11043525069451385,1.0,12/22,31.18%,MAPK3;GSTP1;PDCD10;FOXM1;MAP2K2;KLHDC10;MAPK1;TAOK3;MAPK8IP2;LGALS9;ARL6IP5;AGER
gsea,regulation of receptor internalization (GO:0002090),0.45664692654232114,1.3713653224966815,0.1022964509394572,0.11089374064923851,1.0,7/15,20.70%,ARRB2;SDCBP;ARF1;ATAD1;MTMR2;LRPAP1;MKLN1
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.45080447028110665,1.3704290116313667,0.08928571428571429,0.11131613866049747,1.0,9/24,27.95%,UNC119;SEMA4D;STAT3;HCLS1;TGFB1;PAK2;SRC;FGFR3;IL11
gsea,regulation of macromolecule metabolic process (GO:0060255),0.35668418062591734,1.3682079432658107,0.0888030888030888,0.1124601904324784,1.0,21/42,35.98%,PRDM1;TAPBP;CGGBP1;ARF1;LAMTOR1;SCARB2;RNF187;PSEN1;NKAP;C1D;TBC1D16;MTMR9;TRIM27;MTMR2;MKLN1;DHH;NKAPL;ADNP;TRIM11;ANKRA2;POU5F1
gsea,nucleus organization (GO:0006997),0.4090658321216979,1.366119014420925,0.12114989733059549,0.11354738573292232,1.0,12/22,25.00%,PDCD6IP;CHMP2A;CHMP6;BIN1;TPR;VPS4A;CHMP5;CHMP3;CHMP2B;VPS4B;CHMP1B;CHMP4B
gsea,skeletal system development (GO:0001501),0.419911210531826,1.3638566967104002,0.07407407407407407,0.11477071249465175,1.0,11/32,25.26%,PPIB;EBP;TRAPPC2;DDRGK1;SLC10A7;TRIP11;ANKRD11;GNAS;UFD1;DEAF1;FGFR3
gsea,mRNA catabolic process (GO:0006402),-0.4376240997789752,-1.3636886965185449,0.11222444889779559,0.21101459361479202,1.0,10/17,42.26%,TUT4;DDX5;NBDY;XRN2;AGO4;NUDT12;NUDT16L1;TUT7;DHX34;RC3H1
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4510971685426082,1.3635865962126035,0.11498973305954825,0.11472234532524041,1.0,5/16,18.22%,UFM1;CBFB;DDRGK1;RNF6;KCTD6
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.43121692450339827,1.3591539118256128,0.10996563573883161,0.11734410571274315,1.0,11/23,31.55%,CASP8;GSTP1;TRADD;EYA2;CFLAR;ITGAV;NOL3;SRC;RNF34;EYA1;NOS3
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.45994372822406493,1.356203784735677,0.11610486891385768,0.11911388995031492,1.0,7/15,39.85%,SLA2;PIP4K2C;EFR3B;SOCS4;PIP4K2A;PIK3C2B;EFR3A
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.47558961636534136,1.3502414319302376,0.10571428571428572,0.12299309040544443,1.0,6/18,21.93%,SEMA4D;HCLS1;HCST;NTRK1;BECN1;SRC
gsea,positive regulation of signal transduction (GO:0009967),-0.31603559402055376,-1.3488375668770662,0.06333333333333334,0.22397839757121865,1.0,36/63,44.73%,RPS3;HIF1A;NPTN;KLF2;TSPAN14;DLG4;ATP6V0C;DSTYK;TERT;TM2D3;PTPRC;LY96;RWDD3;KIF7;SMO;TTC23;CRADD;MAML1;ARMC9;ZRANB1;IL7;SPIN1;NLGN3;LIMS2;ASXL2;DACT1;TREM2;TXNDC15;PDE6H;LOXL3;CDKN2AIP;NOD2;TPD52L1;PTEN;MBD5;ULK3
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.38248759352700107,1.3470121495015732,0.09137931034482759,0.12499046251022844,1.0,13/34,32.45%,TGFBR2;UBC;UBE2D1;SNX6;FKBP1A;SORL1;TGFB1;UBE2D3;FAM89B;SMURF1;SMAD2;TGFB1I1;IL17RD
gsea,cellular metal ion homeostasis (GO:0006875),-0.39503430824527225,-1.3467861668645449,0.10955056179775281,0.2233212844357741,1.0,6/23,19.45%,TPT1;NPTN;LETM2;SLC24A3;NEDD4L;TMPRSS3
gsea,negative regulation of mitotic cell cycle (GO:0045930),-0.4288553519253441,-1.3410189803436112,0.12718204488778054,0.22693129009004853,1.0,7/17,16.27%,BTG1;CDKN1B;CTNNB1;ANGEL2;HECA;TOM1L2;PRCC
gsea,chromosome organization (GO:0051276),0.40801267064935565,1.3374617294220212,0.10674157303370786,0.13144566798007987,1.0,9/24,28.74%,RBX1;HMGB2;GATAD1;UBC;COPS8;LDB1;COPS6;CETN2;HDAC3
gsea,nuclear export (GO:0051168),0.4233727130770864,1.336377581865441,0.11133200795228629,0.13197168845696966,1.0,11/18,31.24%,TPR;TGFB1;SLU7;SRSF11;CHTOP;PHAX;RANBP17;SMURF1;NUP62CL;CDC40;U2AF1L4
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.4064868357409467,-1.3362913321753391,0.12386706948640483,0.22922481573523276,1.0,10/20,33.50%,DGKZ;DLG4;AKAP9;EIF4EBP2;GRIK5;NPAS4;BEGAIN;NLGN3;DLGAP3;BTBD9
gsea,DNA metabolic process (GO:0006259),0.31003546186862596,1.3329564459020364,0.08924485125858124,0.13414654442410143,1.0,33/63,45.69%,HMGB2;HMGB1;POLE4;RAD21;UHRF2;SP100;UBE2A;UBC;GLRX2;ALKBH3;INIP;SMARCAD1;NSMCE3;FBXO6;SIRT7;SMUG1;ERCC1;EID3;PARP4;TERF1;STN1;XRCC3;EXD2;TOP3B;DFFB;ACD;NABP2;PNKP;RAD51B;KAT5;HUS1B;DNASE1L2;DNASE1L1
gsea,protein import into nucleus (GO:0006606),-0.4317070086293824,-1.3309129914986209,0.12080536912751678,0.23275324048864057,1.0,7/16,21.25%,RPL23;KPNA1;FAM53A;PTTG1IP;PRICKLE1;IPO13;KPNA4
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.39936044385847225,1.3270253382608241,0.11129296235679215,0.1382814816519645,1.0,12/27,30.76%,NDUFA13;TMBIM6;GSTP1;CFLAR;ITGAV;NOL3;SRC;MAPK8IP2;PSMD10;NR4A2;TRIAP1;RTKN2
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.4666243415616598,1.325481116183584,0.16051660516605165,0.139127878653715,1.0,7/17,19.45%,HMGB2;HMGB1;PDCL3;EMC10;AGGF1;PDCD6;PPP1R16B
gsea,spindle assembly (GO:0051225),0.43182401003885645,1.3246386646499768,0.13778705636743216,0.1394792511272572,1.0,8/17,28.74%,RHOA;MAPRE2;MAPRE1;RAB11A;MZT1;ABRAXAS2;ARHGEF10;HDAC3
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),-0.41817941451204765,-1.320928486096859,0.15625,0.24127610479962802,1.0,6/20,24.25%,RPS3;BCL10;BMF;FIS1;CRADD;DEDD2
gsea,protein localization to cilium (GO:0061512),0.4216709170708831,1.318363295228155,0.11743119266055047,0.14388920313198839,1.0,6/19,30.96%,EHD1;RAB29;RABEP1;TULP1;ATP6V1D;ARL6
gsea,regulation of neuron projection development (GO:0010975),0.3417145364540945,1.3140459039993653,0.09634551495016612,0.14700380215242906,1.0,18/49,26.11%,RAB29;SNX3;SCARB2;GSK3A;PSEN1;MARK2;NTRK1;TWF2;DBN1;LTK;CHN1;MINAR1;PAK2;RTN4RL1;CDK5;TWF1;TBR1;LRRC4C
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.39465789372183574,1.313036570228769,0.142,0.14747665043450475,1.0,12/25,24.60%,RBX1;RAP1B;SH3GLB1;PSMC3;GTF2H5;TGFB1;MYD88;ERCC1;SRC;TERF1;TPPP;FNIP2
gsea,regulation of osteoblast differentiation (GO:0045667),0.41486080561893834,1.3129442531875049,0.1503623188405797,0.14729185293390035,1.0,11/21,33.26%,SEMA4D;SUCO;RUNX2;LRP5;CTNNBIP1;TRPM4;ATP6AP1;LIMD1;PRKACA;CITED1;FGF23
gsea,regulation of inflammatory response (GO:0050727),0.34997418132860203,1.3085290636719447,0.10338983050847457,0.15030019990279891,1.0,21/45,27.01%,CD47;NMI;TRADD;IFI35;SNX6;OTULIN;VAMP3;SHARPIN;GBA;GPSM3;GPS2;TYRO3;PTPN2;MYD88;PPARD;VAMP2;GGT1;BRD4;DAGLB;NAPEPLD;CEBPA
gsea,actin cytoskeleton reorganization (GO:0031532),0.44052689393623323,1.3084107792284865,0.14109347442680775,0.15014460415501066,1.0,9/17,25.23%,RHOA;GRB2;INSRR;PARVG;MKLN1;ATP2C1;CDC42BPG;CXADR;CDC42BPA
gsea,regulation of epithelial cell proliferation (GO:0050678),0.45000230285625903,1.3064264586313887,0.143317230273752,0.1514844351872015,1.0,4/16,11.89%,B2M;RUNX3;LIMS1;TGFB1
gsea,protein glycosylation (GO:0006486),0.38330745631830343,1.3034150697072748,0.11509715994020926,0.15365029848270242,1.0,13/34,25.85%,KRTCAP2;MGAT2;MGAT3;ALG5;DPM3;GALNT2;B4GALT7;TMEM258;PMM2;C1GALT1C1;ALG1;GAL3ST1;ST6GALNAC2
gsea,response to molecule of bacterial origin (GO:0002237),-0.38369026276268164,-1.3032889120891336,0.12151898734177215,0.25927912030134026,1.0,24/24,99.16%,IFNAR1;FOXP1;TAB2;OTUD5;LY96;GGT7;GGT5;IRAK1;PALM3;SRR;FER;TNFRSF11A;FZD5;CD6;TIRAP;IL12A;CITED1;NOS3;LGALS9;GGT1;PTPN22;SIRT2;PELI1;HMGB2
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4376417072541475,1.3011030005672797,0.13622291021671826,0.1553675498607464,1.0,7/20,24.01%,MEF2A;RAB8A;RAB3A;CDK5;POU4F1;TBCD;MAPK8IP2
gsea,protein-containing complex disassembly (GO:0032984),-0.3716264156510952,-1.3004759015185827,0.14395393474088292,0.2595858624800378,1.0,13/29,28.35%,RPL23;GABARAPL1;WIPI2;CTNNB1;FRAT1;UVRAG;AMER1;GABARAP;DVL2;DVL1;APC;EPG5;DVL3
gsea,axonogenesis (GO:0007409),0.35425805390723647,1.3001952295284827,0.09103078982597054,0.15591766008267785,1.0,19/56,29.00%,VASP;SEMA4D;MAPK3;GRB2;RAB8A;LYPLA2;PTPRA;SH3KBP1;MAPK1;RAB3A;CDK5;FEZ2;SRC;POU4F1;DOK4;SEMA6B;SLC9A6;EPHA1;DOK1
gsea,epithelium development (GO:0060429),0.44245221037252563,1.2992882117304771,0.13657056145675264,0.1563693119637738,1.0,4/21,16.58%,CTSB;PKD2;TGFB1;SLC9A3R1
gsea,axon development (GO:0061564),0.41464699550589684,1.2988437085842925,0.13282442748091602,0.15644376990850922,1.0,12/23,39.91%,RAB8A;MARK2;SVBP;AMIGO1;RAB3A;RTN4RL1;CDK5;POU4F1;MAP1S;MAPT;MAP1B;ATL1
gsea,response to lipid (GO:0033993),-0.34051027159932123,-1.2946481283311304,0.10952380952380952,0.26381383177478257,1.0,16/37,40.66%,IFNAR1;FOXP1;CTNNB1;TAB2;FOXO1;OTUD5;TMEM161A;LY96;GGT7;ESR1;RXRB;PAQR8;GPX3;ACER2;STRN3;OVCA2
gsea,positive regulation of T cell proliferation (GO:0042102),0.4171879068676394,1.2936781915054965,0.1694915254237288,0.16048148709735366,1.0,10/17,38.81%,HMGB1;IL12RB1;PYCARD;PNP;JAK3;CD3E;NCK1;AGER;NCKAP1L;CD6
gsea,response to interleukin-1 (GO:0070555),-0.41142351482754025,-1.291983924292476,0.1282051282051282,0.2640125166400911,1.0,8/18,42.26%,HIF1A;IGBP1;MAPK11;IRAK2;RELA;HYAL1;TRAF6;RC3H1
gsea,cholesterol metabolic process (GO:0008203),0.4160335283809432,1.2915917463421078,0.15163934426229508,0.16198843795491774,1.0,9/18,29.81%,EBP;SOAT2;GBA;OSBPL1A;STARD3;PPARD;SNX17;CLN8;INSIG2
gsea,positive regulation of cellular catabolic process (GO:0031331),-0.3325394847100629,-1.287616172692812,0.10743801652892562,0.26611999486910143,1.0,47/47,99.00%,HIF1A;PTPN1;INSR;ZC3HAV1;PRXL2C;VGLL4;TMEM59;PRKCD;FOXO1;TPCN1;FLCN;ITCH;PTTG1IP;AMER1;TNFRSF1B;PFKFB4;LIN28B;MSN;PHKG2;DACT1;GPLD1;RC3H1;SNX33;TRIM68;MLXIPL;ORMDL3;BAD;GSK3B;PFKFB2;KAT5;CNOT8;GTPBP1;CNOT7;DAGLB;PNPLA2;AKT2;GAPDHS;STK11;TRIM27;TICAM1;NPRL2;ABHD5;PSEN1;GSK3A;SH3GLB1;LAPTM5;HMGB1
gsea,mRNA metabolic process (GO:0016071),0.38210958139954143,1.286450944077436,0.15384615384615385,0.1658368646929718,1.0,14/25,32.56%,LSM5;LSM6;RNH1;AURKAIP1;NUDT21;PRPF18;KIN;SRSF11;YTHDF2;LSM10;PRMT9;PRKACA;AGO3;DCP2
gsea,protein K63-linked ubiquitination (GO:0070534),0.4306850997797012,1.2847203564039729,0.1728395061728395,0.1669769316966612,1.0,8/16,24.15%,UBE2V1;PELI1;WWP2;RNF4;TRIM27;ARIH2;RNF115;RNF135
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.4174357900021234,1.2838844998167989,0.18181818181818182,0.16748890066337813,1.0,5/17,19.80%,HMGB1;CTSB;UBC;NOD1;MYD88
gsea,peptidyl-lysine modification (GO:0018205),0.3681276818767232,1.2757110854928921,0.15498154981549817,0.1741090178920189,1.0,17/29,44.78%,UBE2I;TPR;METTL21A;SIRT2;NSMCE2;TRPM4;SIRT7;NUP50;VCPKMT;EYA1;TOPORS;EEF1AKMT1;ATP7A;LIPT1;KAT5;VIPAS39;EEF1AKMT3
gsea,cell chemotaxis (GO:0060326),-0.40699258697241664,-1.2746650174582843,0.17307692307692307,0.27974047756712,1.0,10/17,25.62%,LEF1;PRKCQ;NR4A1;BIN2;PRKCD;PIP5K1A;DOCK4;RHOG;HGF;ACKR4
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.3212556186845326,1.2738222762509734,0.13398058252427184,0.1755108484880206,1.0,26/46,43.08%,SLA2;IMPA1;ARF1;DPM3;INPP5D;RAB14;MTMR9;PIGO;MTMR2;PLEKHA3;PIGM;PIP4K2C;DPM2;MTMR6;EFR3B;ARF3;PLEKHA4;PIP5K1B;SOCS4;PIP4K2A;PIK3C2B;PIGW;INPP5K;EFR3A;INPP5E;DPM1
gsea,carbohydrate homeostasis (GO:0033500),-0.38568751271199414,-1.2723950001560154,0.17010309278350516,0.2794015410210389,1.0,22/22,97.23%,RPS6;INSR;ADIPOR2;IGF1R;SOX4;CRTC2;GCK;MLXIPL;MBD5;BAD;KCNB1;INPP5K;ADIPOR1;CEBPA;WFS1;STK11;USF1;PTPN2;SELENOT;SLC8B1;CYB5R4;STAT3
gsea,negative regulation of type I interferon production (GO:0032480),0.3917618843710241,1.2690116964160965,0.16204690831556504,0.17925278044073278,1.0,11/19,35.15%,PYCARD;TBK1;RNF125;ILRUN;UFD1;RNF135;PPM1B;CYLD;GPATCH3;IRF3;TAX1BP1
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3922686961921752,1.2683969758123328,0.1622222222222222,0.1794661279674687,1.0,7/19,28.63%,AZI2;TRADD;TBK1;UBC;SHARPIN;TICAM1;NKIRAS1
gsea,positive regulation of epithelial cell migration (GO:0010634),0.40123818525450144,1.265742576787774,0.18106312292358803,0.1813591369607809,1.0,8/23,21.93%,MAPRE2;RAC1;ITGB1BP1;RAB11A;ARF6;EMC10;PDCD6;SRC
gsea,sulfur compound biosynthetic process (GO:0044272),0.3680026786894136,1.264631846665663,0.13636363636363635,0.18206190030852173,1.0,17/36,37.09%,ESD;GCLM;CHST12;GSTP1;CNDP2;AKR1A1;SLC35B2;SLC10A7;B4GALT3;B4GALT2;CHST14;GGT1;UGDH;OGN;CSPG5;OPLAH;HPGDS
gsea,regulation of programmed cell death (GO:0043067),-0.33271378116515216,-1.261599139432225,0.15966386554621848,0.28981597202678966,1.0,40/40,99.55%,RPS3;RAF1;TPT1;BNIP3L;NOP53;PRDX2;BCL2L14;RTN4;TMEM219;CRADD;CASP6;HS1BP3;PPP1R13B;STEAP3;ACTN3;ACER2;MARK4;MOAP1;DCPS;ZBTB7A;IRF3;CASP2;CITED1;RABGGTA;TRIAP1;POU4F1;BRMS1;CDK5;WFS1;DAPK3;CD3E;LCMT1;SRA1;HTATIP2;NTRK1;ASAH1;JAK3;STK26;CTSB;IKZF3
gsea,protein catabolic process (GO:0030163),-0.36829932673681254,-1.2600524798855772,0.18072289156626506,0.2885062653251253,1.0,22/22,89.94%,CAPN3;USE1;SIAH2;LRSAM1;UBE2G1;ATE1;RNF41;FBXO17;NR1D1;TPP1;FBXO27;MANBA;UBE2G2;CLN8;NEU4;RAB12;PPT1;FBXO6;NGLY1;FBXO2;BAG6;LAMP2
gsea,erythrocyte differentiation (GO:0030218),0.42175620985710416,1.2586422747721877,0.19832985386221294,0.18695576267664615,1.0,6/15,18.53%,ID2;HCLS1;JAK3;CEBPG;KMT2E;PTPN2
gsea,regulation of JNK cascade (GO:0046328),0.3913388542118361,1.2572881553715296,0.1579778830963665,0.18784090224205097,1.0,12/28,36.14%,HMGB1;PYCARD;SDCBP;GPS2;TAOK3;ANKRD6;MAPK8IP2;HDAC3;AGER;CYLD;MBIP;TIRAP
gsea,negative regulation of cell growth (GO:0030308),-0.3396741245459008,-1.2465596700325006,0.17954070981210857,0.30258656152777397,1.0,35/35,96.36%,BTG1;CDKN1B;DIP2B;VGLL4;MAG;FLCN;CCDC85B;BMPR2;PRDM11;RTN4;SMAD4;ACVR1B;HYAL1;ADAM15;CAPRIN2;CDKN2AIP;NAIF1;DACT3;CRLF3;NDRG3;NDUFS3;APBB2;MUL1;SERTAD3;STK11;PPT1;MINAR1;RNF6;SERTAD2;TGFB1;PPP2R1A;PPP2CA;GSK3A;SIPA1;NDUFA13
gsea,histone modification (GO:0016570),0.3514278097455438,1.2444135176513895,0.17228464419475656,0.19913901202334072,1.0,15/37,33.04%,TAF10;MTA3;SIN3B;UBE2A;EYA2;RPS6KA4;SIRT2;MORF4L1;SIRT7;PHF20L1;BRMS1;EYA1;USP51;RCOR2;SUDS3
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.4072450241521899,1.2425695073231493,0.18055555555555555,0.2006156404503446,1.0,7/18,21.93%,CDC42;HMGB1;SORL1;GBA;LCMT1;RIOK3;SRC
gsea,cognition (GO:0050890),-0.4181297896601418,-1.241450145594601,0.18064516129032257,0.30653585443640574,1.0,8/15,27.73%,TUSC3;NIPBL;METTL23;RP9;LINS1;SOBP;SETD5;GPR155
gsea,regulation of mitochondrion organization (GO:0010821),0.3933173907431783,1.2410356185543499,0.19444444444444445,0.20176852187726757,1.0,14/20,47.86%,GSK3A;SREBF1;MIEF2;MFF;DNM1L;SIRT7;MUL1;MAPT;RHOT1;SQSTM1;GOLPH3;STOX1;EP300;FZD5
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.4137793676696779,1.2409634733100077,0.17990275526742303,0.20149334483251422,1.0,14/22,37.17%,RHOA;SIRT2;NTRK1;LTK;RPS6KB1;PLCL2;TYRO3;PLCD4;EXOC1;NYAP1;KCNH1;PLCB3;PIK3C2B;MYO16
gsea,positive regulation of cellular protein localization (GO:1903829),0.37066201945999633,1.2361942401697676,0.18809980806142035,0.2057931709382211,1.0,8/24,38.68%,VPS28;LAMTOR5;DDRGK1;TGFB1;ENTR1;F2;MEAK7;MAPT
gsea,calcium ion homeostasis (GO:0055074),-0.39799129617510065,-1.2355042431220824,0.19331742243436753,0.31125334065003396,1.0,17/17,92.24%,TPT1;NPTN;SLC24A3;DMPK;ATP2B1;STIM1;TMEM165;TPCN2;SLC24A1;ATP2A1;VAPB;ATP2C1;WFS1;GCM2;SLC8B1;SLC10A7;TMCO1
gsea,lipid homeostasis (GO:0055088),-0.37939956663585356,-1.2351537341615748,0.18208092485549132,0.3083796544831635,1.0,8/19,36.40%,ABHD8;ORMDL1;USF2;DGAT2;NR1D2;PNPLA3;TREM2;RBP1
gsea,intraciliary transport involved in cilium assembly (GO:0035735),0.42703654367331034,1.2347550913053018,0.2202486678507993,0.20688781120775498,1.0,3/15,11.57%,DYNLL1;DYNLRB1;TRIP11
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.38958527539952204,1.233129986091459,0.19831223628691982,0.20806489964110872,1.0,9/20,37.05%,PYCARD;GSTP1;RGS14;PRKAR1A;SORL1;LRP5;GBA;CEBPA;INPP5K
gsea,regulation of insulin secretion (GO:0050796),0.4011677010793332,1.2323208311326554,0.18394160583941604,0.20850977655404695,1.0,4/23,15.71%,UQCC2;PSMD9;LRP5;SLC8B1
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.38896318234221827,-1.2318691232924837,0.18159806295399517,0.30945811463662215,1.0,18/18,96.62%,RAF1;STK4;AKAP9;CREBL2;ARAF;TENM1;RAPGEF3;CAPRIN2;STOX1;BRAF;IL11;MTCP1;FNIP2;TGFB1;MAD2L2;TBK1;PDCD10;HCLS1
gsea,activation of protein kinase activity (GO:0032147),0.35398296732824686,1.2309862076163525,0.18281535648994515,0.2094062235131938,1.0,15/29,38.88%,ITGB1BP1;TGFBR2;PRKAR1A;COPS8;MARK2;ADCY3;ADCY7;TAOK3;PRKACB;PAK2;STK11;PRKACA;PRRC1;TIRAP;STRADB
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3943687249661659,-1.230187642007463,0.169921875,0.3083924163791198,1.0,8/19,38.09%,RPS27;EML4;SBDS;TNKS;B9D2;NDEL1;TUBG2;CEP126
gsea,regulation of apoptotic signaling pathway (GO:2001233),-0.39460362341139227,-1.2275368611764048,0.1867612293144208,0.3085029518512164,1.0,6/16,44.26%,RPS3;BCL2L14;CRADD;ASAH2;DEPTOR;TPD52L1
gsea,G1/S transition of mitotic cell cycle (GO:0000082),-0.4309258681743827,-1.2272872907290133,0.23161764705882354,0.30568296992074245,1.0,8/15,30.07%,CDKN1B;MAX;GPR132;CDK17;ACVR1B;KHDRBS1;MNAT1;CACUL1
gsea,regulation of endothelial cell migration (GO:0010594),0.4045917353004003,1.2258398002891322,0.21201413427561838,0.21431891400994288,1.0,6/18,18.77%,RAC1;ITGB1BP1;SP100;EMC10;SVBP;PDCD6
gsea,kidney development (GO:0001822),-0.38223639618675964,-1.2208100727352489,0.1880597014925373,0.3112187430115677,1.0,6/17,35.45%,NIPBL;SOX4;ARL3;PKD1;NPHP3;VANGL2
gsea,cellular response to reactive oxygen species (GO:0034614),0.3999921525751291,1.216659146892848,0.22058823529411764,0.22319924954261203,1.0,6/15,16.43%,MAPK3;MAPK9;PXN;PRDX5;PKD2;MAPK1
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.29728285094625323,1.208047319346472,0.1746641074856046,0.23186840065720843,1.0,28/58,37.05%,CSNK2B;IMPA1;ARF1;INPP5D;RAB14;CDS2;PHOSPHO1;ABHD5;AGPAT3;MTMR9;MTMR2;PLEKHA3;PLA2G4C;PTDSS1;CEPT1;PIP4K2C;LPCAT4;PCYT1B;MTMR6;ARF3;ABHD3;PLEKHA4;LPCAT3;PIP5K1B;PIP4K2A;PIK3C2B;CSNK2A1;INPP5K
gsea,peptidyl-serine phosphorylation (GO:0018105),-0.29909869852746707,-1.2074139572644034,0.17996289424860853,0.3264404187281428,1.0,59/59,99.25%,TLK1;PRKCQ;STK4;DYRK1B;TTBK1;SRPK2;CSNK1G3;PRKCD;SMG1;SBK1;TNKS;CDK5R1;AKT3;CSNK1D;MKNK1;MAP3K10;PKN3;VRK2;PKD1;MAPK14;MARK3;PDK3;DMPK;CAMK4;MKNK2;ULK3;SGK3;TGFBR1;GSK3B;RPS6KA2;TOP1;STK38;CSNK1A1;DGKQ;IKBKB;MAP3K12;CSNK2A1;PKN1;PRKX;RPS6KB2;PRKACA;CAB39;UHMK1;CSNK1G2;AKT2;CDK5;PAK2;MAPK1;RPS6KB1;MAP2K2;MARK2;MORC3;PRKCH;RPS6KA4;PKN2;TBK1;TGFBR2;MAPK9;RPS6KA1
gsea,regulation of TORC1 signaling (GO:1903432),0.39599161792915755,1.2005585279103088,0.205761316872428,0.2394539305827299,1.0,8/16,41.06%,LAMTOR5;RRAGC;KPTN;RRAGA;STK11;SIK3;PIP4P1;DGKQ
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.35496229658464135,1.2004055913537124,0.2138364779874214,0.2392372068685767,1.0,9/24,25.23%,CSNK2B;TGFBR2;TBK1;GSK3A;MARK2;MAPK1;CDK5;CDC42BPG;CDC42BPA
gsea,protein O-linked glycosylation (GO:0006493),-0.3495041771727813,-1.200255556019647,0.2134502923976608,0.33322149202962875,1.0,11/23,38.32%,OGT;B3GNT2;GALNT9;CRPPA;LARGE1;ST3GAL2;GALNT11;B3GNT4;B3GNT8;MUC4;TMTC3
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4030218759435827,-1.1964091174618985,0.2367816091954023,0.33523951832744353,1.0,7/16,31.22%,HIF1A;DDX5;NFATC3;TERT;ATOH8;RELA;KLF5
gsea,response to tumor necrosis factor (GO:0034612),-0.3583203708187413,-1.1943460958564818,0.21184510250569477,0.3347337020228192,1.0,23/23,96.19%,RPS3;IGBP1;GGT7;MAP2K7;RELA;MAP4K3;HYAL1;TRIM32;GGT5;NR1D1;TNFRSF11A;IKBKB;CIB1;INPP5K;HYAL3;ADAM10;GGT1;GBA;ZFAND6;ASAH1;TRADD;CASP8;PYCARD
gsea,peptidyl-serine modification (GO:0018209),-0.294862957193025,-1.1917884429949552,0.20555555555555555,0.3351721846085688,1.0,60/60,99.25%,TLK1;PRKCQ;STK4;DYRK1B;TTBK1;SRPK2;CSNK1G3;PRKCD;SMG1;SBK1;TNKS;CDK5R1;AKT3;CSNK1D;MKNK1;MAP3K10;PKN3;VRK2;PKD1;MAPK14;MARK3;PDK3;DMPK;CAMK4;MKNK2;ULK3;SGK3;TGFBR1;GSK3B;RPS6KA2;TOP1;STK38;CSNK1A1;DGKQ;IKBKB;MAP3K12;CSNK2A1;PKN1;PRKX;RPS6KB2;PRKACA;CAB39;UHMK1;CSNK1G2;AKT2;CDK5;GALNT4;PAK2;MAPK1;RPS6KB1;GALNT2;MARK2;MORC3;PRKCH;RPS6KA4;PKN2;TBK1;TGFBR2;MAPK9;RPS6KA1
gsea,peptidyl-threonine modification (GO:0018210),0.3369603463232961,1.191182777265231,0.22708333333333333,0.2487464526953989,1.0,11/27,25.23%,CSNK2B;TGFBR2;TBK1;GSK3A;MARK2;GALNT2;MAPK1;GALNT4;CDK5;CDC42BPG;CDC42BPA
gsea,aminoglycan biosynthetic process (GO:0006023),-0.36989486482137823,-1.1894051585416061,0.2125340599455041,0.3351867078808202,1.0,8/18,33.42%,B3GNT2;EXT1;HS3ST3B1;NDST2;NDST1;B3GNT9;B3GNT4;B3GNT8
gsea,cation transport (GO:0006812),0.37328325916426686,1.1878592221927453,0.22727272727272727,0.25203636159583565,1.0,15/36,38.44%,NDFIP2;PANX1;KCNK6;SLC8B1;TRPM4;SLC36A1;KCNA4;MCOLN1;NDUFA9;KCNH1;SLC4A11;ASIC1;SLC11A2;SLC25A29;SLC1A1
gsea,long-chain fatty acid metabolic process (GO:0001676),0.3889164839055043,1.1841258001252095,0.24745762711864408,0.2557050530929282,1.0,7/20,24.56%,ELOVL1;GSTP1;LTA4H;ACOT8;ACSBG1;PLA2G4C;DAGLB
gsea,negative regulation of growth (GO:0045926),-0.3227959587731153,-1.178291921027787,0.23705179282868527,0.34791471227368853,1.0,33/33,96.36%,BTG1;CDKN1B;VGLL4;FLCN;ING4;CCDC85B;BMPR2;PRDM11;RTN4;SMAD4;ACVR1B;HYAL1;ADAM15;CAPRIN2;CDKN2AIP;NAIF1;DACT3;CRLF3;NDRG3;NDUFS3;APBB2;MUL1;FGFR3;SERTAD3;STK11;PPT1;MINAR1;SERTAD2;TGFB1;PPP2R1A;PPP2CA;SIPA1;NDUFA13
gsea,regulation of secretion by cell (GO:1903530),0.4066021773948977,1.1763580265652411,0.25206611570247933,0.26401578043236884,1.0,7/15,24.87%,RAB8B;RAB8A;DNAJC1;VAMP3;RAB3A;VAMP2;RAB12
gsea,regulation of smoothened signaling pathway (GO:0008589),-0.38305653880043194,-1.1752820511698625,0.25609756097560976,0.3488983846922558,1.0,9/15,35.41%,HERC4;KIF7;SMO;FBXL17;TTC23;IFT122;ARMC9;SUFU;TXNDC15
gsea,myeloid leukocyte differentiation (GO:0002573),0.38090140445177223,1.1721781286915764,0.25,0.26816239773961437,1.0,10/20,47.92%,CDC42;CASP8;TGFBR2;PIR;LGALS9;CEBPA;OSTM1;EFNA2;EP300;TNFRSF11A
gsea,negative regulation of cell cycle process (GO:0010948),0.3846892834119585,1.1704909168798663,0.2755741127348643,0.2697165745345316,1.0,7/16,23.63%,YAF2;CHMP2A;AURKAIP1;VPS4A;UXT;RYBP;TERF1
gsea,fat cell differentiation (GO:0045444),-0.3520235292062198,-1.1682911805249458,0.24946236559139784,0.35531600572296496,1.0,22/22,99.42%,NR4A3;NR4A1;BBS2;FOXO1;FAM120B;OSBPL8;PER2;SENP2;TRIM32;OSBPL11;BBS7;BBS9;ZBTB7A;EP300;HMGA2;IL11;CEBPA;NR4A2;CTBP1;AKT2;BSCL2;PSMB8
gsea,positive regulation of cellular component organization (GO:0051130),0.36985302946155013,1.1680783318580754,0.24224519940915806,0.27206581604085567,1.0,13/29,36.14%,TMEM30A;SH3GLB1;SURF4;TMED9;ANAPC2;TGFB1;GBA;TPPP;FNIP2;CALY;CBLL1;TFR2;TIRAP
gsea,regulation of angiogenesis (GO:0045765),-0.31370432100218487,-1.1680168889681315,0.21068249258160238,0.3524443678244119,1.0,32/32,94.32%,HIF1A;BTG1;KRIT1;CTNNB1;EMILIN1;ATF2;YJEFN3;SEMA3E;RAPGEF3;HYAL1;SYNJ2BP;RRAS;GATA2;SASH1;STIM1;FOXC1;MECP2;HSPB6;HMGA2;ETS1;NOS3;EPHA1;PPP1R16B;PDCD6;MINAR1;HTATIP2;NAXE;AGGF1;EMC10;RNH1;SP100;PDCL3
gsea,regulation of endocytosis (GO:0030100),0.38158663976808005,1.1661092481957027,0.26357827476038337,0.2738320131822206,1.0,12/22,35.49%,RAB5C;AP2S1;RAB4B;MTMR2;SNX12;LRPAP1;RUBCN;SRC;SNX17;CALY;CBLL1;TFR2
gsea,DNA replication (GO:0006260),0.3818937645459213,1.1655765185618503,0.2472885032537961,0.27404325278794406,1.0,10/16,49.53%,RBMS1;PTMS;KIN;RMI1;PNKP;KAT5;NT5M;TOP1;TREX1;ATRIP
gsea,regulation of protein-containing complex assembly (GO:0043254),0.3363094657157021,1.1653886339472372,0.2627450980392157,0.2738473607080583,1.0,14/27,36.14%,CDC42;SH3GLB1;SAR1B;SAR1A;SORL1;TGFB1;GBA;LCMT1;RIOK3;SRC;TPPP;FNIP2;ANKRA2;TIRAP
gsea,DNA repair (GO:0006281),0.2694459303654872,1.1644480547542808,0.1960352422907489,0.27452820098818176,1.0,34/62,44.65%,UBE2V1;RAD21;UBE2A;MAD2L2;CENPX;COMMD1;UBC;GTF2H5;ALKBH3;ACTR5;INIP;NSMCE3;FBXO6;SMUG1;BABAM2;ERCC1;EID3;PARP4;TEX264;XRCC3;UBXN1;CETN2;EYA1;UIMC1;EXD2;CIB1;NABP2;PNKP;RAD51B;HMGA2;KAT5;BABAM1;HUS1B;ACTR8
gsea,regulation of hydrolase activity (GO:0051336),0.3739490597523458,1.1631116903565895,0.24671052631578946,0.27564785917442003,1.0,9/23,27.57%,ITGB1BP1;PAFAH1B1;SCARB2;RALBP1;CHN1;VAV1;FBXW11;ARHGAP9;EPHA1
gsea,negative regulation of protein ubiquitination (GO:0031397),-0.3886298696635393,-1.1628734953300215,0.2569832402234637,0.3565419516209634,1.0,17/17,98.28%,RPS3;OGT;SOX4;HDAC8;PER2;SENP2;CHP1;SQSTM1;SPOPL;UBXN1;SIRT7;USP4;MINAR1;SVBP;N4BP1;VPS28;ARRB2
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.33807424355459825,-1.15167616537305,0.2594594594594595,0.3694722834609004,1.0,26/26,96.62%,RAF1;STK4;AKAP9;CREBL2;NSD1;ARAF;SPTBN4;TENM1;RAPGEF3;CAPRIN2;MLXIPL;PTEN;STOX1;INPP5K;DMD;BRAF;IL11;MTCP1;FNIP2;NCK1;PDE4D;TGFB1;MAD2L2;TBK1;PDCD10;HCLS1
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3788886481526549,1.1488114626730486,0.2880143112701252,0.29195417414630387,1.0,10/19,30.43%,RPS6KA1;DNAJB6;BEX3;LAMTOR5;BCL2L12;PAK2;NOL3;SRC;TRIAP1;RNF34
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3672275022581132,1.1459280035218984,0.2875226039783002,0.2949487618104365,1.0,11/22,37.86%,TGFBR2;UBC;SNX6;FKBP1A;TGFB1;FAM89B;SMURF1;SMAD2;TGFB1I1;IL17RD;CD109
gsea,regulation of calcium ion transport (GO:0051924),-0.38931776365177784,-1.1448815007848703,0.2639225181598063,0.3764395162212541,1.0,5/15,18.84%,SARAF;CD84;CTNNB1;CACNA1D;CAMK2B
gsea,cellular response to peptide hormone stimulus (GO:0071375),-0.3145312700187526,-1.1393783061904035,0.26824034334763946,0.38170737901826457,1.0,32/32,96.77%,NR4A3;NR4A1;INSR;PRKCD;FOXO1;RELA;LPIN3;RAB10;GCK;GPLD1;ADCY9;ADCY5;FER;INPP5K;INSIG2;PRKACA;NR4A2;RAB12;AKT2;VAMP2;SRC;USF1;PRKACB;ADCY7;RAB31;RPS6KB1;SYAP1;ADCY3;PRKAR1A;GSK3A;RAB8A;RAB8B
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3588714053598788,-1.1393759415793419,0.2617924528301887,0.37833639091809196,1.0,20/20,92.24%,TPT1;NPTN;SLC24A3;SLC39A8;DMPK;ATP2B1;STIM1;TMEM165;SLC30A9;TPCN2;SLC30A5;SLC24A1;ATP2A1;VAPB;ATP2C1;GCM2;SLC8B1;LCK;SLC10A7;TMCO1
gsea,double-strand break repair via homologous recombination (GO:0000724),0.3495434820909618,1.135962955140636,0.27171903881700554,0.30652911514962916,1.0,11/24,31.37%,SEM1;RAD21;NSMCE2;SWI5;MORF4L1;SFR1;MEIOB;RMI1;XRCC3;SWSAP1;EXD2
gsea,metal ion transport (GO:0030001),0.3544973307971958,1.133176875344068,0.2844175491679274,0.30950356469507395,1.0,11/28,28.54%,NDFIP2;PANX1;SELENOK;NIPA2;PSEN1;PKD2;CACNG8;ATP2C1;ATP2A1;CHRNB2;CACNG7
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.3663859361477276,1.1293825673328923,0.2848101265822785,0.3136536427554977,1.0,9/21,27.57%,MAPK3;JAK3;ITK;NTRK1;ZAP70;LCK;SRC;FGFR3;EPHA1
gsea,lymphocyte differentiation (GO:0030098),0.35854134239762725,1.1285451322891247,0.29508196721311475,0.3141425894750508,1.0,10/18,27.95%,JAK3;LFNG;CEBPG;ZAP70;LCK;PTPN22;GPS2;PTPN2;DNAJB9;IL11
gsea,RNA 3'-end processing (GO:0031123),-0.3415301309035367,-1.1278309271638693,0.28051001821493626,0.392400064403868,1.0,12/22,34.96%,TUT4;THOC7;SRSF5;WDR33;RPRD2;CLP1;MTPAP;ZC3H11A;LIN28B;FIP1L1;PABPN1;TENT2
gsea,positive regulation of protein binding (GO:0032092),-0.3636762191536865,-1.126850580592223,0.2939958592132505,0.3904773487684581,1.0,17/17,98.89%,RPL11;STK4;TERT;SPPL3;PKD1;MARK3;DACT1;CAPRIN2;LRP1;GSK3B;NMD3;AMFR;DERL1;FKBP1A;PPP2CA;PSEN1;B2M
gsea,positive regulation of phosphorylation (GO:0042327),0.2902636900357751,1.1260310005030731,0.27007299270072993,0.31683209543644103,1.0,26/60,45.04%,SEMA4D;RAC1;MAPK3;ILK;SDCBP;BTBD10;RALBP1;PSEN1;NTRK1;TGFB1;INSRR;LTK;TYRO3;GAPDHS;AKT2;FGFR3;EPHA1;HDAC3;CRKL;AGER;F2;FGF23;NCKAP1L;CIB1;ERBB3;PFKFB2
gsea,establishment of protein localization to plasma membrane (GO:0061951),0.36512211006279877,1.1248279477604373,0.31393298059964725,0.3178842948067244,1.0,12/20,44.90%,GGA1;GOLGA7;SYS1;ARFRP1;RAB31;VAMP2;RILPL1;BLZF1;GOLPH3L;VAMP4;AMN;GOLPH3
gsea,cellular response to light stimulus (GO:0071482),0.3523107855122615,1.123508337267361,0.3071297989031079,0.3190836724459211,1.0,10/21,46.54%,GNB1;N4BP1;COPS9;NSMCE3;OPN1SW;TRIAP1;CASP9;SDE2;YY1;EP300
gsea,positive regulation of neurogenesis (GO:0050769),0.36408951521012994,1.1224211520319773,0.30960264900662254,0.31996019172010126,1.0,8/22,38.84%,RHOA;RGS14;AMIGO1;SMARCD3;MME;FZD3;CDKL5;NUMBL
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3381077760915555,1.1219689497873853,0.30632411067193677,0.32007951292361014,1.0,10/22,47.97%,RBX1;UBC;GTF2H5;ERCC1;PDE12;EXD2;RNASE4;DNASE1L2;DNASE1L1;TREX1
gsea,recombinational repair (GO:0000725),0.3555160242263114,1.1212002330331339,0.30265848670756645,0.32052834716433193,1.0,10/20,31.37%,SEM1;NSMCE2;SWI5;MORF4L1;SFR1;MEIOB;RMI1;XRCC3;SWSAP1;EXD2
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.31292920276613767,1.1197408635440038,0.28499156829679595,0.32192421388966164,1.0,15/37,37.86%,SDCBP;TGFBR2;UBC;ZEB2;SNX6;FKBP1A;TGFB1;FAM89B;STK11;SMURF1;SMAD2;TGFB1I1;CITED1;IL17RD;CD109
gsea,regulation of translational initiation (GO:0006446),-0.32445631029432803,-1.1191831294674912,0.3016157989228007,0.3988597660680025,1.0,13/28,32.48%,PAIP2;EIF3E;EIF3H;ALKBH1;EIF4EBP2;EIF4A2;EIF4EBP3;EIF2B2;CSDE1;EIF1;KHDRBS1;YTHDF3;CTIF
gsea,peptidyl-tyrosine modification (GO:0018212),-0.36220053131821406,-1.1176423888916498,0.3020304568527919,0.3978750352063595,1.0,16/16,91.93%,FYN;TTBK1;INSR;FGFR1;PKDCC;ABL2;ABI1;PTK2;FER;EPHA1;FGFR3;SRC;LCK;ZAP70;NTRK1;JAK3
gsea,Notch signaling pathway (GO:0007219),0.3592057357410794,1.1145600419878072,0.3147482014388489,0.328071581471968,1.0,9/20,36.47%,RBPJ;PSEN1;APH1B;NCSTN;ADAM10;HEY1;APH1A;JAG1;TRAF7
gsea,purine ribonucleotide metabolic process (GO:0009150),0.3657094963974322,1.108725102806876,0.3157894736842105,0.3352621006956117,1.0,7/16,38.32%,ACOT7;CROT;SULT4A1;ACOT8;GTPBP1;ACBD6;GNAI3
gsea,cellular respiration (GO:0045333),-0.35438471319712367,-1.1081387714166762,0.32730560578661844,0.40934872970805547,1.0,10/20,28.75%,NR4A3;UQCRH;SURF1;OXA1L;UQCR10;BLOC1S1;COQ10B;UQCRC2;COQ10A;MTFR1L
gsea,regulation of endothelial cell proliferation (GO:0001936),-0.3589973874299474,-1.1079838996497715,0.3089430894308943,0.40611020738120174,1.0,10/17,38.94%,HIF1A;NR4A1;KRIT1;AKT3;BMPR2;ATOH8;AIMP1;ANG;SYNJ2BP;EGF
gsea,fatty acid oxidation (GO:0019395),-0.3543057786635877,-1.1079609223242781,0.32437275985663083,0.40275869414047377,1.0,11/21,39.29%,ADIPOR2;ACADVL;ACAD10;ACAT1;SCP2;PHYH;ACAA2;ACADS;ECHS1;HSD17B4;PEX13
gsea,positive regulation of developmental process (GO:0051094),0.29398101127582155,1.1060690798803725,0.310126582278481,0.33829630868642646,1.0,16/46,36.96%,RPS6KA1;MAD2L2;RALBP1;PSEN1;SORL1;ANAPC2;CORO1B;MIEF2;MFF;TRPM4;DNM1L;SRC;TLE6;MUL1;MIEF1;PPP1R13L
gsea,response to ionizing radiation (GO:0010212),0.37806154063731967,1.1036004937534583,0.32998324958123953,0.34094978770091117,1.0,8/17,31.32%,GRB2;SWI5;INIP;BABAM2;STK11;TRIM13;EYA1;UIMC1
gsea,positive regulation of kinase activity (GO:0033674),0.33369739884827143,1.0999975488734701,0.3125948406676783,0.34522488782304894,1.0,11/28,32.28%,IQGAP1;LAT;AGAP2;NTRK1;INSRR;LTK;TYRO3;PRKAG1;FGFR3;EPHA1;F2
gsea,regulation of RNA metabolic process (GO:0051252),-0.34849081604010906,-1.0992031419907917,0.3235294117647059,0.4129659863383618,1.0,9/20,19.74%,CLK1;MBNL2;PCBP3;SON;PQBP1;TNFRSF1B;CLK4;PCBP2;HNRNPH2
gsea,visual perception (GO:0007601),0.3678232448032354,1.095754858197308,0.33575581395348836,0.35006797907242976,1.0,12/25,28.24%,UNC119;DNAJC19;EML2;PITPNA;DRAM2;TULP1;CABP1;WFS1;COL18A1;RABGGTA;CHRNB2;CRYBB3
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.33027391157733715,-1.0949039273870875,0.32015065913371,0.416372376945034,1.0,12/23,39.72%,LEF1;TNRC6B;TNRC6C;CTNNB1;MED25;PPM1D;AGO4;RELA;THRA;MED26;MED17;MED15
gsea,Golgi to plasma membrane protein transport (GO:0043001),0.36612406718978263,1.0938195776240882,0.32971014492753625,0.3520975448295274,1.0,12/18,44.90%,GGA1;GOLGA7;SYS1;ARFRP1;RAB31;VAMP2;KRT18;BLZF1;GOLPH3L;VAMP4;AMN;GOLPH3
gsea,positive regulation of inflammatory response (GO:0050729),0.366909606528427,1.090783603298882,0.3134057971014493,0.35564171392194005,1.0,9/16,41.13%,CD47;NMI;TRADD;IFI35;GPSM3;NAPEPLD;CEBPA;ETS1;SNX4
gsea,BMP signaling pathway (GO:0030509),0.39153247258180357,1.0883031312987812,0.3486394557823129,0.3577077186263879,1.0,6/15,29.42%,MAPK3;RUNX2;TGFB1;SMURF1;FAM83G;SMAD2
gsea,cellular response to BMP stimulus (GO:0071773),0.39153247258180357,1.0883031312987812,0.3486394557823129,0.3577077186263879,1.0,6/15,29.42%,MAPK3;RUNX2;TGFB1;SMURF1;FAM83G;SMAD2
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3377237298135108,1.07750161722212,0.36980306345733044,0.3713379189228063,1.0,10/19,31.24%,AGFG1;TPR;SEC13;SLU7;SRSF11;CHTOP;NUP50;CDC40;SMG5;U2AF1L4
gsea,mRNA transport (GO:0051028),0.3377237298135108,1.07750161722212,0.36980306345733044,0.3713379189228063,1.0,10/19,31.24%,AGFG1;TPR;SEC13;SLU7;SRSF11;CHTOP;NUP50;CDC40;SMG5;U2AF1L4
gsea,negative regulation of neuron apoptotic process (GO:0043524),-0.318740821326784,-1.0748847902819727,0.3512658227848101,0.4447164195047317,1.0,21/21,95.35%,HIF1A;MAG;CPEB4;MDK;NRBP2;FGF20;SOD1;ERBB3;FZD9;UNC5B;CRLF1;SIX1;CNTF;CITED1;POU4F1;WFS1;PPT1;TYRO3;NTRK1;SNX6;AGAP2
gsea,water-soluble vitamin metabolic process (GO:0006767),-0.3550028164002118,-1.0697521729718098,0.39592760180995473,0.4493135625487317,1.0,6/16,26.50%,LMBRD1;PANK2;CYB5A;PCCB;GSTO2;TPK1
gsea,negative regulation of cell cycle (GO:0045786),-0.3351724186245635,-1.0692628237043105,0.3904109589041096,0.44644191985120985,1.0,11/21,35.49%,BTG1;CDKN1B;NR4A1;ANGEL2;HECA;HEXIM2;APC;CHMP1A;RNF167;PPP1R13B;CDKN1C
gsea,positive regulation of endothelial cell migration (GO:0010595),0.3498842392621724,1.0630170476530219,0.37320574162679426,0.39150689030452995,1.0,8/21,36.16%,HMGB1;RAC1;ITGB1BP1;EMC10;TGFB1;PDCD6;NOS3;ETS1
gsea,regulation of cell death (GO:0010941),0.31040817979457946,1.0588979809694679,0.3776978417266187,0.3967277139764357,1.0,15/28,32.91%,RAB29;CHMP2A;ATG5;TBK1;BECN1;VPS4B;LRPAP1;PDE12;NCK1;PARP16;CHMP4B;TXNDC12;TRIM13;SNCB;RILPL1
gsea,protein localization to nucleus (GO:0034504),0.30022582241359036,1.0563795590196023,0.3808630393996248,0.39981155788073364,1.0,16/30,37.96%,TOR1AIP1;STAT3;TPR;TOR1AIP2;SEC13;MORC3;CNEP1R1;NUP50;NXT2;RANBP17;SUPT7L;NUP62CL;SPRN;TOPORS;SIX1;PAF1
gsea,activation of GTPase activity (GO:0090630),-0.2854824341394725,-1.0530530064505235,0.3810810810810811,0.46907704816536,1.0,18/32,35.75%,TBC1D10A;TBC1D17;RABGAP1L;PIP5K1A;ARHGAP45;RHOG;TBC1D12;SYDE1;GMIP;TBC1D15;APC2;TIAM2;RALGAPA1;ARHGAP29;RAP1GAP2;RAP1GAP;SIPA1L2;SIPA1L3
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.32246181990702305,1.050516218970926,0.3902439024390244,0.4075260333126298,1.0,11/20,51.10%,HNRNPL;SAP18;TRA2B;PUF60;NSRP1;RBM11;WTAP;RBM4;FAM172A;ZBTB7A;FXR1
gsea,cellular macromolecule catabolic process (GO:0044265),0.3456139952148625,1.0503033996754239,0.3811188811188811,0.40728113609167066,1.0,13/19,45.69%,RNASEH2C;FBXO2;NGLY1;SKIV2L;FBXO6;RAB12;NEU4;UBE2G2;DFFB;MANBA;FBXO27;DNASE1L2;DNASE1L1
gsea,regulation of cilium assembly (GO:1902017),0.29534561606454635,1.049191117614699,0.4078091106290672,0.40834407467101935,1.0,12/26,38.03%,ATG5;ATG3;TBC1D10C;TBC1D9B;TBC1D16;TBC1D2B;RABEP2;ENTR1;TBC1D19;CYLD;TBC1D2;CDKL5
gsea,organic anion transport (GO:0015711),0.35417020377403036,1.0483864357346164,0.3987341772151899,0.40891356005063406,1.0,9/20,32.00%,LRRC8C;MFSD10;SLC35B2;CYB5R4;SLC9A3R1;SLC25A4;SLC35B4;SLC4A11;SLC2A8
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.334414758211824,-1.0415576706478036,0.3710691823899371,0.48434916588514254,1.0,9/15,40.60%,SLC12A8;SLC9A7;SLC39A8;KCNJ13;ATP1B3;SLC5A2;KCNH2;ATP4A;ATP1B2
gsea,regulation of kinase activity (GO:0043549),-0.2914946736320262,-1.0396357199773019,0.40117994100294985,0.4838032290508905,1.0,23/23,89.06%,CDKN1B;INSR;IGF1R;DSTYK;DDR1;FGFR1;TREM2;EPHB6;CDKN1C;NLRC5;SOD1;ERBB3;MAPT;EPHA1;FGFR3;ANKRD54;SLC9A3R1;TYRO3;LTK;NPRL2;INSRR;LDB1;NTRK1
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3065063324919006,-1.038370539535064,0.4042145593869732,0.48215112506000046,1.0,28/28,97.58%,TUT4;DDX6;CNOT6L;CNOT2;PAN3;DCP1B;CNOT4;EDC3;PNLDC1;TUT7;RC3H1;LSM1;DCPS;SAMD4B;WDR61;CNOT8;DCP2;CNOT7;POLR2D;PDE12;CNOT6;CNOT11;SKIV2L;CNOT3;NT5C3B;LSM4;LSM6;LSM5
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.3518091583888816,-1.0373951959430086,0.39357429718875503,0.47997443146444707,1.0,7/15,24.31%,CDKN1B;TTBK1;CDK5R1;CCNI;CDK5RAP3;CCNT2;MNAT1
gsea,protein methylation (GO:0006479),0.350592865195142,1.0373099327344804,0.3980392156862745,0.42443092150864153,1.0,8/16,37.58%,PCMT1;METTL21A;SETD3;LCMT1;RAB6A;VCPKMT;EEF1AKMT1;CAMKMT
gsea,lysosome localization (GO:0032418),-0.35333236700902393,-1.0358483588041487,0.4090056285178236,0.4789225859632993,1.0,17/17,99.35%,NR4A3;KXD1;TMEM106B;FLCN;BLOC1S1;NDEL1;BORCS6;SNAPIN;PIP4P1;SPAG9;HPS6;KLC2;ARL8B;RAB3A;BORCS5;LAMTOR1;S100A13
gsea,RNA export from nucleus (GO:0006405),0.32266633483687973,1.033541957732784,0.41935483870967744,0.42921584652711714,1.0,11/20,31.24%,AGFG1;TPR;SEC13;SLU7;SRSF11;CHTOP;NUP50;NUP62CL;CDC40;SMG5;U2AF1L4
gsea,regulation of telomere maintenance via telomerase (GO:0032210),-0.34122040328744285,-1.0320523372609338,0.42293233082706766,0.48162184131048585,1.0,7/17,33.31%,PRKCQ;TNKS2;CTNNB1;TNKS;FBXO4;MAP2K7;HMBOX1
gsea,B cell activation (GO:0042113),0.34952720610129484,1.0317321187763524,0.430939226519337,0.43127037181840394,1.0,9/15,27.95%,CASP8;JAK3;CEBPG;ZAP70;GPS2;PTPN2;DNAJB9;CHRNB2;IL11
gsea,endosome organization (GO:0007032),0.3465945146409881,1.0229874696708998,0.42125237191650855,0.4431972717710995,1.0,5/15,42.01%,LAMTOR1;SNX3;CHMP2B;RAB22A;SQSTM1
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),0.31042635362023374,1.0136631284723812,0.4220665499124343,0.45663222368266565,1.0,13/24,46.80%,SDCBP;TGFBR2;MAD2L2;PPP2CA;TGFB1;SDHAF2;SMAD2;TGFB1I1;IL17RD;ADIPOR1;HPN;SNAI1;FOXC1
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3308311364561616,1.0131344052071305,0.43506493506493504,0.45677887821063806,1.0,7/16,31.70%,ITGB1BP1;GSTP1;RGS14;SLC9A3R1;PTPN2;PTPRR;DUSP9
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.299637129147149,1.0110197810147936,0.4378585086042065,0.45945005705010444,1.0,13/26,33.46%,STK24;PYCARD;SELENOK;BAG6;STK11;CUL2;POU4F1;FNIP2;ATP2A1;ARL6IP5;CASP9;CASP2;TOPORS
gsea,response to insulin (GO:0032868),0.30680842686804083,1.0068800012209849,0.44876325088339225,0.46503612011625595,1.0,15/25,37.05%,RAB8B;RAB8A;GSK3A;SYAP1;RPS6KB1;RAB31;USF1;VAMP2;AKT2;RAB12;INSIG2;CITED1;ZBTB7B;MEAK7;INPP5K
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3306039656096329,1.001918750859212,0.4566831683168317,0.4719877076473499,1.0,12/33,27.77%,GNAI2;P2RY12;ADCY3;GALR3;ADGRB2;ADCY7;PRKACB;GNAS;GNAQ;GALR2;AVPR2;GNAZ
gsea,defense response to virus (GO:0051607),-0.3418333822990993,-1.0016860931381015,0.4438305709023941,0.5291228803028989,1.0,8/15,27.17%,BNIP3L;PQBP1;IRF2;PTPRC;SERINC5;ZDHHC1;RELA;ZMYND11
gsea,vascular transport (GO:0010232),-0.319390929422661,-1.0010830529846075,0.42333333333333334,0.5222327114309998,1.0,9/16,40.60%,INSR;SLC24A3;SLC2A10;SLC4A3;SLC22A5;SLC27A4;SLC29A2;SLC5A6;ATP1B2
gsea,transport across blood-brain barrier (GO:0150104),-0.319390929422661,-1.0010830529846075,0.42333333333333334,0.5222327114309998,1.0,9/16,40.60%,INSR;SLC24A3;SLC2A10;SLC4A3;SLC22A5;SLC27A4;SLC29A2;SLC5A6;ATP1B2
gsea,histone acetylation (GO:0016573),-0.30856294772573634,-0.9970687619081562,0.47339449541284406,0.5253111777386865,1.0,10/23,26.17%,LEF1;DR1;EPC1;ING4;BRD1;NAA60;ATF2;MSL3;MRGBP;ING3
gsea,import into nucleus (GO:0051170),0.3241033106317251,0.9965410748650386,0.45342706502636204,0.47952720923449743,1.0,11/19,34.09%,STAT3;TPR;SEC13;HTATIP2;GEMIN7;NUP50;NXT2;RANBP17;NUP62CL;SPRN;GEMIN4
gsea,mRNA export from nucleus (GO:0006406),0.2999176572505973,0.9962593121825549,0.4539614561027837,0.4792595695356174,1.0,11/22,31.24%,AGFG1;TPR;SEC13;SLU7;SRSF11;CHTOP;NUP50;POLR2D;CDC40;SMG5;U2AF1L4
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),0.35118425237202405,0.9943893462355636,0.4645390070921986,0.4814144477663568,1.0,9/16,38.81%,STAT3;PYCARD;TICAM1;CUEDC2;ADCY7;MYD88;F2;PLD3;CD6
gsea,glycoprotein metabolic process (GO:0009100),0.3339283792523453,0.9930573200035563,0.47266881028938906,0.4828348950470014,1.0,9/18,26.43%,ERP44;MAN2B1;FBXO2;B4GALT7;NGLY1;FBXO6;MAN1A2;NEU4;ENGASE
gsea,inositol lipid-mediated signaling (GO:0048017),0.372625346252988,0.9925382739287744,0.47303543913713403,0.4829193502762602,1.0,9/15,36.68%,RHOA;NTRK1;RPS6KB1;PLCL2;PLCD4;EXOC1;KCNH1;PLCB3;PIK3C2B
gsea,regulation of proteolysis (GO:0030162),-0.30493934958335506,-0.9884912212750101,0.4763636363636364,0.5359897371693246,1.0,22/22,95.46%,TBC1D10A;OGT;CAPN3;IST1;SPOP;ITCH;TRIM32;LTBP4;BAD;SPOPL;F2;CLN8;CYFIP2;RNF139;FBXW11;CDK5;BAG6;NEDD8;DNAJC1;AURKAIP1;CSTB;CASP8
gsea,glycerophospholipid metabolic process (GO:0006650),-0.2826775053518696,-0.9856369978123781,0.4467005076142132,0.5371161655588013,1.0,25/25,95.84%,ABCA3;PIP5K1A;HDHD5;GPCPD1;PIGP;ENPP6;SERINC5;GDPD1;ABHD12;PNPLA3;LCAT;GPLD1;GDPD3;PLCD1;PIGW;PLCB3;ABHD3;DPM2;PLA2G4C;PIGM;PLA2G15;PIGX;SERINC1;PAFAH1B1;PRDX6
gsea,mitochondrion disassembly (GO:0061726),-0.3005760431797594,-0.9787891935301203,0.5207956600361664,0.5447495888518823,1.0,22/22,94.83%,GABARAPL1;WIPI2;FUNDC1;RB1CC1;WDR45;GABARAP;FIS1;ATG9A;WIPI1;CISD2;FBXO7;ATG12;SQSTM1;MAP1LC3A;MAP1LC3B;FUNDC2;GABARAPL2;WDR45B;BECN1;MARK2;ATG3;ATG5
gsea,positive regulation of lymphocyte proliferation (GO:0050671),-0.3304674506400649,-0.9765072745480909,0.48558758314855877,0.5448264250388688,1.0,16/16,94.70%,CD28;IL18;PTPRC;IL15;IL7;CD46;CD6;TIRAP;NCKAP1L;IL12A;CHRNB2;NCK1;CD3E;SASH3;JAK3;PNP
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3368961237142817,0.9746763885412982,0.49706457925636005,0.5105296712273608,1.0,9/15,44.08%,NDUFA13;TMBIM6;NOL3;SRC;TXNDC12;RTKN2;ARMC10;SNAI1;NDUFS3
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3397823603862364,0.972780238061425,0.4922779922779923,0.5129457302421281,1.0,7/15,31.27%,GSTP1;FOXM1;PTPN22;GPS2;TAOK3;HDAC3;CYLD
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3024153709234433,-0.9726953894254569,0.4830917874396135,0.5473512888374525,1.0,9/19,28.38%,PTPN1;BMPR2;NBL1;EMILIN1;CADM4;SMAD4;DAND5;ACVR2B;ACVR2A
gsea,sensory perception of mechanical stimulus (GO:0050954),0.3448703660044474,0.970253740886953,0.5049365303244006,0.5160808764030828,1.0,8/19,30.82%,WDR1;NDUFB9;EML2;OTOS;WFS1;LHFPL3;CHRNB2;EYA1
gsea,sensory perception of sound (GO:0007605),0.33992320350824007,0.9647197543191479,0.5027855153203342,0.5242425292814072,1.0,8/20,30.82%,WDR1;NDUFB9;EML2;OTOS;WFS1;LHFPL3;CHRNB2;EYA1
gsea,RNA transport (GO:0050658),0.31874017931916787,0.9595157249925106,0.5139146567717996,0.5317315686822554,1.0,8/16,31.24%,TGFBR2;TPR;SLU7;SRSF11;CHTOP;NUP62CL;CDC40;U2AF1L4
gsea,negative regulation of MAPK cascade (GO:0043409),-0.27759733003682435,-0.9578485274526987,0.5374280230326296,0.5695473161963899,1.0,28/28,95.21%,PTPN1;IGBP1;PRKCD;FOXO1;FLCN;PTPRC;EMILIN1;CDK5RAP3;SMAD4;PRDM15;PPEF2;RANBP9;SYNJ2BP;PTEN;DLG1;STK38;INPP5K;DUSP9;PSMD10;PTPRR;PTPN2;SLC9A3R1;GBA;SORL1;FOXM1;RGS14;GSTP1;ITGB1BP1
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.2668168368705187,-0.9577084871269598,0.5,0.5657897452555029,1.0,28/28,95.37%,B3GNT2;B4GALT1;EXT1;GLCE;HS3ST3B1;NDST2;NDST1;B4GALT6;ST3GAL2;B3GNT4;OMD;HYAL1;HAS3;AGRN;GPC2;XYLT2;CSPG5;OGN;EXT2;UGDH;CHST14;B4GALT2;HS3ST6;B4GALT7;B4GALT3;SLC10A7;B3GAT3;CHST12
gsea,fatty acid beta-oxidation (GO:0006635),0.2881042260753331,0.9562313842424249,0.5190156599552572,0.5361902801221917,1.0,9/20,41.87%,AUH;CROT;ACOT8;ETFA;HADHB;PPARD;ECI2;ACOX3;ABCD4
gsea,purine ribonucleotide biosynthetic process (GO:0009152),0.3292390480610701,0.954611659777537,0.5360443622920518,0.5379113222091244,1.0,6/16,21.22%,ACOT7;SLC35B2;ADCY3;ADCY7;NUDT2;SLC25A16
gsea,autophagy of mitochondrion (GO:0000422),-0.2892790588885633,-0.9537954844505204,0.55,0.5686566141552379,1.0,23/23,94.83%,GABARAPL1;WIPI2;FUNDC1;RB1CC1;WDR45;GABARAP;FIS1;ATG9A;ATG13;WIPI1;CISD2;FBXO7;ATG12;SQSTM1;MAP1LC3A;MAP1LC3B;FUNDC2;GABARAPL2;WDR45B;BECN1;MARK2;ATG3;ATG5
gsea,sensory perception of light stimulus (GO:0050953),0.3170578356776673,0.9530019399599596,0.5410557184750733,0.5397724508115385,1.0,12/26,28.24%,UNC119;DNAJC19;EML2;PITPNA;DRAM2;TULP1;CABP1;WFS1;COL18A1;RABGGTA;CHRNB2;CRYBB3
gsea,calcium ion transmembrane transport (GO:0070588),0.283005512067374,0.9425994975890106,0.5481727574750831,0.5555727849284939,1.0,14/27,48.07%,TMCO1;SMDT1;PKD2;FKBP1A;SLC8B1;TRPM4;ITGAV;MCOLN1;ATP2C1;ATP2A1;MAIP1;SLC24A1;MICU1;TMEM165
gsea,fatty acid catabolic process (GO:0009062),-0.26677185366788536,-0.9391973157934811,0.5511669658886894,0.590195001634638,1.0,30/30,97.78%,FAAH;ACADVL;ACAD10;ACAT1;SCP2;PHYH;ACAA2;ACADS;PCCB;ECHS1;LPIN3;HSD17B4;SLC27A4;PEX13;EHHADH;NUDT7;HADHA;ILVBL;ABCD4;MMAA;ACBD5;ABHD3;ECI2;ABHD2;PPARD;HADHB;ACOT8;PLA2G15;CROT;AUH
gsea,cellular amino acid catabolic process (GO:0009063),-0.29556619641594956,-0.9385291324588021,0.4979166666666667,0.5874091898677065,1.0,11/17,31.77%,ACAT1;ALDH6A1;GLUD1;HMGCL;KYAT1;PRODH;DAO;ECHS1;SLC25A44;HDC;ALDH5A1
gsea,fatty acid metabolic process (GO:0006631),0.27780307368147583,0.938170473369537,0.5266903914590747,0.5619482231931234,1.0,13/26,50.73%,ACOT7;CROT;PLA2G15;ACOT8;ACSBG1;PPARD;GGT1;ADIPOR1;ACBD5;GPX4;ACOT11;GPAM;AASDH
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.27568538431531864,0.929143139132243,0.5688073394495413,0.5758331149951466,1.0,11/27,37.21%,CASP8;TRADD;GSK3A;TGFB1;ITGAV;FGFR3;DEDD;CASP9;IL12A;CASP2;CIB1
gsea,positive regulation of synaptic transmission (GO:0050806),-0.30303027441524266,-0.924334416772754,0.5669856459330144,0.6082837693269347,1.0,15/15,92.12%,NPTN;DLG4;NLGN3;GRIN2D;MPP2;SQSTM1;SLC24A1;RIMS3;AGER;DTNBP1;CACNG7;VAMP2;ZDHHC3;CACNG8;RGS14
gsea,glycosaminoglycan metabolic process (GO:0030203),-0.3010609890084074,-0.9163984298319698,0.6,0.6183804777632869,1.0,9/18,34.30%,EXT1;SGSH;HS3ST3B1;NDST2;NDST1;FUCA1;B3GAT2;GLB1;IDUA
gsea,chemical homeostasis (GO:0048878),-0.28597272510488037,-0.9107974595775125,0.6099071207430341,0.6240254528820852,1.0,9/18,36.40%,ABHD8;USF2;NEDD4L;NR1D2;PNPLA3;SLC4A3;TREM2;AQP11;RBP1
gsea,glycosaminoglycan catabolic process (GO:0006027),0.32819494917250924,0.9041444723364653,0.6022187004754358,0.6163787170650159,1.0,7/16,33.08%,HEXB;TGFB1;STAB2;OGN;IDS;HYAL3;CSPG5
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.26347475677337223,0.9023188366724387,0.6209048361934477,0.6185875981648481,1.0,16/33,49.62%,JAK3;STAP1;NTRK1;ZAP70;LCK;INSRR;LTK;TYRO3;CD3E;SRC;FGFR3;EPHA1;SHC4;ERBB3;FRS2;FER
gsea,bicellular tight junction assembly (GO:0070830),0.32626969409859174,0.8935292702316555,0.5910493827160493,0.6323144376921899,1.0,10/15,49.72%,PDCD6IP;PAK2;TBCD;F11R;CRB3;GRHL2;CLDN7;CLDN23;PARD6B;DLG1
gsea,histone H3 acetylation (GO:0043966),-0.30100297613403393,-0.8896892469598854,0.6182495344506518,0.6563438154510742,1.0,15/15,98.76%,LEF1;DR1;ING4;BRD1;NAA60;PHF14;TAF5L;TRIM16;MBIP;SUPT7L;MEAF6;TADA1;LDB1;TAF12;TAF10
gsea,regulation of defense response (GO:0031347),0.28778433894076777,0.885106867337279,0.62248322147651,0.6456800390236617,1.0,10/21,36.14%,CASP8;N4BP1;PTPN22;MYD88;GGT1;BRD4;RNF135;DAGLB;CYLD;TIRAP
gsea,negative regulation of supramolecular fiber organization (GO:1902904),-0.258093339734523,-0.883289178261156,0.6337662337662338,0.6630103081199117,1.0,23/23,96.45%,PFDN5;ATXN7;PRKCD;EMILIN1;CHADL;SMAD4;SSH3;APC;APC2;TREM2;PFDN1;CAMSAP3;TUBB4A;SPEF1;CIB1;KANK3;ARPIN;TBCD;TWF1;PFDN2;TWF2;EML2;MAPRE1
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.26267988677894233,-0.8824805800011076,0.6224489795918368,0.6600259992883468,1.0,12/24,35.49%,CDKN1B;MAPRE3;CDK5R1;HEXIM2;CCNY;CCNI;CDK5RAP3;CCNT2;APC;PKD1;MNAT1;CDKN1C
gsea,tight junction assembly (GO:0120192),0.3162516932594729,0.8792720290251481,0.6289808917197452,0.6545491313802988,1.0,11/16,49.72%,PDCD6IP;PAK2;TBCD;F11R;CLDN12;CRB3;GRHL2;CLDN7;CLDN23;PARD6B;DLG1
gsea,regulation of neuron apoptotic process (GO:0043523),0.2694491937901555,0.8777396131314035,0.6594827586206896,0.6560792244488206,1.0,20/31,44.06%,AGAP2;SNX6;NTRK1;TYRO3;NSMF;PPT1;WFS1;CDK5;POU4F1;EGLN2;TRIM2;CITED1;CNTF;SIX1;CRLF1;UNC5B;FZD9;KCNB1;TFAP2A;ERBB3
gsea,sodium ion transport (GO:0006814),-0.28007374737681295,-0.8727353541386372,0.6321070234113713,0.6720608057964788,1.0,9/16,42.56%,SLC6A19;SLC24A3;HCN3;NEDD4L;SCN3B;ATP1B3;SLC5A2;SLC5A6;SLC38A7
gsea,calcium ion transport (GO:0006816),0.2596533648463559,0.8705726347303501,0.6707317073170732,0.6665526782321867,1.0,20/33,45.00%,PANX1;SELENOK;TMCO1;PSEN1;PKD2;FKBP1A;CACNG8;TRPM4;ITGAV;MCOLN1;ATP2C1;ATP2A1;CHRNB2;CACNG7;CACNA1I;ORAI3;SLC24A1;CRACR2B;NMUR1;MICU1
gsea,sodium ion transmembrane transport (GO:0035725),-0.267092248977039,-0.865384650644613,0.7098039215686275,0.6799137576854851,1.0,17/17,89.76%,SLC6A19;SLC9A7;SLC24A3;HCN3;SCN3B;ATP1B3;SLC5A2;ATP4A;ATP1B2;SLC9A5;SLC6A8;SLC24A1;ASIC1;SLC9A6;TRPM4;HCN2;PKD2
gsea,mRNA 3'-end processing (GO:0031124),0.24509045757898532,0.8523719777636332,0.6840909090909091,0.6949745577114783,1.0,11/24,39.78%,NUDT21;SSU72;SLU7;SRSF11;CHTOP;POLR2D;CDC40;PAPOLA;U2AF1L4;PAF1;POLDIP3
gsea,anion transmembrane transport (GO:0098656),0.26948980034696535,0.8492098188256775,0.6804511278195489,0.6992406388844539,1.0,12/19,46.05%,LRRC8C;SLC25A11;SLC25A12;SLC25A4;SLC35B4;ARL6IP5;MFSD12;SLC25A29;SLC1A1;SLC35A2;LRRC8A;SLC6A8
gsea,gland development (GO:0048732),0.30457831561207394,0.8420740433459665,0.6940418679549114,0.7097163182830716,1.0,6/15,36.86%,PKD2;CEBPG;SLC9A3R1;GCM2;CEBPA;SIX1
gsea,phospholipid dephosphorylation (GO:0046839),0.2767304925876043,0.8275420776769765,0.7175572519083969,0.7316294848459551,1.0,10/17,40.83%,PIP4P2;MTMR9;MTMR2;MTMR6;MTMR11;MTMR10;INPP5K;PIP4P1;EPHX2;PLPP6
gsea,inorganic cation transmembrane transport (GO:0098662),0.23075295295354512,0.8259201665554081,0.768170426065163,0.7331173354746983,1.0,31/64,42.87%,TMCO1;UCP2;ATP6V1A;PKD2;FKBP1A;KCNK6;ATP6V0D1;UCP3;HCN2;TRPM4;ITGAV;SLC36A1;KCNA4;ATP6V1H;MCOLN1;ATP2C1;ATP2A1;SLC9A6;KCNA7;SLC46A1;TMEM175;KCNH1;SLC4A11;RHD;ASIC1;SLC11A2;KCNG3;SLC24A1;SLC30A5;HPN;KCNB1
gsea,sulfur compound catabolic process (GO:0044273),-0.26922522774584756,-0.8006777306524826,0.7345360824742269,0.7787915880722395,1.0,16/16,92.96%,MPST;ACAT1;GGT7;OMD;GLB1;IDUA;HYAL1;GGT5;NUDT7;TST;CSPG5;IDS;OGN;GGT1;FITM2;HEXB
gsea,potassium ion transmembrane transport (GO:0071805),-0.21155379327654592,-0.7821602223368856,0.8709677419354839,0.8010226457887561,1.0,31/31,89.76%,SLC12A8;KCNA3;SLC9A7;SLC24A3;HCN3;KCNK12;KCNJ13;ATP1B3;KCNK3;KCNH2;KCNH4;ATP4A;ATP1B2;KCNIP2;KCND1;KCNC3;SLC9A5;KCNAB3;KCNB1;HPN;SLC24A1;KCNG3;KCNH1;TMEM175;KCNA7;SLC9A6;SLC12A9;KCNA4;HCN2;KCNK6;PKD2
gsea,glycoprotein biosynthetic process (GO:0009101),-0.23253575066080034,-0.7781001161397282,0.8185185185185185,0.8017384493176144,1.0,22/22,95.37%,B3GNT2;BMPR2;CANT1;LARGE1;ST3GAL2;B3GNT9;B3GNT4;B3GNT8;DAD1;B3GALT2;GOLPH3;MGAT1;ATP7A;GAL3ST4;FUT10;B3GALT1;ST6GALNAC2;ALG1;PMM2;B4GALT7;ALG5;CHST12
gsea,determination of left/right symmetry (GO:0007368),-0.24664801503902684,-0.7590143091381114,0.815625,0.8227471983728557,1.0,8/15,32.38%,RFX3;SMO;GALNT11;DNAAF4;ENKUR;DAND5;DNAH11;NPHP3
gsea,neurotransmitter transport (GO:0006836),0.2532859596073664,0.7526656957311738,0.812199036918138,0.8379070726398336,1.0,12/20,47.28%,STXBP2;RAB3A;VAMP2;SLC17A7;NRXN2;LIN7C;DNAJC5;SLC1A1;TSPOAP1;SLC28A2;SLC29A4;CASK
gsea,organic acid transport (GO:0015849),0.2473690591763461,0.7023403307225383,0.8642335766423358,0.8937172978641692,1.0,10/19,46.98%,SLC25A11;SLC36A1;PPARD;SLC7A4;SLC46A1;ABCC3;SLC25A29;SLC26A6;SLC22A13;SLC7A7
gsea,potassium ion transport (GO:0006813),0.21597802961239335,0.6441490601852169,0.925,0.9412925241472678,1.0,12/28,42.87%,PKD2;KCNK6;HCN2;KCNA4;SLC9A6;KCNA7;TMEM175;KCNH1;KCNG3;SLC24A1;HPN;KCNB1
